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Abstract 
Pseudomonas aeruginosa is a highly adaptable bacterium that thrives in a broad range of 
ecological niches. In addition, it can infect hosts as diverse as plants, nematodes, and 
mammals. In humans, it is an important opportunistic pathogen in compromised individuals, 
such as patients with cystic fibrosis, severe burns, or impaired immunity. P. aeruginosa is 
difficult to control because of its ability to develop resistance, often multiple, to all current 
classes of clinical antibiotics. The discovery of novel essential genes or pathways that have not 
yet been targeted by clinical antibiotics can underlie the development of alternative effective 
antibacterials to overcome existing mechanisms of resistance. 
The main focus of my PhD thesis was the discovery of novel essential genes of P. aeruginosa 
by shotgun antisense screening. Our antisense screenings identified 33 growth-impairing 
single-locus genomic inserts that allowed us to generate a list of 27 “essential-for-growth” 
genes: among them 15 were “novel” essential genes with no homologs reported to have an 
essential role in other bacterial species. Interestingly, the essential genes in our panel were 
suggested to take part in a broader range of cellular functions than those currently targeted 
by extant antibiotics. Our study also identified 43 growth-impairing inserts carrying multiple 
loci targeting 105 genes. Taken together, our results show the feasibility of antisense 
technology in P. aeruginosa for identifying novel essential genes and we expect that our 
methodology could be well suited for antisense-mediated searches of essential genes in other 
Gram-negative bacterial species. These results were presented in publication 1 (PART II). 
Then, we focused on two loci, PA2873 and P0580, found in our antisense screenings in PAO1.  
The PA2873 gene product was annotated as a hypothetical membrane protein endowed with 
a periplasmic region harboring a structural domain belonging to the transglutaminase-like 
superfamily, a group of archaeal, bacterial, and eukaryotic proteins homologous to animal 
transglutaminases. We show that the periplasmic portion of the PA2873 protein, which we 
named TgpA, does possess transglutaminase activity in vitro. This is the first report of 
transglutaminase activity in P. aeruginosa. In addition, we have provided strong evidence that 
TgpA plays a critical role in the viability of P. aeruginosa. The results on TgpA were presented 
in publication 2 (PART II). 
The PA0580 locus encodes the protein Gcp belonging to the Kae1/Qri7/YgjD family. 
Combining several genetic approaches, we showed that Gcp is essential for P. aeruginosa. In 
addition, we focused on the product of PA3685 locus, the YeaZ protein, a putative partner of 
1
Gcp. We obtained evidence that YeaZ also plays a critical role in P. aeruginosa viability. A 
manuscript describing the results on Gcp is in preparation and presented in PART III. 
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PART I 
3
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1. Pseudomonas aeruginosa
Pseudomonas aeruginosa is a motile, non-fermenting, Gram-negative organism belonging to 
the Pseudomonadaceae family that has the ability to thrive in a broad range of ecological 
niches. It is found in diverse habitats, including soil, water, plants, and animals (Rahme et al., 
2000), and can infect multiple hosts (Mahajan-Miklos et al., 2000). 
P. aeruginosa is both capable of a wide variety of acute, severe, invasive diseases and also - 
evading immune defenses - persistent human infections (Kerr and Snelling, 2009). Serious P. 
aeruginosa infections are often nosocomial and associated with compromised host defenses 
such as severe burns, urinary tract infections, AIDS (Manfredi et al., 2000), lung cancer, 
chronic obstructive pulmonary disease, and cystic fibrosis (CF)(Valderrey et al., 2010). 
Figure 1. Scanning electron microscopy images of P. aeruginosa isolates attaching to glass surfaces. 
The extreme versatility and adaptability encoded in its genome are the key features that make 
P. aeruginosa a very challenging opportunistic pathogen. As of January 2014, 48 strains of P. 
aeruginosa from both clinical and environmental sources have been fully or partly sequenced 
according to Pseudomonas Genome Database (PGD). Compared with most other pathogenic 
bacteria, P. aeruginosa has a relatively large genome, ranging from 6.22 to 6.91 Mb (Silby et 
al., 2011) arranged as a combination of conserved regions spaced by regions of genomic 
plasticity that contain genes unique to each strain. 
P. aeruginosa is famously metabolically versatile and has been isolated from numerous 
nutrient-poor settings to the extent that it is able to survive even in distilled water. 
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Despite its optimum temperature for growth being 37°C, it is able to tolerate temperatures as 
high as 50°C and is capable of growing under both aerobic as well as anaerobic conditions, 
using preferentially nitrate as a terminal electron acceptor (Schreiber et al., 2007). 
Even more striking than its metabolic diversity is the huge number of regulatory genes 
encoded by P. aeruginosa (Stover et al., 2000): nearly 10% of its genome, about 520 genes, is 
predicted to encode regulatory proteins. Bacteria that can adapt in diversified environments 
have a larger proportion of their genomes dedicated to regulatory genes than ones that are 
specialized to survive in a specific environment (Goodman and Lory, 2004). In P. aeruginosa 
many of these regulatory genes belong to the two-component class systems, which allow the 
bacterium to rapidly adapt to an environmental change (Alm et al., 2006). 
Nevertheless, over a decade after P. aeruginosa PAO1 strain was sequenced (Stover et al., 
2000), it was possible to assign a functional class to only 57% of its open reading frames 
(ORFs): out of these, 12% have functions experimentally demonstrated in P. aeruginosa; 8% is 
highly similar to a gene experimentally demonstrated in another organism; and 37% are 
homology-based bioinformatics predictions. Thus 43% of predicted ORFs contained genes for 
which no function could be assigned or predicted. 
A large portion of its genome is involved in the expression of an impressive arsenal of 
virulence factors (Feinbaum et al., 2012) which explains the wide range of infections caused 
by the bacterium. A summary of virulence factors is illustrated in Figure 2 and Chapter 2. 
Figure 2. Summary of virulence factors produced by P. aeruginosa. Flagella and Type IV pili are the main adhesins, along with 
LPS, which are also highly inflammatory. Once contact with the host has occurred, the T3SS can be activated and starts to 
inject cytotoxins directly into the cells. Several virulence factors are secreted and proteases expressed. Pyocyanin can 
interfere with host cell electron transport pathways and redox cycling. Pyoverdine captures Fe3+ to allow for a competitive 
edge in an environment in which free iron is scarce. Adapted from Gellatly & Hancock, 2013. 
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2. Virulence factors of P. aeruginosa
Virulence factors include pili and flagella, which play a critical role in motility and adhesion to 
the epithelium as well as elastase, alkaline protease, the endotoxin lipopolysaccharide (LPS), 
and four effector proteins already identified: exotoxin A, exoenzyme S (ExoS), exoenzyme U 
(ExoU), exoenzyme T (ExoT), exoenzyme Y (ExoY). 
All these factors together are thought to be crucial for maximum virulence of P. aeruginosa. 
However, based on several studies in diverse animal models, the relative contribution of any 
given factor may vary with the type of infection (Mahajan-Miklos et al., 2000).  
2.1 Lipopolysaccharide 
Lipopolysaccharide is a complex glycolipid that constitutes the main component of the outer 
membrane of Gram-negative bacteria and plays a crucial role in antigenicity, inflammatory 
response, exclusion of external molecules, and in mediating interactions with antibiotics (King 
et al., 2009). The molecule produced by P. aeruginosa is a typical Gram-negative bacterial LPS 
consisting of three different regions: the membrane-anchored lipid A, the polysaccharide core 
region, and a highly variable O-specific polysaccharide (O-antigen or O-polysaccharide). 
While the structure of the inner core is rather preset (two D- manno -2-keto- octulosonic acid 
residues and two L- glycero -D- manno -heptose residues), significant variability can be 
detected in both the Lipid A moiety and in the O-antigen (Figure 3). 
The lipid A domain is diglucosamine biphosphate backbone with O- and N-linked primary and 
secondary fatty acids that anchors the LPS in the bacterial outer membrane. The main 
structural differences are observed in the number, the position, the nature of the linked acyl 
groups, and the modification or type of substituent of the phosphate groups (Lam et al., 2011). 
Many lipid A modifications are regulated and can be induced as a response to an 
environmental change or during CF infection (Ernst et al., 2007; Cigana et al., 2009): among 
them, it is worth mentioning the altered bacterium’s susceptibility to polymyxins and cationic 
antimicrobial peptides (Gutu et al., 2013) as well as changes in its inflammatory properties 
(Ernst et al., 2003).  
Moreover, 85% of outer core molecules are uncapped (they also lack the terminal core 
rhamnose molecule) while 15% is capped by a variable number of repeated saccharide (O-
antigen) units of 3–5 sugars with defined linkage.  
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Figure 3. Representations of the heterogeneity of the LPS glycoforms present on the surface of P. aeruginosa. From Lam et al. 
2011.
Two different types of O-antigen have been characterized: A-band LPS is a homopolymer of D-
rhamnose which elicits a weak antibody response; B-band LPS is a heteropolymer with three 
to five distinct sugars in its repeat units with a strong antibody response and is the chemical 
basis for serotyping (Knirel et al., 2006). Some isolates, lacking the O-antigen, have a “rough” 
colony morphology compared to the smooth isolates producing it, while others, identified as 
“semi-rough”, substitute the lipid A and core with only one O-saccharide unit (Knirel et al., 
2001). The O-antigen is a major target for protective immunity as evidenced by numerous 
animal studies, and LPS relative amounts can change in a given strain dependant on the 
growth conditions affecting its pathogenicity (Ernst et al., 1999). 
Significantly, many reports indicate that over time chronic P. aeruginosa isolates change the 
type of LPS expressed, from the more antigenic B-band to the A-band: most likely this switch 
is driven by selective pressure to evade host adaptive immune responses (King et al., 2009). A 
number of LPS vaccines have been investigated for use especially in CF patients and, although 
they have reached phase II and III clinical trials, these have not been successful (Jones et al., 
1979, 1980; Langford and Hiller, 1984; Cryz et al., 1997; Erridge et al., 2002). Despite these 
extensive efforts over more than 30 years, realization of clinically applicable LPS-based 
vaccines remains elusive, providing little immunity and not showing protection against 
infection with P. aeruginosa (Pier, 2003; Sharma et al., 2011). 
8
2.2 Flagella and Type IV pili 
P. aeruginosa typically possesses a single unsheathed polar flagellum and several much 
shorter Type IV pili also localized at a cell pole. Through a rotating corkscrew motion, the 
flagellum contributes to the swimming motility in an aqueous environment and, on semi-solid 
media, provides swarming motility. Its movement is typically described as straight-line 
swimming interspersed with tumbles, in which flagella rotation is transiently reversed and 
motility is arrested in order to reorient itself (Köhler et al., 2000; Yeung et al., 2009). 
However, its contribution in virulence goes beyond mere motility, since several different 
flagellar proteins have been reported to play critical roles in attachment, invasion, biofilm 
formation, and in the mediation of inflammatory responses (Toutain et al., 2007; Parker and 
Prince, 2013). Non-flagellated mutants are a very representative portion of the isolates from 
chronic infections in CF patients: loss of these appendages is considered to be an event 
involved in the evasion of the host immune system (Wolfgang et al., 2004), as described 
before for the switch in LPS nature. In fact, it has been demonstrated that flagellin - the 
structural protein forming the major portion of flagellar filaments - mediates the 
inflammatory response interacting specifically with a leucine-rich region of host Toll-like 
receptor 5 (Verma et al., 2005) and causing production and release of proinflammatory 
cytokines that recruit neutrophils to the infected region (Hayashi et al., 2001; Smith et al., 
2003). 
In an era of increasing drug resistance, immunotherapy is a desirable treatment against P. 
aeruginosa infections: flagellar vaccines have been investigated in pre-clinical studies in 
mouse models. However, limited protection was observed with a monovalent vaccine and 
future development of a bivalent vaccine has been terminated (Döring and Pier, 2008; 
Campodónico et al., 2010). 
Regarding the Type IV pili, they are, without doubt, the most important adhesins of P. 
aeruginosa with a fundamental role in phenomena such as tissue tropism, initiation of biofilm 
formation (Barken et al., 2008), and non-opsonic phagocytosis (Heale et al., 2001). From the 
cell pole, they extend and retract like hooks to pull the cell along solid surfaces in a process 
called “twitching motility” (Kipnis et al., 2006) and can also lead to aggregation, causing the 
bacteria to form microcolonies on target tissues (Sriramulu et al., 2005). Like flagella, pili are 
targets of antipseudomonal therapy, including immunization; however, these attempts are 
frustrated by the extreme antigenic variability of pili across different strains (Giltner et al., 
2012). 
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2.3 Type III Secretion 
P. aeruginosa has a variety of secretion systems, of which at least four most probably play a 
role in virulence (Type I, II, III, and VI): in particularl, Type III (T3SS) is evolutionarily 
connected with the flagellar system, although it is not clear which developed first (Saier, 
2004). The T3SS is a complex macromolecular machinery, encoded by 36 genes on five 
operons, spanning the inner bacterial membrane, the periplasmic space, the peptidoglycan 
layer, the outer bacterial membrane, the extracellular space, and, finally reaching the host cell 
membrane (Figure 4). 
This secretion apparatus is able to deliver effector proteins from the bacterium directly into 
the host cell through a pore formed in the membrane. Despite extensive characterization by a 
number of laboratories, so far only four effector toxins have been identified - ExoY, ExoS, 
ExoT, ExoU - a number that is much lower compared to other bacterial pathogens, such as 
Salmonella (≈13) or Shigella (≈ 25) (Hauser, 2009). While all P. aeruginosa strains encode the 
T3SS, most strains do not carry a complete set of effector-encoding genes (Feltman et al., 
2001): nearly all express one of the two major exotoxins exoU or exoS, but very rarely both 
(Shaver and Hauser, 2004). 
Figure 4. P. aeruginosa Type III secretion. a. Thirty-six genes, encoded in five clustered operons, are involved in the T3SS. b. 
T3SS can be functionally divided into five components: the needle complex, the translocation apparatus, the regulatory 
proteins, the effector proteins, and the chaperones. These five parts work together to inject effector proteins into host cells in 
a highly regulated manner. From Hauser 2009. 
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ExoS and ExoT are bifunctional cytotoxins, including both N-terminal GTPase-activating 
protein and C-terminal ADP ribosyltransferase activities. These molecules display a number of 
adverse effects on the host cell, including cell death, actin cytoskeletal disruption, inhibition of 
DNA synthesis, vesicular trafficking, and endocytosis (Pederson and Barbieri, 1998; Barbieri 
et al., 2001; Würtele et al., 2001).  
Perhaps the most crucial activity is the one connected with irreversible disruption of the 
cytoskeletal structure: indeed, a substantial reduction in cell-cell adherence facilitates P. 
aeruginosa penetration through epithelial barriers and the spread of infection (Shaver and 
Hauser, 2004). ExoU is a potent - 100 times more than ExoS - phospholipase capable of 
causing rapid cell death in eukaryotic cells due to loss of plasma membrane integrity 
consistent with necrosis (Finck-Barbançon et al., 1997; Sato and Frank, 2004). ExoY is an 
adenylate cyclase that, when injected into mammalian cells, results in an elevation of 
intracellular cAMP concentration leading to differential expression of multiple genes and 
eventually disruption of the actin cytoskeleton (Cowell et al., 2005) and increased endothelial 
permeability (Sayner et al., 2004).  
2.4 Proteases 
Several proteases are synthesized and secreted by P. aeruginosa. These enzymes cooperate to 
dismantle host tissue, playing a critical role in both acute lung infections (Ingmer and 
Brøndsted, 2009) and in ocular infections (Hobden JA., 2002).  
Alkaline protease (AprA) is a type 1 secreted zinc protease that degrades several components 
of the host immune system and host fibronectin (Hong and Ghebrehiwet, 1992). In addition, it 
assists P. aeruginosa to screw-on the immune response by degrading free flagellin and so 
preventing Toll-Like receptor 5 activation (Bardoel et al., 2011). 
LasA and LasB are two elastases that are regulated by the lasI quorum-sensing system and 
secreted via Type II secretion apparatus (de Kievit and Iglewski, 2000). LasA, also known as 
staphylolysin, is a 20 kDa serine protease able to cleave the pentaglycine bonds in the 
peptidoglycan of Staphylococcus aureus (Vessillier et al., 2001). It possesses only a small 
fraction of the elastolytic abilities of LasB and rather is thought to enhance its partner’s 
proteolytic activity (Matsumoto, 2004). On the contrary, it has been observed that LasB is 
capable of degrading a number of connective tissue proteins, including elastin, fibrin, and 
collagen (Hamdaoui et al., 1987; Miyajima et al., 2001).  
Although their role in chronic infection is still not well understood, they clearly play a 
fundamental role in interference with host defense mechanisms (Alhede et al., 2014). 
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2.5 Quorum Sensing 
Quorum-sensing (QS) represents a form of cell-cell communication based on small diffusible 
molecules called autoinducers - since one of their effects is to enhance their own synthesis - 
that allow bacteria to coordinate gene expression in a cell population density dependent 
manner (Miller and Bassler, 2001; Bassler, 2002).  
The number of autoinducer molecules in the medium is proportional to the concentration of 
bacteria so, when a critical number of bacteria (i.e. “quorum”) is reached, the concentration of 
autoinducers triggers the activation of specified downstream genes which affects the entire 
bacterial population (Vasil, 2003).
This cell-density response has evolved as a means to provide advantages to a group of cells, 
such as improving access to environmental niches or enhancing their defense capabilities 
against other microorganisms or eukaryotic host-defense mechanisms (Ng and Bassler, 
2009). In Gram-negative bacteria, the most common signal molecule used is an acyl 
homoserine lactone (AHL) molecule, which was first described in the marine bioluminescent 
bacterium Vibrio fischeri (Ruby, 1996).
In P. aeruginosa, QS consists of two separate but interrelated systems, las and rhl (Gambello 
and Iglewski, 1991; Ochsner et al., 1994) that regulate - via three autoinducers - a wide range 
of cellular processes, such as biofilm formation, swarming motility, and a broad array of 
virulence factors (Venturi, 2006).  
Two of these autoinducers are AHL molecules: the Las system is comprised of the 
transcriptional regulator LasR and its cognate AHL signal 3-oxo-dodecanoyl homoserine 
lactone (3-oxo-C12-HSL), while the Rhl system is constituted of RhlR together with its partner 
N-butyryl-L-homoserine lactone (C4-HSL). 
Importantly, the Las and Rhl systems are not interchangeable, meaning that the C4-HSL 
molecule cannot activate LasR and also the opposite, namely that 3-oxo-C12-HSL cannot 
activate RhlR (Pearson et al., 1995, 1997). 
P. aeruginosa produces a third signaling molecule, 2-heptyl-3-hydroxy-4(1H)-quinolone, 
named Pseudomonas Quinolone Signal (PQS), which requires the presence of biosurfactant to 
increase its solubility and hence its bioactivity as a signal molecule (Calfee et al., 2005).  
This molecule is synthesized by a complex multistep process involving two operons 
(pqsABCDE and phnAB), and three genes apart, pqsR, pqsH, and pqsL (Deep et al., 2011; Heeb 
et al., 2011). 
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These systems are intertwined in a hierarchical manner, auto-regulated and intimately 
connected forming a complicated regulatory cascade (Schuster and Greenberg, 2006; 
Williams and Cámara, 2009). 
Novel QS systems are continually being discovered so that the challenge is not just to 
elucidate the chemical identity of the QS signal molecules but to understand why certain 
bacteria prefer one particular chemical class over another and how different systems 
cooperate in gene regulation. An extremely simplified view of the matter requires that the Las 
system is at the top of the hierarchy regulating both Rhl and the production of quinolones at 
either transcriptional or posttranslational levels.  
Different independent studies have shown that as many as 10% of genes and more than 20% 
of the expressed bacterial proteome are regulated by QS systems (Schuster et al., 2003; 
Wagner et al., 2003; Deep et al., 2011), in particular those associated with the virulence itself 
(Table 1). 
Factor References 
AHLs (Seed et al., 1995) 
Alkaline protease (Gambello et al., 1993; Latifi et al., 1995) 
Catalase (Hassett et al., 1999) 
Elastase (Toder et al., 1994) 
Exotoxin A (Gambello et al., 1993) 
Hydrogen cyanide (Pessi and Haas, 2000) 
Lectins (Winzer et al., 2000) 
Pyocyanin (Brint and Ohman, 1995; Latifi et al., 1995) 
Rhamnolipid (Ochsner and Reiser, 1995; Pearson et al., 1997) 
Secretion proteins (Chapon-Hervé et al., 1997) 
Superoxide dismutase (Hassett et al., 1999) 
Table 1. Known quorum-sensing-regulated virulence factors in P. aeruginosa. 
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2.6 Biofilm 
Biofilms are complex organized structures of bacteria attached to one another and to a surface 
(Kolter and Greenberg, 2006), and their formation is intricately linked to QS (Bjarnsholt et al., 
2010). 
These highly organized structures are characterized by extracellular polymeric substances 
(EPS), composed of polysaccharides, nucleic acids, lipids, and proteins (O’Toole et al., 2000). 
EPS, the major component of biofilm volume (about 50 to 90%), is designed in order to 
maintain its architecture and functions as glue, holding the biofilm community together and 
protecting it from the environmental forces counterproductive to breaking it down (Stoodley 
et al., 2002). In addition, by forming such a multicellular aggregate, cells are deeply protected 
from penetration of toxic chemicals (e.g., antibiotics, host defense molecules) and can also 
escape, or at least significantly slow down, the process of phagocytosis by mammalian host 
(Hall-Stoodley and Stoodley, 2009). 
Furthermore, it has been reported that bacteria within the biofilm differ substantially with 
respect to their planktonic form, mainly regarding their transcriptional profile: indeed, more 
than 25% of the PAO1 genome was differentially expressed in the biofilm’s condition (Waite 
et al., 2005, 2006). The transition of P. aeruginosa from the motile to the aggregate state in 
biofilms is a complex multistep process (Figure 5) that involves a multitude of physiological 
changes (O’Toole et al., 2000). The first phase is an initial reversible adhesion to the surface, 
which is mostly controlled by physiochemical properties such as Van der Waals interactions, 
electrical charge, and hydrophobicity (Jucker et al., 1996). In the presence of opportune 
conditions, adhesion, mediated by Type IV pili, flagella, and the more recently discovered Cup 
fimbria (Mikkelsen et al., 2011), become irreversible and cells start to duplicate forming a 
monolayer called microcolony. After this irreversible attachment, microcolonies multiply and, 
producing the EPS matrix, a mature bioflim could develop. Three different 
polysaccharidesalginate, Pel, and Psl - are synthesized by P. aeruginosa EPS, with various 
relevance and relative percentages according to different strains, environmental conditions, 
and the age of the biofilm (Harmsen et al., 2010). 
Alginate is an acetylated polysaccharide composed of non-repetitive monomers of β-1,4-
linked L-guluronic and D-mannuronic acids (Govan and Deretic, 1996) overproduced by 
mucoid strains often isolated from the lungs of patients with CF (Høiby et al., 2010). Its 
predicted role is to protect the bacterial community from the host response. In addition, 
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alginate-overproducing strain have been identified as more resistant to the antibiotic 
tobramycin (Hentzer et al., 2001): this anionic polysaccharide acts as a physical barrier for 
antibiotics because, if the alginate matrix is disrupted by an alginate lyase treatment, the 
strain becomes significantly more sensitive to the aminoglycosides (Hatch and Schiller, 1998). 
The glucose-rich Pel polysaccharide, encoded by the pel cluster, is produced by most strains, 
while the mannose-rich Psl polysaccharide is not fully encoded in all strains (López et al., 
2010). These two polysaccharides mainly mediate cell-to-surface and cell-to-cell interactions, 
which are essential for P. aeruginosa biofilm formation and maintenance (Ma et al., 2006, 
2009). 
As the microcolony develops, the EPS forms and encloses the biofilm in a mushroom-shaped 
structure that is crossed with specifically designed channels allowing the exchange of waste 
products and nutrients to the deep rooted cells (Ryder et al., 2007; Kaplan, 2010). 
Figure 5. Schematic representation of biofilm maturation model. Stage 1, initial attachment; stage 2, irreversible attachment; 
stage 3, maturation I; stage 4, maturation II; stage 5, dispersion. Each stage of development in the diagram is paired with a 
photomicrograph of a developing P. aeruginosa biofilm. From Monroe 2007. 
In the last step of its life cycle, the biofilm undergoes a structural fragmentation with the 
release and dispersal of cells through the environment, where they are able to adhere to 
another surface, renewing the cycle. Although this process can be influenced by mechanical 
events, biofilm detachment and desegregation is a cell-driven process carried out in response 
to different environmental signals, such as nutrient reduction (Gjermansen et al., 2010) or the 
accumulation of oxygen and nitrogen reactive species (Barraud et al., 2006; Nijland et al., 
2010).
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3. Mechanisms of resistance of P. aeruginosa
All known mechanisms of antibiotic resistance can be displayed by this bacterium (intrinsic, 
acquired, and adaptive), sometimes all within the same isolate (Table 2). 
Table 2. Example of resistance mechanisms in P. aeruginosa. From Gellatly & Hancock, 2013. 
P. aeruginosa exhibits intrinsic resistance to almost all of the available antibiotics (Bonomo 
and Szabo, 2006; Lister et al., 2009). One of the major factors contributing to this intrinsic 
resistance is the low permeability of its outer membrane that plays a critical role in defining 
small molecules rate of uptake, and so antibiotics (Hancock, 1998).  
Low outer membrane permeability works in collaboration with multidrug efflux whereby the 
slow uptake of antibiotics is countered by rapid efflux. The P. aeruginosa genome contains a 
large number of drug efflux systems belonging to Resistance-Nodulation-Division (RND) and 
major facilitator superfamily (MFS) types (Livermore, 2001).  
These two intrinsic elements work in concert with chromosomally encoded AmpC β-
lactamases to degrade many β-lactam antibiotics. β-lactamases are hydrolyzing enzymes that 
are able to cleave the lactam ring, leading to inactivation of the antibiotic (Livermore, 1995).  
All these mechanisms act synergistically, defining the really high intrinsic resistance exhibited 
by P. aeruginosa to reduce active intracellular levels of many antibiotics (Nikaido, 2001). In 
addition, the most recent evidence supports the idea of a larger resistome with more than 100 
genes that, when mutated, lead to altered susceptibility to several antibiotics (Schurek et al., 
2008). 
On the another hand, the acquired resistance could be the consequence of the genetic transfer 
and expression of a resistance cassette or it may be the result of mutations in targets or in the 
genes, including regulators, which stabilize or enhance intrinsic resistance mechanisms. 
(Breidenstein et al., 2011). DNA elements, such as plasmids, transposons, integrons, 
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prophages, and resistance islands, can harbor antibiotic resistance genes and can be obtained 
by conjugation, transformation, or transduction.  
This can increase antibiotic resistance and, if plasmids contain multiple resistance cassettes, 
even multidrug resistance. These acquired elements can also reinforce the intrinsic resistance 
of P. aeruginosa: overexpression of a second β-lactamase can increase resistance to certain 
antibiotics or widen the range of β-lactams that can be resisted (Bagge et al., 2002).  
A second form of acquired resistance is due to a mutation event in a regulatory gene that 
causes de-regulation of a preexistent resistance mechanism like those leading to 
overexpression of efflux pumps, reduced uptake of antibiotics, hyperproduction of β-
lactamases, and altered antibiotic targets. For example, a point mutation in the suppressor 
mexZ leads to the overexpression of the MexXY efflux pump (Matsuo et al., 2004); or a 
mutation in DNA gyrase reduces the binding affinity for fluoroquinolones leading to 
resistance (Schweizer, 2003); or an overexpression of β-lactamases occurs upon regulatory 
mutations especially in ampC repressor gene ampD (Langaee et al., 1998). 
Finally, significant differences in in vitro susceptibility determinations and time-kill studies 
for P. aeruginosa isolates and treatment results in CF patients have been reported and can be 
assigned to a phenomenon called “adaptive resistance” (Gilleland et al., 1989; Barclay et al., 
1996). Adaptive resistance has been observed in vitro and in vivo for P. aeruginosa and other 
Gram-negative and it is defined as reduced antimicrobial killing in bacterial cultures pre-
exposed to a certain agent (Karlowsky, Zelenitsky, & Zhanel, 1997). It is a form of inducible 
resistance that does not necessarily involve mutations and its best characterized mechanisms 
overlay with acquired ones, and may indeed foreshadow the development of mutational 
resistance. In P. aeruginosa a well-known mechanism causes resistance to cationic 
antimicrobial peptides: under specific conditions (limiting Mg2+, exposure to peptides, and 
polymyxins), a large number of sensor kinases upregulate the expression of the arnBCADTEF-
udg operon, which drives the addition of amino-arabinose to lipid A (McPhee et al., 2003, 
2006). This modification, lowering the negative charge of lipopolysaccharide, reduces the 
interactions of these cationic peptides with the outer membrane in a transient manner since 
susceptibility is restored when inducing conditions are removed. 
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4. P. aeruginosa infections
Hospital-acquired (nosocomial) infections can be defined as those occurring within 48 hours 
of hospital admission, 3 days of discharge, or 30 days of an operation. They affect 1 in 10 
patients admitted to hospital and annually result in more than 5000 deaths (Inweregbu, 
2005). P. aeruginosa infections are typically of the late onset category, often presenting more 
than 5 days after admission. 
As stated in the 2009–2010 report by the National Healthcare Safety Network (NHSN), P. 
aeruginosa is the 5th most common healthcare associated pathogen causing 12% of catheter-
associated urinary tract infections, 4% of central line–associated bloodstream infections, 17% 
of ventilator-associated pneumonia (VAP) and 6% of surgical site infections (Sievert et al., 
2012). 
From these numbers it is easy to understand how P. aeruginosa is the second most common 
pathogen causing respiratory infections in hospitalized patients and also amongst the most 
lethal, since reports suggest up to 70–80% mortality when confined to the lungs (Hunter, 
2006). 
Infections of the respiratory tract are often grouped into two types: acute or chronic. Acute 
hospital infections are generally the effect of direct trauma, such as damage to the epithelium 
due to intubation or smoke inhalation. On the other hand, chronic ones affect primarily 
patients with weak or non-effective immune response, such as in the elderly or individuals 
with CF. 
4.1 Acute lung infections 
P. aeruginosa rarely infects the human lung without an underlying defect in immunity or 
mechanical barrier (Williams et al., 2010).  
As mentioned before, patients with VAP often suffer from a breached epithelium induced by 
the insertion of the endotracheal tube, which, as a plastic surface, may serve as a cover and 
reservoir for P. aeruginosa growth as biofilms (Schaber et al., 2007).  
These structures are extremely difficult to eradicate and, as biofilm-associated bacteria, P. 
aeruginosa exhibit even more resistance to all classes of antibiotics and disinfectants: for this 
reason, antibiotic treatments undertaken before the biofilm has developed are the most 
effective (Brooun et al., 2000). 
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Acute lung infections also occur in all those nosocomial categories who are not able to develop 
an adequate immune response, such as elderly people, patients with neutropenia due to 
cancer chemotherapy, or immunocompromised people due to organ transplant (Williams et 
al., 2010). Nosocomial infections are also of high incidence because immune deficient patients 
are frequently hospitalized and therefore exposed to Pseudomonas reservoirs in the 
healthcare setting. 
4.2 Chronic lung infections and cystic fibrosis 
P. aeruginosa, if not eradicated during the acute infection phase, can adapt to the lung 
environment, resulting in a chronic infection. Currently there is no universally accepted 
deﬁnition of chronic P. aeruginosa infection (Pressler et al., 2011): those most used are based 
on microbiological results from sputum cultures. 
Nevertheless, chronic infection can be described as an infection that persists in spite of 
therapy, and in spite of the host’s immune and inﬂammatory response. The most well-known 
cases of chronic pseudomonal lung infections are those borne by CF patients. 
CF is an autosomal, recessive, multi-organ disorder affecting 1:2,500 in the Caucasian 
population (Ratjen and Döring, 2003). It is caused by the presence of one of more than 1,500 
possible mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene; 
these mutations lead to the malfunction or loss-of-function of CFTR, a cAMP-regulated 
chloride ion channel, resulting in defective chloride ion transport across epithelial cell 
surfaces (Boucher, 2004).  
These abnormalities lead to a thick and dehydrated mucus secretion that impairs mucociliary 
clearance of bacterial pathogens (Collins, 1992), which can therefore more easily colonize the 
airways and cause an initial acute infection and vigorous inflammatory response, including 
polymorphonuclear leukocytes and antibodies (Høiby et al., 2005). The hyperactive 
inflammatory response causes the progressive destruction of lung function and ultimately 
death. 
Improvements in clinical care have resulted in a dramatic increase in the life expectancy of CF 
patients over the last 40 years, if one considers that, in 1974, the international median age at 
death was 8 years while nowadays, in several European countries, it is between 30 and 40 
years (Cystic Fibrosis Foundation Patient Registry 2012 Annual Data Report). 
The microbial flora of the airways of CF patients emblematize a really complex and 
heterogeneous ecosystem in which multispecies communities coexist (Harrison, 2007). Most 
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studies of CF pathogens have focused on four major bacterial species: P. aeruginosa, 
Haemophilus influenzae, Staphylococcus aureus, and Burkholderia cepacia complex species 
group. The prevalence of these species in the airways does not remain unchanged over time; 
on the contrary, it undergoes significant modifications, as illustrated in Figure 6. 
Figure 6. Progression of P. aeruginosa infections in patients with CF. Prevalence of several common human respiratory 
pathogens in patients with cystic fibrosis as a function of age. P. aeruginosa is the most frequently found pathogen in adults. 
P. aeruginosa airways colonization frequently occurs after initial establishment by S. aureus; it 
then replaces the other bacterium becoming the predominant one in the CF lung. By the age of 
25, approximately 70% of patients with CF are infected in the respiratory tract; however, the 
specific mode of colonization is still unknown. Generally the initial colonizing strains are 
unique environmental isolates (Burns et al., 2001), although epidemic isolates are also known 
(Salunkhe et al., 2005). Chronic airway infection with P. aeruginosa is usually preceded by a 
period of recurrent, intermittent colonization of the airway, as schematized in Figure 7. 
Figure 7. Schematic representation of the progression of P. aeruginosa infection. Different colors represent phylogenetically 
independent P. aeruginosa clones. From Folkesson et al., 2012. 
At later times CF patients are reinfected with different P. aeruginosa strains, but about 25% of 
cases are re-colonizations with the same genotype (Munck et al., 2001).  
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This intermittent colonization phase should last for several years, but will inevitably 
transform into a chronic infection characterized by a high bacterial load that ultimately 
triggers a prolonged inflammatory response. This protracted and higher degree of 
inflammation causes the variety of symptoms (e.g., cough, sputum production, damage to the 
epithelial layer, loss of lung function, and breathing problems) accompanying CF chronic 
infections and leads to respiratory distress and eventual failure and death (Lee et al., 2003). 
Figure 8. Blue circles=mucus layer; yellow squares=airway epithelial cells. For oxygen gradient: red=no gradient; blue=steep, 
hypoxic gradient. Because of blocked chloride secretion, excessive sodium absorption and water absorption, normal 
mucociliary clearance (A) is defective in cystic fibrosis (B). Mucus secretion leads to plug formation (C). Steep hypoxic 
gradients (blue bar) are sensed by penetrating bacteria (D) leading to increased alginate (E) and macrocolony formation (F). 
Neutrophil functions are impaired by anoxic conditions and macrocolonies (F). From Ratjen & Döring, 2003.
During the process of infection, P. aeruginosa undergoes a number of adaptations to highly 
stressful conditions leading to its characteristic persistence and antibiotic resistance (Figure 
8). One of the most striking features of P. aeruginosa adaptation to the airways of CF patients 
is the conversion to mucoid phenotype due to overexpression of extracellular polysaccharide 
alginate (Govan and Deretic, 1996). Indeed, while the environmental isolates involved in the 
initial colonization usually present a non-mucoid phenotype, as the bacterium penetrates the 
thickened mucus of the airways, travelling down the oxygen gradient, it increases its 
expression of alginate and switches to a mucoid phenotype coincidently with the 
establishment of chronic infection (Starner, 2005).  
The mucoid form of P. aeruginosa is associated with 90% of P. aeruginosa CF infections 
compared to only 2% of P. aeruginosa non-CF infections (Pritt et al., 2007). 
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Alginate production seems to be part of the general envelope stress response of several 
bacterial species, protecting them from adverse environmental stresses. During CF lung 
colonization, this extracellular polysaccharide preserves P. aeruginosa from the consequences 
of inflammation by inhibiting part of the innate immune response activation and decreasing 
phagocytosis by neutrophils and macrophages (Meshulam et al., 1984; Leid et al., 2005). 
In general, as the process of infection progresses, a fundamental transition in the gene 
expression profile occurs in P. aeruginosa strain. This switch is mainly governed by the algU 
regulon, which is activated under stress conditions and leads to a coordinated 
downregulation of central metabolism, motility, and virulence (Aspedon et al., 2006), and a 
simultaneous upregulation of genes affecting membrane permeability, efflux and, as 
mentioned before, alginate production (Jones et al., 2010)(Figure 9).  
Figure 9. The function of the RNA polymerase σ-factor σ22 (encoded by algU) and pathway upregulated and downregulated 
in response. Adapted from Folkesson et al. 2012.
Not surprisingly, similar divergences in gene expression are observed when comparing early-
colonizing CF-associated strains with chronical ones (Yang et al., 2011). 
It is therefore evident that chronic colonization and infection with P. aeruginosa is an 
inevitable reality for the majority of adults with CF and, unfortunately, resistance to all 
clinically relevant classes of antibiotics is routinely exhibited by P. aeruginosa isolates (Lister 
et al., 2009). 
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5. P. aeruginosa as a Superbug
The simultaneous occurrence of multiple resistance mechanisms in the clinical isolates of P. 
aeruginosa has resulted in strains that are multidrug resistant (MDR). MDR bacterium is 
defined as non-susceptible to one or more antimicrobials in three or more antimicrobial 
classes, while strains that are non-susceptible to all antimicrobials are classified as extreme 
drug-resistant strains (Kallen and Srinivasan, 2010). This utmost resistance, together with 
demonstrated high morbidity and mortality infections, has led P. aeruginosa to be considered 
one of the most challenging superbugs (Boyle et al., 2012). 
As stated by the NHSN, focused on nosocomial infections in intensive care units, not only were 
resistance rates increasing, so was the incidence of occurrence in most infection types 
(Gaynes and Edwards, 2005). 
Figure 10. Percentage (%) of invasive isolates with combined resistance (resistance to three or more antimicrobial classes 
among piperacillin (±tazobactam), ceftazidime, fluoroquinolones, aminoglycosidesand carbapenems). From Antimicrobial 
Resistance Surveillance in Europe of 2012.  
According to Antimicrobial Resistance Surveillance in Europe of 2012 
(http://www.ecdc.europa.eu) high percentages of resistance in P. aeruginosa isolates were 
reported, with almost all the countries showing percentages above 10% for all antimicrobial 
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groups under surveillance. In particular, 37.7% of the isolates were resistant to one or more 
of the five considered antimicrobial classes, while 16.3% were resistant to at least three 
antimicrobial groups and 6% of the isolates were resistant to all five antimicrobial classes 
(piperacillin, ceftazidime, fluoroquinolones, aminoglycosides, and carbapenems). Trends for 
the period 2009–2012 were calculated for 23 countries and significant increases were 
observed for four countries (Austria, Ireland, Portugal, and Sweden) and slight increases for 
another 12 (Figure 10).  
Nowadays, colistin, and polymyxin B are increasingly used as the last-line therapeutic options 
for treatment of infections caused by MDR P. aeruginosa (Li et al., 2006), and, while resistance 
rates remain low, mortality of 80% has been observed for infections caused by colistin 
resistant Gram-negative bacilli (Beno et al., 2006). 
It is easy to observe how these kinds of numbers associated with extreme difficulties in the 
treatment of such infections, and high rates of morbidity and mortality, have made 
Pseudomonas one of the most dangerous and challenging hospital pathogens. 
However, despite this alarming scenario, since the new millennium only three new classes of 
antibiotics have been introduced to the market for human use (Figure 11). 
Figure 11. Number and functional classes of approved antibiotics during the last 30 years. 
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6. The crucial role of antibiotics
To fight bacterial infections, in the past 90 years, various classes of antimicrobial drugs have 
been developed following two parallel and independent lines of discovery. One approach has 
been the identiﬁcation of small-molecule natural products with an observed antibacterial 
activity. Among these, the most famous and well-known examples are penicillins and 
cephalosporins, the glycopeptides like vancomycin, and the aminoglycosides (Clardy et al., 
2009).  
The other approach is represented by the discovery that “man-made” molecules had antibiotic 
activity: this is the case of the aromatic sulfa scaffolds originally from the chemical dyes 
industry or the ﬂuoroquinolones (Blondeau, 2004). 
Figure 12. Timeline showing the “Golden Age” of antibiotics and of antibiotic medicinal chemistry. No new structural classes 
of antibiotics were introduced between 1962 and 2000. From Walsh & Wencewicz, 2013. 
The so called “Golden Age” of discovery of natural antibiotics was actually a short two decades 
(Figure 12), between 1940 and 1960, when one-half of the drugs commonly used today were 
discovered. From the 1960s to the 1970s, the rise of antibiotic resistance, especially in the 
hospital environment, led to a frantic search for new active compounds, but unfortunately 
screening programs mostly rediscovered existing antibiotics (Lewis, 2013).  
So pharmaceutical companies developed new antibiotics by improving the existing ones 
through chemical modifications, tailoring on the periphery of major antibiotic classes, while 
leaving the core intact (Bérdy, 2005). This approach obviously involved less risk as the target, 
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selectivity, and toxicity of the starting antibiotic backbone had already been defined 
(Fernandes, 2006). 
Despite the short-term effectiveness of 
this strategy, resistances against new 
versions of old-fashioned antibiotics 
quickly arise (Table 3). 
Simultaneously, the lack of success from 
natural compound screening led 
companies to redirect their efforts to 
small-molecule chemical libraries, 
obtaining, also in this case, a very poor 
return of new antibacterial agents. 
Thus, the development of brand new 
molecules with antibiotic effects must be 
a priority in microbiological research.  
    Table 3. Evolution of resistance to clinical antibiotics. 
    Adapted from Walsh & Wencewicz, 2013. 
6.1 Antibiotics in current use target a small number of cellular functions 
Historically, the treatment of human bacterial infections by antibiotics targets a surprisingly 
small number of vital cellular functions: cell wall, DNA, RNA, folate and protein biosynthesis 
(Lewis, 2013)(Figure 13). 
As pictured in Figure 13, β-lactams and vancomcyin-type glycopeptides are among the classes 
of antibiotics that interfere with specific steps in homeostatic cell wall biosynthesis. Their 
successful treatments result in changes to cell shape and size, induce cellular stress responses, 
and culminate in cell lysis (Tomasz, 1979; Barclay et al., 1996). 
A second category comprises the blockade of DNA replication, most notably targeting DNA-
topoisomerase complexes by the synthetic quinolone class of antimicrobials, including the 
clinically relevant fluoroquinolone. These molecules interfere with the maintenance of 
chromosomal topology by hitting DNA gyrase and topoisomerase IV, trapping these enzymes 
at the DNA cleavage stage and preventing strand rejoining (Drlica et al., 2008). 
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Figure 13. The five major clinically validated antibacterial targets/pathways. Adapted from Walsh & Wencewicz, 2013. 
The inhibition of RNA synthesis is due to the action of the rifamycin class of semi-synthetic 
bactericidal antibiotics. These drugs inhibit DNA-dependent transcription by stable binding, 
with high affinity, to the subunit encoded by the rpoB gene and blocking RNA polymerase 
enzyme (Floss and Yu, 2005). 
Regarding protein synthesis is one of the targets more explored by antibiotics which can 
inhibit, although with different degrees of specificity, virtually every step of the translation. In 
fact, there are more than 50 molecules targeting the small and large ribosomal subunits and 
the interface between them (Wilson, 2009). 
The last category of antimicrobials targets the folate biosynthetic pathway, responsible for the 
de novo synthesis of thymidine and other key cellular components. Folate analogs and sulfa 
derivate drugs, mostly used in combination, block two sequential steps in that biosynthetic 
pathway (Lange et al., 2007). 
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7. Looking for novel essential genes as antimicrobial targets
Thus, there is absolutely no doubt about the utmost need to develop new antibacterial agents 
to combat the growing problem of antibiotic-resistant bacteria: targeting of novel essential 
pathways will likely play an important role in the discovery of these new molecules (Gerdes et 
al., 2002). In fact, a number of crucial cellular pathways, such as secretion, cell division, and 
many other metabolic functions, remains uncharacterized and untargeted up to today 
(Kohanski et al., 2010). Obviously, the most accurate knowledge possible of related biological 
processes in bacterial pathogens eases the choice of the target, thus the essential function 
expressed, which is one of the key moments in the long and expensive process of drug 
development. 
In recent years, high-throughput automated genomic DNA sequencing, together with 
improvement in bioinformatic analysis, has provided plenty of information to help in the 
search for new targets to the extent that, in many cases, entire biochemical pathways can be 
reconstructed and compared (Zhang and Lin, 2009; Deng et al., 2011). Considering the matter 
from a different angle, the need to identify novel antibacterial targets has been one of the 
major drivers in the development of techniques designed to determine gene essentiality, 
recently concerning mainly the bioinformatic area (Duffield et al., 2010; Cooper and Duffield, 
2011; Cheng et al., 2013; Wei et al., 2013). Although the genome sequences of approximately 
2700 bacteria have already been released in public databases (Pagani et al., 2012; Huang et 
al., 2014), the function of a large fraction of these bacterial genes is still unknown, as 
mentioned in Chapter 1, as regards, for example, P. aeruginosa. Furthermore, although 
important, many processes and pathways are not ubiquitous and, in most cases, are only 
shared by a subset of bacterial strains that are not well characterized (Jordan et al., 2002). It is 
therefore evident that understanding and modeling the complexity of a living organism 
require global elucidation of gene function as well as the identification of the essential genes 
(de Berardinis et al., 2008). An essential gene is defined as one whose loss is lethal under a 
certain environmental condition (Xu et al., 2011) but, regarding laboratory conditions where 
this essentiality is assessed, it typically refers to the ability to grow on solid media and form a 
colony in different experimental requirements (Fang et al., 2005). Finally, the identification of 
essential genes plays a primary role not only in the research of potential targets for 
antimicrobial drug development but also in unraveling the minimal gene set for living 
organisms (Koonin, 2003; Gil et al., 2004; Glass et al., 2006) and deciphering bacterial 
relationships during evolution (Liao et al., 2006; Koonin, 2009). 
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7.1 Transposon mutagenesis based screenings 
One powerful procedure for the detection of gene essentiality is based on transposon 
mutagenesis (TM). Transposons are discrete pieces of DNA that can move - transpose - from 
one location in a genome to another: hundreds of transposons have been identified, allowing a 
very large number of possible genetic tools to become available (Muñoz-López and García-
Pérez, 2010). The simplest transposon is pictured in Figure 14 as a segment of DNA flanked by 
sequences recognized by a protein, transposase, which enables its movement. 
Figure 14. Transposon structure. The transposon ends are defined by two short inverted repeat sequences (open triangles). 
By supplying the transposase exogenously, the transposon can be simplified as an experimental tool. In this case, the terminal 
transposase recognition sequences bracket DNA that contains the desired sequences. For example, the transposon can be 
constructed to contain an appropriate antibiotic resistance gene, outward-facing T7 promoters, and a loxP site. 
There are two different mechanisms by which transposition occurs: the first is cut-and-paste 
transposition (e.g., Tn5 and Tn10) (Reznikoff, 2008), in which the transposon is precisely 
excised from its original location in the donor DNA and is then inserted into a target sequence. 
The second is replicative transposition (e.g., Tn3, and Mu) by one or both enzymes of 
transposase and resolvase, leaving one copy on the target DNA or two copies on both donor 
and target DNA respectively (Ton-Hoang et al., 2010). 
Although the recognition sequence for some transposons is not clear or has not yet been fully 
determined, in general transposon-based gene integration does not require homologous 
sequences for transfer to the chromosome, and the genomic position to which a transposon 
can move depends only on the sequence recognized and cleaved by the enzyme (Choi and 
Kim, 2009). TM results in disruption of the region of the genome where the transposon has 
inserted. Failure to isolate such a knockout mutation in a particular ORF is taken as 
presumptive evidence that the targeted gene is essential in the tested growth conditions.  
With TM there are two opposite approaches for identifying essential genes of the bacterial 
chromosome (Figure 15): 
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 the so called “negative” approach, which determines many ORFs as non-essential and
assumes that non-inserted genome stretches are essential;
 the “positive” approach, which identifies genes that are essential by generating growth-
conditional mutants and showing that they have a lethal phenotype.
Figure 15. A) Negative approach to identify essential bacterial genes: the whole bacterial chromosome is the target for 
transposon mutagenesis generating a huge number of viable insertions subsequently analyzed and sequenced. This method 
requires many insertions to be sequenced before statistically significant conclusions can be drawn. B) Positive approach: 
transposon contains an outward-facing inducible promoter at one edge. Strains generated by such an insertion are dependent 
on the inducer for viability. The insertional junction is sequenced, allowing the identification of the downstream essential 
gene. Adapted from Judson & Mekalanos, 2000. 
However, such large-scale systematic analysis of gene essentiality cannot be accomplished 
without unbiased and accurate annotations generating both false positives and negatives 
(Deng et al., 2013). Indeed, even if saturation is reached, it is unavoidable that some genes, 
particularly the shorter ones, may circumvent the insertion and be wrongly annotated as 
essential (Gerdes et al., 2003; Gallagher et al., 2007). On the other hand, false negative errors 
in which essential genes are determined as non-essential may take place if the insertion 
occurs at gene ends and does not fully inactivate the function (Akerley et al., 2002; Glass et al., 
2006). 
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Table 4. Advantages and disadvantages of transposon-based approaches to identify essential bacterial genes. Adapted from 
Judson & Mekalanos, 2000. 
Some inconveniences of the “negative” TM approach were overcome by using the “positive” 
one described above. However, conditional TM can also be affected by systematic biases, 
deriving, for example, from transposon tools endowed with outward-facing promoters that 
are not strictly regulated in non-inducing conditions, resulting in a basal level of promoter 
expression (Table 4). Different approaches have been used for the transposon mutagenesis of 
P. aeruginosa (Jacobs et al., 2003; Lewenza et al., 2005). In the former, a library of 30,100 
unique transposon insertions was generated using Tn5 IS50L; in the latter, an insertion 
library of 34,000 mutants was developed using a mariner-based transposon. Both of these 
libraries represent multiple insertions into non-essential genes.
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7.2 Single-gene knockout mutant collection 
The availability of complete genome sequences has permitted the construction of large-scale 
collections of mutants and a comprehensive understanding of organisms at the molecular 
level. Indeed, an alternative strategy to TM has been represented by directed approaches such 
as the complete gene deletion method already effectively used for Saccharomyces cerevisiae 
(Giaever et al., 2002), Acinetobacter baylyi (de Berardinis et al., 2008), Bacillus subtilis 
(Kobayashi et al., 2003), E. coli (Gerdes et al., 2003; Baba et al., 2006), and Streptococcus 
sanguinis (Xu et al., 2011). 
A single-gene deleted mutant collection should provide a fundamental tool for “reverse 
genetics” approaches, permitting analysis of the consequences of the complete loss of gene 
function, in contrast to forward genetics approaches, in which mutant phenotypes are 
associated with the corresponding genes.  
The approach used for systematic gene deletion is based on homology directed recombination 
with linear fragments generated by PCR containing a resistance cassette, in most cases 
kanamycin, flanked, in some cases, by FLP recognition target (FRT) site and at least 50 bp 
homologous to adjacent chromosomal sequences.  
To avoid polar effect on the downstream gene, the targeting PCR products were designed to 
create, after excision of the resistance cassette with the FLP recombinase, in-frame deletions 
of the 2nd through the 7th codon from the C-terminus, leaving the ORF start codon and 
translational signal intact. Regarding overlapping genes by more than 9 nt, fortunately they 
are only a small portion of the genome (e.g., E. coli) and so a small number of primers were 
specifically re-designed to avoid altering two genes simultaneously (Baba et al., 2008). 
Furthermore, the antibiotic cassette used lacked a promoter to prevent potential 
dysregulation of downstream genes, which could affect subsequent mutant library results.  
As previously mentioned, the availability of a large number of sequenced and properly 
annotated genomes (Brent, 2005) allows highly accurate primers to be designed. The length 
of homologous sequences to the adjacent upstream or downstream flanking regions varies 
depending on the species studied: in E.coli 50 bp are sufficient (Baba et al., 2006) while in A. 
baylyi (de Berardinis et al., 2008) at least 300 bp are needed; on the other hand, in S. sanguinis 
long flanking sequences (approximately 1 kb) are required to ensure an efficient homologous 
recombination (Xu et al., 2011). 
32
Figure 16 Schematic representation of the single-gene deletion mutants approach. Primers P1 to P6 are used for integration 
cassette construction while P7, P8, S1, and S2 for verifications. The kanR integration cassette is obtained by PCR amplification 
using P1 and P2 primers on plasmid template. The flanking regions, specific for the target gene, are amplified on wild-type 
DNA template by P3/P4 primers (R1 region) and P5/P6 primers (R2 region). The primers P7 and P8 are used for external 
PCR verification of the correct replacement of the targeted gene by the integrative cassette. The primers S1 and S2 located 
within the kanR cassette are used to sequence junctions of the cassette on the P7/P8 PCR product. Structures created after 
excision of the resistance gene are verified by PCR with neighboring gene-specific primers and by direct DNA sequencing of 
the region encompassed as described by Datsenko and Wanner, 2000.  
The PCR products, obtained after three different step reactions, were re-amplified to generate 
the auspicated linear fragments. These were usually digested with proper restriction enzyme 
and ethanol-precipitated to purify them from contaminating the template plasmid DNA (used 
for resistance cassette amplification) and excess primers. The resulting products were 
directly transformed into host cells and then clones were selected on minimal medium agar 
plates supplemented with kanamycin.  
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This is clearly one of the limiting steps of the technology: in fact, if on the one hand some 
species are naturally competent and allow an optimal transformation frequency, such as E. 
coli (Sinha and Redfield, 2012) or A. baylyi ADP1 (Metzgar et al., 2004), others are much more 
recalcitrant to the acquisition of genetic material (e.g., S. sanguinis) and ad hoc experiments 
(Paik et al., 2005) are required to optimize transformation efficiency and avoid the false 
identification of genes as essential. Unfortunately, many other bacterial species, especially 
Gram-positive ones such as Staphylococcus aureus (Veiga and Pinho, 2009; Corvaglia et al., 
2010), and Bacillus subtilis (Stephenson and Jarrett, 1991; Yang et al., 2010), are not naturally 
competent, and this extremely low transformation efficiency is an insurmountable limitation 
and the main reason why this technique is not applicable. Moreover, although this technology 
has been successfully applied for the creation of single mutants in “difficult strains” - P. 
aeruginosa (Lesic and Rahme, 2008) or Salmonella enterica (Husseiny and Hensel, 2005) - it is 
very difficult to envisage its application on a large scale for the creation of a library of mutants 
since, as stated by the authors of the technique (Baba et al., 2006), the most critical step is the 
preparation of highly electrocompetent cells (>109 transformants per 1 µg of plasmid DNA) 
with standards hardly reachable for the previously mentioned strains. 
In addition, this approach requires the phage λ Red recombinase expression in the bacterial 
strain for an efficient recombination between the targeted gene and a linear PCR product 
(Datsenko and Wanner, 2000). The Red system includes three genes: γ, β, and exo, whose 
products are called Gam, Bet, and Exo respectively. Gam binds to the bacterial RecBCD 
exonuclease V and inhibits its activities so that the other two components can promote 
recombination in concert: Exo processively digests the 5'-ended strand of a dsDNA while Bet 
binds to ssDNA and promotes strand annealing (Poteete, 2001; Sharan et al., 2009). 
Expression of the λ Red recombinase under the control of an inducible promoter is required 
from low copy helper plasmids, such as pKD46 or pKD20, which are temperature-sensitive 
and thus can easily be eliminated after recombination event. 
Thus, mutants of the targeted gene are isolated as antibiotic-resistant colonies: typically, for 
each gene deletion experiment, at least two KanR colonies were picked and each re-isolated 
twice. The mutants that could not be obtained in the high-throughput process were 
reattempted individually (up to five times), and, after this last failure, assessed as essential. 
Mutants were checked for correct structure and size by different PCR amplifications as 
schematized in Figure 16. 
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7.3 Antisense RNA approaches for essential genes detection 
The genome-wide identification of “essential-for-growth” genes can be performed also via 
antisense RNA technology. Almost 20 years ago antisense RNA technology found its 
application in eukaryotic systems to inhibit gene expression (Davies et al., 1996). Since that 
time, in mammalian systems, RNA interference (RNAi) has become a powerful methodology 
for studying loss-of-function phenotypes, as well as being a proved crucial technique in 
interpreting gene function on a genome-wide scale (Fellmann and Lowe, 2014). 
Furthermore, even in microorganism systems, RNAi has been used effectively to identify 
essential genes and virulence factors as well as to study gene functions of Staphylococcus 
aureus (Ji et al., 2001; Forsyth et al., 2002; Yin and Ji, 2002), mycobacteria (Parish and Stoker, 
1997), Streptococcus mutans (Wang and Kuramitsu, 2005), and Candida albicans (De Backer et 
al., 2001).  
The mechanisms of natural and artificially antisense RNAs are heterogeneous and are 
generally described as relating to mRNA destabilization (Storz, 2002): key factors for a 
competent and enduring RNAi, which is unfortunately very difficult to predict, are the 
possibility and accessibility to participate in RNA-RNA duplexes (Rana, 2007). 
Furthermore, it has been observed that not all the different antisense RNAs that target a 
particular gene, attempting to saturate it, are able to generate the same structure and 
therefore inhibition (Ji et al., 2001; Forsyth et al., 2002). This differing efficacy of various 
antisense RNAs for a given gene can obscure the functional difference between a marginally 
effective antisense targeting an essential gene and, for example, a highly efficacious antisense 
targeting a gene required merely for rapid growth. For this reason it is easy to understand 
that, searching for new essential gene targets, a genome-wide antisense fragmentation 
approach is preferable with respect to a specific antisense RNA design directed against 
hypothetical essential genes.  
This approach, already used on the bacterial pathogen Staphylococcus aureus (Forsyth et al., 
2002), is based on the construction and screening of Shotgun Antisense Libraries (SALs) as 
schematized in Figure 17. 
The cloning strategy employed should comprehensively represent the genome of interest in 
small random overlapping fragments. For this purpose, restriction digests, although easiest to 
obtain, are proven to produce poor randomization (Forsyth and Wang, 2008).  
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Figure 17. Schematic representation of construction and screening of a shotgun antisense library (SAL). 
Alternatively, shearing genomic DNA using physical force (e.g., with a nebulizer or sonicator) 
seems to allow a more complete coverage when one balances the size of the fragments with 
the number of clones in the library. 
The resulting fragments are then size-selected on a gel (choosing ones spanning between 
200–800 bp), bluntended using enzymes (e.g., Klenow, T4 DNA polymerase), and cloned into 
an appropriate vector under the control of an inducible promoter. 
The goal of the SAL approach is to identify those clones that produce an antisense RNA to an 
essential gene: to this end, fragments are screened to identify those whose expression, in the 
presence of promoter induction, impairs growth. Generally, only a really small percentage, 
approximately 1% of shotgun clones (Forsyth et al., 2002; Wang and Kuramitsu, 2005; Meng 
et al., 2012), will be sensitive to induction, of which about 70% will be antisense ones. 
The genes targeted and insert orientation of clones are identified by DNA sequencing of the 
growth-impairing fragments previously amplified by polymerase chain reaction (PCR) with a 
set of vector-specific primers. Bioinformatics analyses are performed to determine the 
original genomic locations of the sensitive clone inserts and insert orientations. 
Typically, two distinct phenotypic classes were identified after selection criteria (Yin and Ji, 
2002; Rusmini et al., 2014): one class exhibits a lethal (total no-growth) phenotype after 
antisense induction; the second displays an impaired phenotype, mainly connected with slow 
or reduced growth, but does eventually give rise to definitive small colonies.  
For the latter defective isolates, additional studies (e.g., knockout via allele replacement) 
would be needed to definitely confirm the phenotypes observed. 
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As relates to the applicability and versatility, this technique originally only showed limited 
success in Gram-negative bacteria (Wagner and Flärdh, 2002): until 2012 no published 
reports were proposed describing the application of the SAL approach for comprehensive 
genome-wide essential gene characterization (Meng et al., 2012) due to an assumed 
inefficiency in conditional silencing mediated by antisense RNAs in Gram-negative bacteria. 
In particular, although precise reasons have not yet been formulated, the involvement of 
different RNA chaperone requirements for trans-acting antisense RNAs was hypothesized 
(Waters and Storz, 2009). Furthermore, a lower abundance of the expressed antisense could 
be explained by a reduced stability of plasmid encoding probably due to the presence of 
RNase E in these bacteria while lacking in Gram-positive ones (Xu et al., 2010). 
However, antisense inhibition technology could also show some complications. For instance, 
antisense destabilization of a polycistronic transcript could result in polar effects: in this 
unfortunate event, an antisense RNA complementary to a non-essential gene destabilizes an 
essential gene which is co-transcribed in the same mRNA (Wiedenheft et al., 2012). 
A further possible limitation lies in the fact that, according to the scheme for SAL construction 
established in S. aureus (Ji et al., 2001; Forsyth et al., 2002), fragments generated in vitro are 
directly introduced into the original host, and selected in permissive conditions (e.g., with the 
promoter vector in an off state) to allow the clones carrying inserts targeting essential genes 
to survive. However, basal vector promoter activity could be sufficient to elicit silencing 
effects against genes transcribed at low levels introducing a bias in the subsequent 
conditional screening and so favoring the identification of highly transcribed essential genes 
(e.g., tRNAs, tRNA synthetases, ribosomal proteins, translation factors, components of the 
transcription machinery) as reported in a recent antisense screening of E. coli (Meng et al., 
2012). To avoid missing the identification of low expressed essential genes owing to out-of-
context use of the PBAD promoter (Qiu et al., 2008), as described in PART II, we included some 
modifications to the original strategy. In detail, P. aeruginosa SALs were firstly generated in E. 
coli, and then arrayed and challenged by conjugative transfer into P. aeruginosa. 
Moreover, this strategy assures a larger sized shotgun library because of the higher 
transformation efficiency of E. coli compared to P. aeruginosa and broadened the functional 
class variety of the identified essential genes in respect to previous reports. 
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http://www.biomedcentral.com/1471-2180/14/24RESEARCH ARTICLE Open AccessA shotgun antisense approach to the
identification of novel essential genes in
Pseudomonas aeruginosa
Ruggero Rusmini1†, Davide Vecchietti1†, Raffaella Macchi1, Faustino Vidal-Aroca1,2 and Giovanni Bertoni1*Abstract
Background: Antibiotics in current use target a surprisingly small number of cellular functions: cell wall, DNA,
RNA, and protein biosynthesis. Targeting of novel essential pathways is expected to play an important role in
the discovery of new antibacterial agents against bacterial pathogens, such as Pseudomonas aeruginosa, that
are difficult to control because of their ability to develop resistance, often multiple, to all current classes of
clinical antibiotics.
Results: We aimed to identify novel essential genes in P. aeruginosa by shotgun antisense screening. This
technique was developed in Staphylococcus aureus and, following a period of limited success in Gram-negative
bacteria, has recently been used effectively in Escherichia coli. To also target low expressed essential genes, we included
some variant steps that were expected to overcome the non-stringent regulation of the promoter carried by the
expression vector used for the shotgun antisense libraries. Our antisense screenings identified 33 growth-impairing
single-locus genomic inserts that allowed us to generate a list of 28 “essential-for-growth” genes: five were “classical”
essential genes involved in DNA replication, transcription, translation, and cell division; seven were already reported as
essential in other bacteria; and 16 were “novel” essential genes with no homologs reported to have an essential
role in other bacterial species. Interestingly, the essential genes in our panel were suggested to take part in a broader
range of cellular functions than those currently targeted by extant antibiotics, namely protein secretion, biosynthesis
of cofactors, prosthetic groups and carriers, energy metabolism, central intermediary metabolism, transport of small
molecules, translation, post-translational modification, non-ribosomal peptide synthesis, lipopolysaccharide
synthesis/modification, and transcription regulation. This study also identified 43 growth-impairing inserts
carrying multiple loci targeting 105 genes, of which 25 have homologs reported as essential in other bacteria.
Finally, four multigenic growth-impairing inserts belonged to operons that have never been reported to play
an essential role.
Conclusions: For the first time in P. aeruginosa, we applied regulated antisense RNA expression and showed
the feasibility of this technology for the identification of novel essential genes.Background
Pseudomonas aeruginosa is a highly adaptable bacterium
that thrives in a broad range of ecological niches. In
addition, it can infect hosts as diverse as plants,
nematodes, and mammals. In humans, it is an important
opportunistic pathogen in compromised individuals,* Correspondence: giovanni.bertoni@unimi.it
†Equal contributors
1Department of Life Sciences, Università degli Studi di Milano, via Celoria 26,
20133 Milan, Italy
Full list of author information is available at the end of the article
© 2014 Rusmini et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the orsuch as patients with cystic fibrosis, severe burns, or
impaired immunity [1,2]. P. aeruginosa is difficult to
control because of its ability to develop resistance,
often multiple, to all current classes of clinical antibiotics
[3-5]. The discovery of novel essential genes or pathways
that have not yet been targeted by clinical antibiotics
can underlie the development of alternative effective
antibacterials to overcome existing mechanisms of resistance.
Whole-genome transposon-mutagenesis (TM) followed by
identification of insertion sites is one of the most practical
and frequently used experimental approaches to screen forl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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http://www.biomedcentral.com/1471-2180/14/24essential bacterial genes [6-8]. Genome-wide surveys of
essential genes in P. aeruginosa have been accomplished
by saturating TM through a “negative” approach [9,10],
specifically, by identifying non-essential genomic regions
by transposon insertion and deducing that non-inserted
genome stretches are essential. However, this approach
can suffer from some systematic biases that generate both
false positives and negatives [7]. For example, even if
comprehensive insertion libraries are produced, it is
inevitable that some genes, especially the shortest
ones, could elude insertion and be spuriously annotated as
essential, while transposon insertions that occur at gene
ends and do not fully inactivate the function could lead to
genes being incorrectly classified as non-essential. To filter
errors resulting from these intrinsic biases in the
“negative” TM approach, a statistical framework has
recently been developed and tested in P. aeuginosa
PAO1 and Francisella tularensis novicida [7] TM
datasets. Some drawbacks of the “negative” TM approach
were overcome by using growth-conditional TM, which
allows identification of essential genes by transcriptionally
fusing them to an outward-facing inducible promoter
located at one end of the transposon [11]. However,
conditional TM can also be affected by systematic
biases, deriving, for example, from transposon tools
endowed with outward-facing promoters that are not
strictly regulated in non-inducing conditions, resulting
in a basal level of promoter expression. In fact, promoter
leakage under non-inducing conditions would not
completely switch off the gene downstream of the
insertion site, significantly increasing the false-negative
identification rate. The TM tools applicable for use with
P. aeruginosa [12] are based on elements used for
tightly regulated gene expression in E. coli, and are
expected to not be completely switched off in non-inducing
conditions when used “out-of-context”. For these reasons,
we set out to screen novel essential genes of P. aeruginosa
using a method other than TM. To this end, we selected
shotgun antisense RNA identification of essential
genes, a technique that was developed a decade ago
in Staphylococcus aureus [13,14]. This technique ori-
ginally only showed limited success in Gram-negative
bacteria [15,16], but has recently been used effectively
in E. coli [17]. In this approach, essential genes are
identified after shotgun-cloned genomic fragments are
conditionally expressed. The fragments are screened
to identify those whose expression impairs growth
[18]. The genes targeted by antisense RNA are identi-
fied by DNA sequencing of the growth-impairing
fragments. This study shows for the first time the
feasibility of the antisense technology in P. aeruginosa
for identifying novel essential genes. Moreover, we
included some modifications to the original strategy
that could have broadened the functional class variety60of the identified essential genes in respect to a recent
report in E. coli [17].
Results
Ad hoc procedure to screen for essential P. aeruginosa
genes by antisense RNA effects
According to the scheme for antisense-mediated
identification of essential genes established in S. aureus
[13,14], the shotgun genomic libraries generated in vitro
are directly introduced into the original host by
transformation, and selected in permissive conditions,
i.e., with the promoter vector in an off state, to allow
the clones carrying inserts targeting essential genes
to survive. However, basal vector promoter activity
could be sufficient to elicit silencing effects against
genes transcribed at low levels. This effect may introduce
a bias in the subsequent conditional screening, favoring
the identification of highly transcribed essential genes
(e.g., tRNAs, tRNA synthetases, ribosomal proteins,
translation factors, components of the transcription
machinery). Cells transformed using constructs targeting
essential genes expressed at low levels will fail to form a
colony in the permissive conditions. The high basal Ptrc
activity was suggested to cause the identification of a
relevant proportion of highly expressed essential genes in
a recent antisense screening of E. coli [17]. A not entirely
negligible basal activity is frequent in the commonly used
expression system tools, especially when they are used
outside the source organism. This is the case in the PBAD
promoter-based systems, like those selected for this
study, which have been used for tightly regulated gene
expression in E. coli, and for efficient arabinose-induced
overexpression in other hosts. However, outside of the
E. coli regulatory context, for instance in Burkholderia
pseudomallei [19] and P. aeruginosa (Bertoni et al.,
unpublished), these systems can display, also in the
presence of glucose, a basal level of activity. To avoid
missing the identification of low expressed essential genes
owing to out-of-context use of the PBAD promoter, we set
out to generate P. aeruginosa genomic shotgun libraries in
E. coli first, and to then array and challenge them by conju-
gative transfer into P. aeruginosa (Figure 1). Moreover, this
strategy assures a larger sized shotgun library because of
the higher transformation efficiency of E. coli compared
with P. aeruginosa. To test the robustness of this approach,
we checked the false-positive rate due to failure of vector
mating transfer and assessed that it was negligible.
Construction of arrayed shotgun genomic libraries of
P. aeruginosa
Genomic DNA was purified from P. aeruginosa
PAO1 and then mechanically sheared to generate
DNA fragments in a size range spanning 200–800 bp
(Additional file 1: Figure S1A). In pilot experiments,
Genomic DNA 
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PAO1 SAL in E. coli
Donor E. coli SAL clones Recipient PAO1
Triparental mating
- Inducer+ Inducer
DNA fragmentation and 
cloning in E. coli
Arraying SAL
PAO1 exconjugants 
replica plating
Figure 1 Construction and screening of PAO1 SALs. (A)
Genomic DNA was isolated from P. aeruginosa PAO1 and nebulized
to obtain sheared fragments of 200–800 bp. After treatment with
exonuclease BAL-31 and Klenow polymerase, the genomic DNA
fragments were cloned into the E. coli strain JM109, downstream
of the arabinose-inducible promoter PBAD of the pHERD20T vector.
(B) E. coli transformants, representing the PAO1 shotgun antisense
library (SAL), were arrayed in 96-well microplates and (C) mated with
P. aeruginosa PAO1 in the presence of a helper strain (triparental
mating). (D) SAL recipient PAO1 exconjugants were selected by
spotting on PIA plates supplemented with Cb both in the absence
and in the presence of the PBAD inducer arabinose. Recipient PAO1
exconjugant spots were inspected for growth defects following 24 h
of incubation at 37°C. (E) The identity of the genomic fragments
eliciting growth defects (lethal effects, indicated by a lack of a spot:
only with inducer, e.g. clones A4, A8, B5, and E4, and with and
without an inducer, e.g. clones A2 and E6; growth impairment, indicated
as gray spots: only with an inducer, e.g. clones C2, A6, and B6, and with
and without an inducer, e.g. C3 and B8) was determined by sequencing
the inserts in the corresponding clones of E. coli SAL.
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polymerase, the 200–800 bp DNA fragments were cloned
into E. coli downstream of the arabinose-inducible
promoter, PBAD, of the broad host-range vector pVI533EH.
Approximately 800 transformant clones were then arrayed
in 96-well microplates. Analysis of cloning efficiency by
PCR indicated that about 30% of transformant E. coli
colonies carried a PAO1 genomic insert. To generate
shotgun antisense libraries (SALs) with a lower background
of clones carrying an empty vector, we selected the broad
host-range vector pHERD-20 T, which facilitates the
identification of clones carrying an insert based on
blue/white screening. We obtained a 7:3 ratio between
dark blue (absence of an insert) and white-light blue
(potential presence of an insert) colonies, with 95% of
white-light blue colonies carrying an insert with the
expected average size (Additional file 1: Figure S1B).
Thus, the probability of selecting a clone with an insert
(Additional file 1: Figure S1C) increased from about 30% to
95% using pHERD-20 T. A pHERD-20 T-based SAL library
was constructed by arraying approximately 10,000
white-light blue transformant clones in 96-well microplates.
Screenings of SALs for growth-impairing inserts
The genomic inserts of both pVI533EH- and pHERD-
20 T-based SALs were screened for their ability to impair
PAO1 growth, supposedly by antisense transcription
effects, by mating transfer of SALs from E. coli to PAO1
(Figure 1C), and then replica plating of exconjugants on
Pseudomonas Isolation Agar (PIA) supplemented with
carbenicillin (Cb), both in the absence and presence of
the PBAD inducer arabinose (Figure 1D). Recipient PAO1
exconjugant spots were inspected for growth defects
following 24 h of incubation at 37°C. Insert-induced61
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could be displayed in some cases even in the absence of
arabinose (Additional file 1: Figure S1C). This suggested
that basal insert expression in PAO1, a regulatory context
for PBAD that is not as restrictive as E. coli, was sufficient to
produce deleterious effects on growth. These screenings re-
sulted in the identification of five and 71 growth-impairing
inserts in the pVI533EH- and pHERD-20 T-based
SALs, respectively. These 76 inserts, recovered in the
corresponding E. coli donor clones (Figure 1E), were
subjected to sequence analysis, and their features are
listed in Additional file 2: Table S2.
Analysis of the growth-impairing inserts
Bioinformatic analysis of the DNA sequences obtained
indicated that 33 of the 76 positive clones (44%) contained
single intragenic fragments. Of these, 20 (26% of the
positive clones) were in antisense orientation. As
listed in Table 1, some of these fragments derived
from conserved genes involved in DNA replication,
transcription, and translation, such as dnaG, rpoC, rpoB,
infB, and rbfA, which can be considered “classical” essential
genes. Fragments derived from rpoC, rpoB, infB, and rbfA
were antisense oriented. Two different fragments were
derived from dnaG, one antisense and the other sense
oriented. As previously suggested [13], it is likely that
sense-oriented intragenic fragments can act as dominant-
negative interfering sequences. Alternatively, we suggest
that transcription noise in the vector backbone from the
other side of PBAD could produce sufficient amounts of
insert antisense transcripts to silence the target essential
gene. One insert targeted PA3820 (secF), which was
previously shown to play an essential role in several
bacterial species [20]. Six intragenic fragments derived
from PA4669 (ipk), PA2951 (etfA), PA3687 (ppc), PA3758
(nagA), PA1183 (dctA), and PA1805 (ppiD), which are
homologous to genes previously shown to be essential in a
limited number of bacterial species [20].
The other inserts shown in Table 1 are derived from
16 genes with no homologs annotated as essential [20].
We recently validated the essential role of one of these
hits, TgpA (PA2873), in P. aeruginosa by insertional and
conditional mutagenesis [21]. In addition, the critical role
of PA1554 (ccoN1) in the aerobic growth of P. aeruginosa
PAO1 was reported previously [22].
The remaining positive clones contained fragments
including multiple loci and targeted a total of 103
genes (Additional file 3: Table S3). Nineteen of these
multigenic fragments included 25 genes with homologs
described as essential in other bacterial species [20].
The rest of the multigenic fragments carried genes
with no evidence of an essential role. Interestingly, four
multigenic inserts included gene sequences belonging to a
single operon (Table 2).62Discussion
The discovery of novel essential genes or pathways that
have not yet been targeted by clinical antibiotics can
underlie the development of alternative effective antibac-
terials to overcome the extant mechanisms of resistance.
In P. aeruginosa, a genome-wide assessment of essential
genes has been performed previously by constructing an
ordered, nonredundant random transposon (Tn) insertion
library [9,10,23]. An approach of this kind has proven
invaluable in studying bacterial genomes and in detecting
novel essential genes. However, there can be some degree
of imprecision in tagging for essentiality owing to Tn
insertions into possible permissive site(s) of essential genes.
For example, “classical” essential genes involved in DNA
replication, transcription, translation, and cell division
(e.g. polA, holE, holB, holC, dnaG, dnaJ, dnaK, rpoC,
infC, and ftsYEX) were Tn inserted in previous investiga-
tions (Additional file 4: Table S4) [9,10,23] and, for this
reason, P. aeruginosa alleles were not included in the
Database of Essential Genes (DEG) [20]. Some disadvan-
tages of this kind of approach could be overcome by using
growth-conditional mutagenesis.
To generate growth-conditional phenotypes, we decided
to use the antisense-mediated strategy established previously
in S. aureus [13,14]. This technique is not affected by some
of the bias linked to transposon mutagenesis mentioned
above. However, it can present limitations in the multi-step
process of antisense libraries preparation such as the
blunt-end cloning of mechanically sheared DNA fragments,
library clones carrying multigenic inserts, the reintro-
duction efficiency of libraries into the original host.
In addition, the efficiency of antisense inhibition, supposed
to affect gene translatability and/or mRNA stability, can
be gene-dependent and also differential for distinct DNA
fragments belonging to the same gene.
We report here, for the first time, successful application
of regulated antisense RNA technology to discover novel
essential functions in P. aeruginosa. To also screen for low
expressed essential genes, we added a preliminary shotgun
library construction in E. coli to the previous strategy,
followed by mating transfer to P. aeruginosa.
The subset of growth-impairing fragments that targeted
single loci (Table 1) directly defined 28 “essential-for-growth”
genes. Only five of these genes were “classical” essential
genes involved in DNA replication, transcription, and
translation. The remaining 23 genes are suggested to
take part in disparate cellular functions, including
protein secretion, biosynthesis of cofactors, prosthetic
groups, and carriers, energy metabolism, central intermedi-
ary metabolism, transport of small molecules, translation,
post-translational modification, non-ribosomal peptide
synthesis, lipopolysaccharide synthesis/modification, and
transcriptional regulation. Finally, some of the gene prod-
ucts described in Table 1 were annotated as “hypothetical”
Table 1 Pseudomonas aeruginosa PAO1 genes targeted by growth-impairing inserts including a single locus
Insert
namea
Insert-included
locus
Gene name and product annotationb Function classb Orthologous proteins in
DEGc
S2F1 PA0577 dnaG - DNA primase (2) DNA replication, recombination,
modification and repair
Bs, Sa, Ec, Hi, Sp, Mt, Fn,
Ab, Mp, Se, Cc, Ss
S3D3
S11F7 PA4269 rpoC - DNA-directed RNA
polymerase beta chain (2)
Transcription, RNA processing
and degradation
Bs, Sa, Ec, Mg, Sp, Mt, St,
Fn, Ab, Mp, Se, Ss, Pg
B1 PA4270 rpoB - DNA-directed RNA
polymerase beta chain (2)
Transcription, RNA processing
and degradation
Bs, Sa, Vc, Ec, Hi, Mg, Mt, St,
Fn, Ab, Mp, Pa, Se, Cc, Ss, Pg, Bt
S6A10 PA4744 infB - translation initiation
factor IF-2 (2)
Translation, post-translational
modification, degradation
Bs, Sa, Vc, Ec, Mg, Mt, St,
Fn Ab, Mp, Pa, Se, Cc, Pg, Bt
S2F6 PA4743 rbfA - ribosome-binding factor A (2) Translation, post-translational
modification, degradation
Sa, Vc, Mg, Hp, Fn, Ab, Se
S6E7 PA3820 secF - secretion protein SecF (2) Protein secretion/export apparatus Ec, Hi, St, Fn, Ab, Pa, Se
S5A10 PA1709d popD - Translocator outer
membrane protein (1)
Protein secretion/export apparatus
S11B13 PA4669 ipk - isopentenyl monophosphate
kinase(2)
Biosynthesis of cofactors, prosthetic
groups and carriers
Vc, Se, Pa
G2 PA2951 etfA - electron transfer flavoprotein
alpha-subunit (2)
Energy metabolism Ab, Cc
H2
S10F8 PA5186 probable iron-containing alcohol
dehydrogenase (3)
Energy metabolism
F1 PA1554 ccoN1\ fixN \ Cytochrome c oxidase,
cbb3-type, CcoN subunit (1)
Energy metabolism
S11G10 PA3687 ppc - phosphoenolpyruvate carboxylase (2) Energy metabolism Hi
S86C PA3758 nagA - probable N-acetylglucosamine-6-phosphate
deacetylase (3)
Central intermediary metabolism Hi, Mt
E5 PA1183 dctA - C4-dicarboxylate transport protein (2) Transport of small molecules Ab
S11C9 PA3382 phnE - phosphonate transport protein PhnE (2) Transport of small molecules
S4E6 PA4903 vanK - probable major facilitator superfamily
(MFS) transporter (3)
Transport of small molecules
B3 PA5548 probable major facilitator superfamily
(MFS) transporter (3)
Transport of small molecules
S4H12
A5 PA1590 braB - branched chain amino acid transporter (1) Transport of small molecules
S3D4 PA1805 ppiD - peptidyl-prolyl cis-trans isomerase
D - Rotamase D (2)
Translation, post-translational
modification, degradation
Cc, Bs
S9G5 PA2402 Probable non-ribosomal peptide synthetase (3) Putative enzymes
S5D4
S5A4 PA5238 probable O-antigen acetylase (3) Membrane proteins,
Cell wall/LPS/capsule
S5G6
S4B10 PA3433 ywbI - probable transcriptional regulator (3) Transcriptional regulators
S5A1 PA2220 oprR - probable transcriptional regulator (3) Transcriptional regulators
M4G6 PA2873e tgpA - transglutaminase protein A TgpA (1) Adaptation, Protection,
Membrane proteins
S10A3 PA0307 hypothetical protein (4) Hypothetical, unclassified,
unknown
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Table 1 Pseudomonas aeruginosa PAO1 genes targeted by growth-impairing inserts including a single locus (Continued)
S841F PA4926 conserved hypothetical protein (4) Hypothetical, unclassified,
unknown
S9A9 PA0262 conserved hypothetical protein (4) Hypothetical, unclassified,
unknown
F2 PA5264 hypothetical protein (4) Hypothetical, unclassified,
unknown
aInserts with antisense orientation are in bold.
bAnnotations according to the Pseudomonas Genome Database (www.pseudomonas.com) [27]. Numbers inside parenthesis indicate the classes of product name
confidence. Class1: Function experimentally demonstrated in P. aeruginosa; Class 2: Function of highly similar gene experimentally demonstrated in another
organism; Class 3: Function proposed based on presence of conserved amino acid motif, structural feature or limited sequence similarity to an experimentally
studied gene. Class 4: Homologs of previously reported genes of unknown function, or no similarity to any previously reported sequences.
cDEG: Database of Essential Genes (DEG 7.0) (www.essentialgene.org) [20]. For each hit, the orthologue proteins, extracted from the Ortholuge DB [30], that were
found in DEG are indicated with the abbreviation of the harboring bacterial species. Bacterial species: Ab (Acinetobacter baylyi), Bs (Bacillus subtilis), Bt (Bacteroides
thetaiotaomicron), Cc (Caulobacter crescentus), Ec (Escherichia coli), Fn (Francisella novicida), Hi (Haemophilus influenzae), Hp (Helicobacter pylori), Mt (Mycobacterium
tuberculosis), Mp (Mycoplasma pulmonis), Mg (Mycoplasma genitalium), Pg (Porphyromonas gingivalis), Pa (Pseudomonas aeruginosa), Se (Salmonella enterica),
St (Salmonella typhimurium), Sp (Streptococcus pneumoniae), Ss (Streptococcus sanguinis), Sa (Staphylococcus aureus), Vc (Vibrio cholerae).
dPrevious reports [24-26] did not mention growth defects associated to deletion of popD gene.
eHit not present in DEG whose essentiality was experimentally demonstrated in P. aeruginosa [21].
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in unexplored essential functions, either as stand-alone pro-
teins or connected to classical housekeeping processes.
This is the case for the inner membrane protein
TgpA (PA2873; Table 1) [21], which was found in our
antisense screenings and was previously reported as
hypothetical, whose transglutaminase activity associated
with the periplasmic domain might be either linked to
cell wall metabolism or be involved in unknown key
functions of protein maturation, secretion, and/or
modification.
Only two of the 23 non-classical essential genes,
PA4669 (ipk) and PA3820 (secF), were already indicatedTable 2 PAO1 growth-impairing inserts including loci belongi
Insert
namea
Operon locib Gene name and product annotationc F
E6 PA1037 yicG - conserved hypothetical protein (4) H
PA1038 hypothetical protein (4)
PA1039 ychJ - hypotetical protein (4)
PA1040 hypothetical protein (4)
S9B6a PA1089 conserved hypothetical protein (4) H
PA1090 conserved hypothetical protein (4)
PA1088 hypothetical protein (4)
S9B6b PA0393 proC - pyrroline-5-carboxylate reductase (1) A
PA0392 yggT - conserved hypothetical protein (4) H
PA0394 yggS - conserved hypothetical protein (4)
S2A4 PA1001e phnA - anthranilate synthase component I (1) A
b
PA1002e phnB - anthranilate synthase component II (1)
aInserts with antisense orientation are in bold.
bLoci included in the insert are in bold.
cAnnotations according to the Pseudomonas Genome Database (www.pseudomona
confidence. Class1: Function experimentally demonstrated in P. aeruginosa; Class 2:
organism; Class 3: Function proposed based on presence of conserved amino acid
studied gene. Class 4: Homologs of previously reported genes of unknown function
dDEG: Database of Essential Genes (DEG 7.0) (www.essentialgene.org) [20].
ePrevious reports [34,35] did not mention growth defects associated to deletion of
64as essential in P. aeruginosa [9,20]. For the remaining 21
genes, no evidence for essentiality has been reported
previously in P. aeruginosa [20]. We propose these genes
as novel essential genes in P. aeruginosa. PA2951 (etfA),
PA3687 (ppc), PA3758 (nagA), PA1183 (dctA), and
PA1805 (ppiD) are homologous to genes previously
shown to be essential in a limited number of bacterial
species [20]. Interestingly, for the remaining 16 genes,
no homologs have been reported as essential in other
bacteria [20]. Among these, PA1709 (popD), coding for a
subunit of the PopB/D translocon complex of the type III
secretion-translocation system (TTSS), is implicated in
effector translocation across the host plasma membrane.ng to a single operon
unction classc Species containing
orthologs in DEGd
ypothetical, unclassified, unknown
ypothetical, unclassified, unknown
mino acid biosynthesis and metabolism E. coli, M. tuberculosis, A. baylyi
ypothetical, unclassified, unknown
daptation, protection; amino acid
iosynthesis
s.com) [27]. Numbers inside parenthesis indicate the classes of product name
Function of highly similar gene experimentally demonstrated in another
motif, structural feature or limited sequence similarity to an experimentally
, or no similarity to any previously reported sequences.
phnAB genes.
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did not mention growth defects associated to deletion of
popD gene. Therefore, the growth-impairing effects of
S5A10 insert corresponding to PA1709 (Table 1) did not
seem to match the PopD role characterized so far. These
discrepancies could be due to differences in experimental
conditions between our study and earlier works.
We evaluated the set of 21 novel candidate essential
genes for degree of conservation in Pseudomonas species
according to the computationally-based analysis of
orthologs of the Pseudomonas Genome Database [27]
(Additional file 5: Table S5). Interestingly, they are
well-conserved in the sequenced Pseudomonas species,
with the exceptions of PA5548 and PA1709 (popD) that are
unique in P. aeruginosa. However, PA5548 and PA1709
(popD) orthologs can be found in other bacterial species.
Remarkably, 17 of 21 novel essential candidates are
conserved in all twelve sequenced P. aeruginosa genomes
(Additional file 5: Table S5). Instead, PA2220 (oprR),
PA5264, PA1709 (popD) and PA3687 (ppc) are present in
3, 8, 9 and 10 of the sequenced genomes, respectively.
Essential genes that are not fully conserved in all
strains of a bacterial species can occur infrequently.
As an example, the Escherichia coli genes ytfI, ypjF,
ymfJ, ymfI and ymcD, coding for hypothetical proteins,
were reported as essential in the K12-MG1655 strain
[28,29] and are conserved in only a limited number
of the sequenced E. coli genomes [30].
Moreover, we compared the novel essential candidates
with a panel of “classical” essential genes that were not
included in the Database of Essential Genes (DEG) [20]
because of the occurence of Tn insertions in previous
screenings in P. aeruginosa [9,10,23]. The Tn insertion
patterns of the novel essential candidates (i.e. number of
insertions and insertion site(s)- terminal vs internal;
Additional file 5: Table S5) were similar to those of
“classical” essential genes (Additional file 4: Table S4).
This study also identified growth-impairing inserts
carrying multiple genes. Because of their multigenic
composition, the tagging of genes in these constructs
for essentiality is not as direct as for single locus
inserts (see above). However, among the multigenic
inserts, we identified sequences corresponding to 25
genes with homologs already annotated as essential in
other bacterial species [20] (Additional file 3: Table S3).
Seven of these genes were indicated previously as essential
in P. aeruginosa [9,20]. The 25 genes were annotated as
involved in multiple cellular functions: lipid A biosynthesis
(lpxA, lpxB; lpxD, fabZ) [31], amino acid biosynthesis
and metabolism (glyA3, proC, hom, lysC, ldh), DNA
replication and recombination (dnaX, recB, recR),
transport of small molecules (potD, mgtA, fadL, fepG, pstC),
biosynthesis of cofactors, prosthetic groups and carriers
(folD), translation and post-translational modification(tufB), nucleotide biosynthesis (purL), protein secretion
(secE), tRNA modification (gcp) [32], central intermediary
metabolism (glpK), and energy metabolism (fdx2). Other
genes present in the multigenic inserts might be essential,
but their identification would require further analysis via
subcloning and/or conditional mutagenesis.
Interestingly, four multigenic inserts contained genes
belonging to a single operon (Table 2), a feature that
suggests a functional association. One such gene, proC,
codes for pyrroline-5-carboxylate reductase [33] and was
reported as essential in E. coli, Mycobacterium tuberculosis
and Acinetobacter baylyi [20]. Other gene products of these
operons are annotated as hypothetical proteins. Therefore,
we suggest that these operonic genes might be involved in
novel essential pathways. Overall, they are well-conserved
in the sequenced Pseudomonas species (Additional file 5:
Table S5). Exceptions are PA1088-1089-1090 which appear
restricted to few Pseudomonas species and not conserved
in all sequenced P. aeruginosa strains. Finally, one operonic
growth-impairing insert included PA1001-1002 (phnAB)
implicated in the biosynthesis of pyocyanin. Previous
reports on P. aeruginosa PAO1 phnA and PA14 phnAB
function [34,35] did not mention growth defects asso-
ciated to deletion of these genes. As in the case of
PA1709 (popD), discrepancies between our results and
previous works could be attributable to differences in
experimental conditions.Conclusions
Taken together, our results show the feasibility of
antisense technology in P. aeruginosa for identifying novel
essential genes. Because of its supposed inefficiency [16],
this approach has been neglected in Gram-negative bacteria
for several years, and was only recently recovered in E. coli
[17]. By comparison with this previous work, the results
presented here strongly suggest that our modification
of the antisense strategy could broaden the class variety
of the identified essential genes. We expect that our
methodology could be well suited for antisense-mediated
searches of essential genes in other Gram-negative bacterial
species.Methods
Bacterial strains, plasmids, and growth conditions
Bacterial strains and plasmids used in this study are
listed in Additional file 6: Table S1. Bacteria were grown
at 37°C in Luria-Bertani (LB) broth, or in M9 minimal
medium supplemented with 0.2% citrate (M9-citrate).
Antibiotics were added at the following concentrations
(μg/ml): Cb, 300; kanamycin; 50. Arabinose was added to
a final concentration of 10 mM. In mating experiments,
exconjugant P. aeruginosa PAO1 clones were selected on
PIA (Difco) containing Cb.65
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Genomic DNA was isolated from P. aeruginosa PAO1
using an illustra GenomicPrep Cells and Tissue DNA
Isolation Kit (GE Healthcare). DNA was diluted in
10 mM TE buffer (pH 8.0) and nebulized to obtain
sheared fragments spanning 200–800 bp (Additional file 1:
Figure S1A). Following ethanol precipitation, fragmented
DNA was treated with nuclease BAL-31 and Klenow
(New England Biolabs) for 10 min at 30°C to obtain
blunt ends. After enzyme inactivation with 1 mM
EDTA, DNA was dialyzed against 20 mM Tris–HCl
(pH 8.0). pVI533EH and pHERD20T were digested with
SmaI (New England Biolabs) and dephosphorylated using
shrimp alkaline phosphatase (Roche). Fragmented DNA
was ligated to dephosphorylated vectors using T4 Ligase
(Takara Bio) at 16°C overnight. Ligation mixtures were
transformed into E. coli JM109 by electroporation, and
transformants were selected on LB plates supplemented
with Cb. The resulting transformant colonies composing
the SAL were arrayed and cultured in 96-well micro-
plates. Quality control by PCR of single colonies, using
primers flanking the multi-cloning site (Additional file 1:
Figure S1B), was performed to check the presence and the
size of a genomic insert.
SALs were mobilized from E. coli to P. aeruginosa PAO1
by conjugative triparental mating. E. coli donor strains
were grown overnight in 96-well microplates in LB broth
supplemented with Cb. The recipient P. aeruginosa PAO1
and helper E. coli HB101/pRK2013 strains were grown
overnight in flasks in LB broth. Thirty microliters each of
helper, recipient, and donor strains were mixed in micro-
plate wells. After mixing, microplates were centrifuged at
750 × g for 5 min and incubated for 3 h at 37°C. Cell
pellets resulting from triparental mating were resuspended
in 90 μl of LB, and 2 μl of each mating mixture were
spotted on PIA plates supplemented with Cb, both in the
absence and presence of 10 mM arabinose, to counter
select E. coli donor and helper strains. Exconjugant cell
spots were inspected for growth defects following 24–48 h
of incubation at 37°C. The PAO1 growth-impairing
inserts in pVI533EH/pHERD20T derivatives were se-
quenced following PCR amplification using oligo
pVI533-F/pVI533-R and pHERD-F/pHERD-R, respectively
(Additional file 6: Table S1). The resulting sequences
were matched to the PAO1 genome at the Pseudomonas
Genome Database [27].Additional files
Additional file 1: Figure S1. Construction and screening for growth
defects of P. aeruginosa shotgun antisense libraries. A. Agarose gel
electrophoresis showing two fractions, F1 and F2 (lanes 2 and 3), of DNA
fragments generated from P. aeruginosa PAO1 genomic DNA (lane 1).66The DNA fragments from F1 and F2 were generated by nebulization at
2.5 and 5 bar pressure, respectively. B. Quality control for cloning: pHERD
vector used for library preparation allows white/blue screening for
positive inserts. White clones were checked by PCR for the presence of
an insert using oligos annealing at both sides of the polylinker sequence.
As an example, a check of a randomly selected pool of 25 white colonies
is shown (M: molecular weight marker; E. empty vector). It is noteworthy
that more than 90% of clones from F1 (23/25) carried an insert within the
expected size range (200–800 bp; average size: 500 bp), and were used
for shotgun cloning. C. SAL recipient PAO1 exconjugants were selected
by spotting on PIA plates supplemented with Cb, both in the absence
and in the presence of the PBAD inducer arabinose. Recipient PAO1
exconjugant spots were inspected for growth defects following 24 h of
incubation at 37°C. For example: red circle indicates growth impairment
only with inducer; yellow circle indicates lethal effects only with inducer;
green circle indicates lethal effects both in the presence and absence of
the inducer. The identity of the genomic fragments eliciting growth was
determined by sequencing the inserts in the corresponding clones of E.
coli SAL.
Additional file 2: Table S2. Growth-impairing inserts resulting from
PAO1 SAL screenings.
Additional file 3: Table S3. PAO1 growth-impairing inserts including
multiple loci.
Additional file 4: Table S4. Additional information on a selection of
PAO1 “classical” essential genes.
Additional file 5: Table S5. Additional information on novel P. aeruginosa
candidate essential genes.
Additional file 6: Table S1. List of bacterial strains, plasmids, and
oligonucleotides.
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SUPPLEMENTARY FIGURES 
Figure S1.Construction and screening for growth defects of P. aeruginosa shotgun antisense 
libraries. A. Agarose gel electrophoresis showing two fractions, F1 and F2 (lanes 2 and 3), of DNA 
fragments generated from P. aeruginosa PAO1 genomic DNA (lane 1). The DNA fragments from F1 
and F2 were generated by nebulization at 2.5 and 5 bar pressure, respectively. B. Quality control for 
cloning: pHERD vector used for library preparation allows white/blue screening for positive inserts. 
White clones were checked by PCR for the presence of an insert using oligos annealing at both sides 
of the polylinker sequence. As an example, a check of a randomly selected pool of 25 white colonies is 
shown (M: molecular weight marker; E. empty vector). It is noteworthy that more than 90% of clones 
from F1 (23/25) carried an insert within the expected size range (200–800 bp; average size: 500 bp), 
and were used for shotgun cloning. C. SAL recipient PAO1 exconjugants were selected by spotting on 
PIA plates supplemented with Cb, both in the absence and in the presence of the PBAD inducer 
arabinose. Recipient PAO1 exconjugant spots were inspected for growth defects following 24 h of 
incubation at 37°C. For example: red circle indicates growth impairment only with inducer; yellow circle 
indicates lethal effects only with inducer; green circle indicates lethal effects both in the presence and 
absence of the inducer. The identity of the genomic fragments eliciting growth was determined by 
sequencing the inserts in the corresponding clones of E. coli SAL.
Rusmini et al. BMC Microbiology 2014, 14:24 
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Table S1: List of bacterial strains, plasmids and oligonucleotides. 
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Strains,plasmids,oligos Genotype or description Reference 
Pseudomonas aeruginosa 
PAO1 [1]
Escherichia coli 
JM109 recA1 endA1 gyrA96 thi hsdR17 supE44, 
relA1, ∆(lac-proAB) F’ (traD36, proAB+ lacIqZ 
∆M15) 
[2] 
HB101 [RK2013] recA, thi, hsdR, hsdM, proA, leu, strA [3] 
Plasmids 
pHERD20T ApR, CbR broad-host-range araC-PBAD 
expression vector; blue/white screening for 
recombinants 
[4] 
pVI533EH ApR, CbR broad-host-range araC-PBAD [5] 
Oligonucleotides 
pVI533-F  ATCACGGCAGAAAAGTCCAC 
pVI533-R CTTCTCTCATCCGCCAAAAC
E2Eco5’ CGCGAATTCTCAGACCGCCGGCAGCGAC 
E2Hind3’ CGCAAGCTTCTGGCAGCGTTGCGTCGA 
pHERD-F ATCGCAACTCTCTACTGTTTCT
pHERD-R TGCAAGGCGATTAAGTTGGGT
69
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Table S4. A
dditional inform
ation on a selection of P
. aeruginosa “classical” essential genes. 
Locus 
G
ene nam
e and product annotation
a 
Putative orthologs
in Pseudom
onas species
b 
Transposon insertion (N
c,IP
d)
N
otes 
P
A
0577 
dnaG
 D
N
A
 prim
ase 
P
ae(12/12), P
br, P
de, P
en, P
fl, P
fu, 
P
m
e, P
po, P
pr, P
pu, P
re, P
st, P
sy 
1(TA
), 1992/1995; 1(TL), 
1990/1995 
P
A
14 ortholog w
as Tn inserted in [1] 
P
A
5493 
polA
 D
N
A
 polym
erase I 
P
ae(10/12),P
br, P
de, P
en, P
fl, P
fu, 
P
m
e, P
po, P
pr, P
pu, P
re, P
st, P
sy 
2(TA
), 2153/2742 - 1628/2742; 
3(TL), 1158/2742 - 2328/2742 - 
2309/2742 
P
A
14 ortholog w
as Tn inserted in [1] 
P
A
3832 
holC
 D
N
A
 polym
erase III, chi subunit 
P
ae(12/12),P
br, P
de, P
en, P
fl, P
fu, 
P
m
e, P
po, P
pr, P
pu, P
re, P
st, P
sy 
P
A
14 ortholog w
as Tn inserted in [1] 
P
A
2961 
holB
 D
N
A
 polym
erase III, delta subunit 
P
ae(12/12) P
br, P
de, P
en, P
fl, P
fu, 
P
m
e, P
po, P
pr, P
pu, P
re, P
st, P
sy 
2(TA
), 971/987 - 963/987; 2(TL), 
953/987 
P
A
14 ortholog w
as Tn inserted in [1] 
P
A
4760 
dnaJ protein 
P
ae(12/12), P
br, P
de, P
en, P
fl, P
fu, 
P
m
e, P
pr, P
pu , P
re, P
st, P
sy 
P
A
14 ortholog w
as Tn inserted in [1] 
P
A
4761 
dnaK
 m
olecular chaperone D
naK
 
P
ae(12/12), P
br, P
de, P
en, P
fl, P
fu, 
P
m
e, P
po, P
pr, P
pu, P
re, P
st, P
sy 
P
A
14 ortholog w
as Tn inserted in [1] 
P
A
4269 
rpoC
 R
N
A polym
erase beta* chain 
P
ae(10/12), P
br, P
de, P
en, P
fl, P
fu, 
P
m
e, P
po, P
pr, P
pu, P
re, P
st, P
sy 
P
A
14 ortholog w
as Tn inserted in [1] 
P
A
2473 
infC
 Translation initiation factor IF-3 
P
ae(12/12), P
br, P
de, P
en, P
fl, P
fu, 
P
m
e, P
po, P
pr, P
pu, P
re, P
st, P
sy 
P
A
14 ortholog w
as Tn inserted in [1] 
P
A
0373 
ftsY
 cell division protein  
P
ae(12/12), P
br, P
de, P
en, P
fl, P
fu, 
P
m
e, P
po, P
pr, P
pu, P
re, P
st, P
sy 
1(TA
), 1359/1368 
P
A
14 ortholog w
as Tn inserted in [1] 
P
A
0374 
ftsE
 cell division protein  
P
ae(12/12), P
br, P
de, P
en, P
fl, P
fu, 
P
m
e, P
po, P
pr, P
pu, P
re, P
st, P
sy  
2(TA
), 196/672 - 268/672 
P
A
14 ortholog w
as Tn inserted in [1] 
P
A
0375 
ftsX
 cell division protein 
P
ae(12/12), P
br, P
de, P
en, P
fl, P
fu, 
P
m
e, P
po, P
pr, P
pu, P
re, P
st, P
sy 
1(TA
), 36/1008; 1(TL) 548/1008 
P
A
14 ortholog w
as Tn inserted in [1] 
a A
nnotations according to the P
seudom
onas G
enom
e D
atabase (w
w
w
.pseudom
onas.com
)[2].  
b For each hit, the com
putationally-predicted putative orthologs that w
ere found in the P
seudom
onas G
enom
e D
atabase (w
w
w
.pseudom
onas.com
) [2] 
are indicated w
ith the abbreviation of the harboring bacterial species. For P
seudom
onas aeruginosa, the num
ber of strains harboring orthologs over 
the total of 12 sequenced strains considered for the analysis at the P
seudom
onas G
enom
e D
atabase is indicated inside parenthesis. S
pecies nam
e 
abbreviations: P
ae (P
. aeruginosa), P
en (P
. entom
ophila), P
m
e (P
. m
endocina), P
re (P
. resinovorans), P
fl (P
. fluorescens), P
br (P. brassicacearum
), 
P
pr (P
. protegens), P
de (P
. denitrificans), P
pu (P
. putida), P
fu (P
. fulva), P
st (P
. stutzeri), P
sy (P
. syringae), Ppo (P
. poae). 
c N
: num
ber of transposon insertions in the P
A
 Tw
o A
llele Transposon Library (TA
) [3] and/or in the Tn5 lux Transposon M
utant Library (TL) [4]. 
d IP
: transposon insertion site given as num
ber of base pairs from
 the gene 5’ / total gene length.  
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Table S5. A
dditional inform
ation on novel P
. aeruginosa candidate essential genes. 
Locus
a 
G
ene nam
e and product annotation
b 
Putative orthologous
in Pseudom
onas species
c 
Transposon insertion (N
d,IP
e)
N
otes 
P
A
2951 
etfA - electron transfer flavoprotein alpha-subunit 
P
ae(12/12), P
br, P
de, P
en, P
fl, P
fu, 
P
m
e, P
po, P
pr, P
pu, P
re, P
st, P
sy 
0(TA
) ; 0(TL) 
P
A
2951 orthologs are reported as essential in 
A
cinetobacter baylyi, C
aulobacter crescentus 
[1]. 
P
A
3687 
ppc - phosphoenolpyruvate carboxylase 
P
ae(10/12), P
br, P
de, P
en, P
fl, P
fu, 
P
m
e, P
po, P
pr, P
pu, P
re, P
st, P
sy 
2(TA
), 2357/2637 - 1408/2637 
P
A
3687 orthologs are reported as essential in
H
aem
ophilus influenzae [1] 
P
A
3758 
nagA
 - probable N
-acetylglucosam
ine-6-phosphate
deacetylase  
P
ae(12/12), P
br, P
en, P
fl, P
po, P
pr 
2(TA
), 552/1092 - 556/1092 
P
A
3785 orthologs are reported as essential in 
H
aem
ophilus influenzae, M
ycobacterium
 
tuberculosis [1] 
P
A
1183 
dctA - C
4-dicarboxylate transport protein 
P
ae(12/12), P
br, P
de, P
en, P
fl, P
fu, 
P
po, P
pr, P
pu, P
re, P
st, P
sy 
2(TA
), 286/1311 - 685/1311 
P
A
1183 orthologs are reported as essential in 
A
cinetobacter baylyi [1] 
P
A
1805 
ppiD
 - peptidyl-prolyl cis-trans isom
erase D
 - R
otam
ase D
P
ae(12/12), P
br, P
de, P
en, P
fl, P
fu, 
P
m
e, P
po, P
pr, P
pu, P
re, P
st, P
sy 
1(TA
), 1429/1866
P
A
1805 orthologs are reported as essential in 
C
aulobacter crescentus, B
acillus subtilis [1] 
PA5186 
probable iron-containing alcohol dehydrogenase 
P
ae(12/12), P
de, P
fu, P
m
e, P
pu, 
P
re, P
st 
2(TA
), 42/1164 - 797/1164; 1(TL), 
524/1164  
 
PA1554 
ccoN
1\C
ytochrom
e c oxidase, cbb3-type, C
coN
 subunit 
P
ae(12/12), P
br, P
d, P
en, P
fl, P
fu,
P
m
e, P
po, P
pr, P
pu, P
re, P
st, P
sy, 
3(TA
), 1188/1428 - 885/1428 -
419/1428 
S
how
n to be critical for aerobic grow
th [2]. 
PA3382 
phnE
 - phosphonate transport protein P
hnE
 
P
ae(12/12), P
de, P
fl, P
m
e, P
pu, 
P
st, P
sy 
3(TA
), 661/795 - 450/795 - 
298/795; 1(TL), 652/795 
The phosphonate transporter function w
as 
reported as essential in M
ycoplasm
a pulm
onis 
[1]. 
P
A
4903 
vanK
 - probable m
ajor facilitator superfam
ily transporter 
P
ae(12/12), P
de, P
fl, P
fu, P
pr, P
pu,
P
re 
1(TA
), 713/1335 
P
A
5548 
probable m
ajor facilitator superfam
ily transporter 
P
ae(12/12)
1(TA
), 611/1206
P
A
1709 
popD
 - Translocator outer m
em
brane protein  
P
ae(9/12) 
1(TA
), 871/888 
P
A
1590 
braB
 - branched chain am
ino acid transporter 
P
ae(12/12), P
m
e, P
st 
1(TA
), 1080/1314 
PA2402 
Probable non-ribosom
al peptide synthetase 
P
ae(12/12), P
br, P
de, P
en, P
fl, 
P
m
e, P
po, P
pr, P
pu, P
re, P
st, P
sy 
2(TA
), 10034/15450 - 462/15450
50%
 identity w
ith the peptide synthase M
btE
 
reported as essential in H
aem
ophilus 
influenzae [1]. 
PA5238 
probable O
-antigen acetylase  
P
ae(12/12), P
br, P
fl, P
fu, P
m
e, P
po, 
P
pr, P
pu, P
re, P
st, P
sy 
2(TL), 915/1989 - 1698/1989 
P
A
3433 
yw
bI - probable transcriptional regulator 
Pae(12/12), P
de, P
en, P
fl, P
po, P
pr, 
P
pu, P
re, P
sy 
0(TA
) ; 0(TL) 
P
A
2220 
oprR
 - probable transcriptional regulator 
P
ae(3/12), P
br, P
de, P
fl, P
pr, P
pu, 
P
st, P
sy 
1(TA
), 58/921 
P
A
2873 
tgpA
 - transglutam
inase protein A
 TgpA
  
P
ae(12/12), P
de, P
fl, P
m
e, P
re, P
st, 
P
sy 
1(TA
), 1568/2007; 1(TL) 
1042/2007 
PA0307 
hypothetical protein  
P
ae(12/12), P
br, P
de, P
en, P
fl, P
fu, 
P
m
e, P
po, P
pr, P
pu, P
re, P
st 
2(TA
), 451/612 - 408/612 
PA4926 
conserved hypothetical protein  
P
ae(12/12), P
br, P
fl, P
fu, P
m
e, P
po, 
P
pr, P
re, P
sy 
1(TA
), 29/936 
P
A
0262 
conserved hypothetical protein  
P
ae(12/12), P
pu, P
re, P
sy 
9(TL), 1703/3060 - 1223/3060 - 
1214/3060 - 1203/3060 - 
396/3060 - 1242/3060 - 
1244/3060 - 1483/3060 - 
1219/3060 
P
A
5264 
hypothetical protein 
P
ae(8/12), P
de, P
st, P
sy 
2(TA
), 567/972 - 559/972; 1(TL), 
851/972 
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TgpA, a Protein with a Eukaryotic-Like Transglutaminase
Domain, Plays a Critical Role in the Viability of
Pseudomonas aeruginosa
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Abstract
The Gram-negative bacterium Pseudomonas aeruginosa is an important opportunistic pathogen in compromised
individuals, such as patients with cystic fibrosis, severe burns or impaired immunity. In this work we aimed to screen
novel essential genes of P. aeruginosa by shotgun antisense identification, a technique that was developed a decade ago for
the Gram-positive bacterium Staphylococcus aureus and was under-used in Gram-negative bacteria for a considerable
period of time. Following antisense screenings in the PAO1 strain of P. aeruginosa, we focused on a locus, PA2873, which
was targeted by an antisense RNA construct that can impair cell growth. The PA2873 gene product was annotated as a
hypothetical membrane protein endowed with a periplasmic region harbouring a structural domain belonging to the
transglutaminase-like superfamily, a group of archaeal, bacterial and eukaryotic proteins homologous to animal
transglutaminases. In this study, we show that the periplasmic portion of the PA2873 protein, which we named TgpA,
does possess transglutaminase activity in vitro. This is the first report of transglutaminase activity in P. aeruginosa. In
addition, we have provided strong evidences that TgpA plays a critical role in the viability of P. aeruginosa.
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Introduction
P. aeruginosa is a highly adaptable bacterium which thrives in a
broad range of ecological niches. In addition, it can infect multiple
hosts as diverse as plants, nematodes and mammals. The broad
habitat and host ranges of P. aeruginosa reflect the large variety of
structural, metabolic and virulence functions found in its large
pangenome [1–4]. In humans, it is an important opportunistic
pathogen in compromised individuals, such as patients with cystic
fibrosis, severe burns or impaired immunity [5,6]. Unfortunately,
P. aeruginosa is difficult to control because of its ability to develop
resistances, often multiple, to all classes of clinical antibiotics [7–9].
The common P. aeruginosa mechanisms of antibiotic resistance
often appear simultaneously and are cephalosporinase AmpC-,
porin OprD- and efflux pumps-mediated [8]. Consequently, P.
aeruginosa is a major concern to medical practitioners who
increasingly face extremely-drug resistant strains (i.e. bacterial
isolates susceptible to only one or two antibiotic categories) [9]
which may require carefully-selected antibiotic combinations [10].
The discovery of novel essential genes or pathways that have not
yet been targeted by clinical antibiotics can underlie the
development of alternative effective antibacterials to overcome
the extant mechanisms of resistance. We screened novel essential
genes of P. aeruginosa by shotgun antisense identification, a
technique that was developed a decade ago in Staphylococcus aureus
[11,12]; following a period of limited success in Gram-negative
bacteria [13,14], the technique has been used effectively in E. coli
[15]. Following our shotgun antisense screenings in P. aeruginosa
PAO1, we focused on a locus, PA2873, which was targeted by an
antisense RNA construct that can impair cell growth. The features
of the predicted protein encoded by PA2873 locus were intriguing.
In fact, it was annotated in the Pseudomonas Genome Database
[16] as a hypothetical membrane protein endowed with a
periplasmic region harbouring a structural domain belonging to
the transglutaminase-like superfamily, a group of archaeal,
bacterial and eukaryotic proteins homologous to animal transglu-
taminases [17]. In this study we show that the periplasmic portion
of the PA2873 protein does have transglutaminase activity in vitro.
This is the first report of a transglutaminase activity in P. aeruginosa.
The PA2873 gene product was called ‘‘transglutaminase protein
A’’ (TgpA). In addition, we provided strong evidences that TgpA
plays a critical role in the viability of P. aeruginosa.
Methods
Bacterial strains, plasmids and growth conditions
The bacterial strains and plasmids used are listed in Table S1.
pVLT31 [18] is an E. coli/Pseudomonas shuttle vector carrying the
lacIq/Ptac pair and tetracycline resistance. pVI533EH [19] and
pHERD20T [20], used for the construction of antisense libraries
(see below), are E. coli/Pseudomonas shuttle vectors carrying araC/
PBAD pair and ampicillin/carbenicillin resistance. Since
pHERD20T allows blue/white screening for the identification of
recombinants, it was used in place of pVI533EH at later stages of
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antisense libraries preparation. pVI533HE is a pVI533EH twin-
plasmid carrying the polylinker sequence in opposite orientation
downstream PBAD promoter. pDM4 [21] is a suicide plasmid in
Pseudomonas species carrying the chloramphenicol resistance.
pVLT31-M4G6 and pVI533HE-M4G6i were obtained by cloning
the EcoRI-HindIII insert of pVI533EH-M4G6, identified in the
antisense libraries screenings, into pVLT31 and pVI533HE,
respectively. pVLT31-M4G6i was obtained by cloning a Hin-
dIII-EcoRI fragment amplified by PCR from pVI533EH-M4G6
with primers M4G6Hind59 and M4G6Eco39 (Table S2) into
pVLT31. PCR reactions were performed using DreamTaq
Polymerase (Fermentas) with the addition of 1 M betaine (Sigma
Aldrich), because of the high GC content of P. aeruginosa genome.
Bacteria were grown at 37uC in Luria–Bertani (LB) broth, or in
M9 minimal medium supplemented with 0.2% citrate (M9-
citrate). Antibiotics were added at the following concentrations
(mg/ml): carbenicillin (Cb) 300; kanamycin (Km) 50; chloram-
phenicol (Cm) 30 and 85 for E. coli and P. aeruginosa, respectively;
tetracycline (Tc) 25; gentamicin (Gm) 25 and 50 for E. coli and P.
aeruginosa, respectively. Arabinose, rhamnose, glucose and IPTG
were used at concentrations of 7.5 mM, 0.2%, 1%, and 1 mM,
respectively. In mating experiments, exconjugant P. aeruginosa
PAO1 clones were selected on Pseudomonas Isolation Agar (PIA;
Difco) with an appropriate antibiotic or on M9-citrate in case of
use of tetracycline.
Construction and screening of PAO1 shotgun antisense
libraries
Shotgun antisense libraries (SALs) of P. aeruginosa PAO1 were
constructed in E. coli into pVI533EH and pHERD20T as
described previously [11,12]. To screen for genomic fragments
interfering with PAO1 growth, SALs were mobilized from E. coli
to PAO1 by conjugative triparental mating. PAO1 exconjugant
cell spots were inspected for growth defects after 24–48 hrs of
incubation at 37uC, both in the presence and in the absence of
arabinose. The inserts pVI533EH and pHERD20T derivatives
impairing recipient PAO1 growth were sequenced after PCR
amplification using oligo pairs pVI533F/pVI533R and pHERD-
F/pHERD-R for pVI533EH and pHERD20T, respectively
(Table S2).
Identification of PA2873 gene product in P. aeruginosa
membrane fractions
P. aeruginosa PAO1 cells, grown in LB with aeration at 37uC
until OD600 of 0.6, were harvested by centrifugation at 40006g for
15 min at 4uC and washed twice with PBS supplemented with
20% sucrose (TIB buffer). PAO1 cells in TIB buffer were disrupted
in a French press device. To remove intact cells that had escaped
lysis, crude extracts were filtered through 0.22 mm filters.
Following incubation for 1 hr at room temperature with RNase
A (Qiagen) and DNase I (Ambion), filtered crude extracts were
ultracentrifuged at 135,0006g for 60 min at 4uC to separate total
membranes from the cytoplasmic fraction. Pellets containing the
membrane fraction were washed in sequence with PBS, 1 M
NaCl, and water to remove the contaminants; they were treated
overnight under stirring with 40 mg/ml trypsin at 37uC for shaving
and the extensive peptide proteolysis required for the Multidi-
mensional Protein Identification Technology (MudPIT) analysis.
Trypsin-digested samples were centrifuged at 16,0006g for 1 hr at
4uC and the supernatants were subjected to MudPIT analysis
using the ProteomeX configuration (Thermo Fisher, San Jose`, CA,
USA). The mass spectra produced by MudPIT analyses were
correlated to in silico peptide sequences of non-redundant P.
aeruginosa protein database (5753 entries) retrieved from NCBI
(http://www.ncbi.nlm.nih.gov/). Data processing of raw spectra
was performed by the Bioworks 3.3.1 software (University of
Washington, licensed to Thermo Fisher Scientific), based on the
SEQUEST algorithm [22].
Purification of TgpA TG180–544 domain and
transglutaminase activity assay
The TgpA periplasmic domain (aa. 180–544; TG180–544) was
expressed in E. coli as N(His)10-tagged protein with an improved
His-tag (MGSDKIHHHHHHHHHHGV) under the control of
T7 promoter in plasmid p2N[M4G6 (180–544 aa)] (PRIMM srl),
and purified using standard protocols of His-tag affinity purifica-
tion. The fractions containing TG180–544 were pooled and stored
at 280uC until use in aliquots at the concentration of 2.7 mg/ml
and 95% purity, determined by SDS-PAGE.
Transglutaminase activity (TGase; EC 2.3.2.13) was assayed by
a Transglutaminase Colorimetric Microassay Kit (Covalab) which
uses immobilized N-carbobenzoxy(CBZ)-Gln-Gly as amine accep-
tor and biotin-conjugated cadaverine as amine donor. Protein
samples were incubated in a 96-well microtiter plate coated with
CBZ-Gln-Gly at 37uC for 15 min with calcium, DTT and
biotinylated cadaverine. The wells were washed three times with
phosphate buffer containing 0.1% Tween 20. To assay the
formation by TGase of cadaverine covalently linked to CBZ-Gln-
Gly (c-glutamyl-cadaverine-biotin), the wells were filled with
streptavidin-labelled horseradish peroxidase (HRP) and incubated
for 15 min at 37uC; they were washed three times with phosphate
buffer containing 0.1% Tween 20, filled with HRP substrate/
chromogen solution containing H2O2 as the substrate and
tetramethyl benzidine as the electron acceptor (chromogen).
These were incubated for 10 min at room temperature, 50 ml of
reaction blocking reagent were added and the mixture quantified
by measuring OD450. As references for the TGase activity, the kit
included purified guinea pig TGase with a specific activity of
0.1 U/mg. By definition, 1 U of TGase catalyzes the formation of
1 mmole of hydroxamate at pH 6.0 at 37uC, using L-glutamic acid
c- monohydroxamate as the standard [23].
RT-PCR analysis of PA2873 genomic region and transcript
59-end mapping
Total RNA was purified from P. aeruginosa PAO1 cells, grown in
LB with aeration at 37uC until OD600 of 0.6 (mid-exponential
phase) or of 1.2 (early stationary phase) was achieved using
RNeasy Mini kits (Qiagen) that included DNase I treatment.
Residual DNA was removed from purified RNA by further
treatment with RNA-free DNase I (Ambion) at 37uC for 15 min,
followed by DNase I inactivation with 2.5 mM EDTA at 65uC for
10 min. cDNA was generated by incubating 1 mg of RNA with
Superscript II Reverse Transcriptase (RT) (Invitrogen), 100 pg of
random primers (Invitrogen) and buffer supplied by the manufac-
turer for 50 min at 42uC. RT was inactivated by incubation at
70uC for 15 min. As a control of DNA contamination in the
subsequent RT-PCR analysis, reactions were also run without RT.
RT-PCR analysis was performed with the oligo pairs listed in
Table S2.
For mapping 59-ends of transcripts upstream PA2873 locus, a
primer extension assay was performed on PAO1 total RNA with
oligo 2873_PE60 (Table S2) end-labelled using [c-32P]-dATP
(3000 Ci mmol21) and polynucleotide kinase (Promega). 50 mg of
total RNA were mixed with 10 units of RNasin (Promega) and
1 pmol of 32P-2873_PE60 in a final volume of 10 ml of SS
hybridization buffer (300 mM NaCl, 10 mM Tris-HCl pH 7.5,
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2 mM EDTA). Reactions were heated at 80uC for 4 min,
incubated at 55uC for 2 hrs, diluted with pre-heated RT-buffer
(1 mM dNTPs, 10 mM DTT, 12.5 mM Tris-HCl pH 8.0,
7.5 mM MgCl2, 1 M betaine, 5 U of RNasin and 100 U of
SuperScript III RT) to a final volume of 50 ml, incubated at 50uC
for 30 min, and stopped with 1 ml of 0.5 M EDTA and 6 ml of
1 M NaOH at 55uC for 1 hr. Samples were neutralized with 6 ml
of 1 M HCl, precipitated, resuspended in Stop Solution (50%
formamide, 5 mM EDTA, 0.05% bromophenol blue and 0.05%
xylene cyanol), and electrophoresed on 50% urea, 6% acrylam-
ide/bis-acrylamide (19:1) gels in TBE buffer. Reference DNA
sequencing reaction was generated using as template a DNA
fragment amplified from PAO1 genomic DNA by PCR with oligo
pair SeqF/SeqR (Table S2). The DNA sequencing reaction was
performed with the fmol DNA Cycle Sequencing System
(Promega) with the addition of 1 M betaine.
Mutagenesis analyses
For pDM4 cointegration targeting, internal 600–800 bp DNA
fragments of PA2875, PA2874, PA2873, dnaG and algR, respec-
tively, were amplified by PCR with oligo pairs containing SalI
restriction sites listed in Table S2, digested with SalI (New England
Biolabs) and cloned into the corresponding site of pDM4. The
cloning was checked by PCR with the oligo pair pDM4-ori/
pDM4-cat (Table S2). This procedure gave rise to pDM4
derivatives listed in Table S1 which were transferred from E. coli
to P. aeruginosa PAO1 by triparental mating (see above for details)
selecting exconjugant PAO1 clones carrying pDM4 cointegration
on PIA plates supplemented with Cm.
The conditional mutagenesis of PA2873 locus was obtained
through upstream insertion of the rhamnose-induced/glucose-
repressed PrhaB promoter. The first 300 bp of PA2873 were
amplified by PCR with TgFullFw and Tg300RevXbaI oligos
(Table S2) carrying NdeI and XbaI sites, respectively. The resulting
DNA fragment was digested with NdeI and XbaI (New England
Biolabs) and cloned into the corresponding sites of the vector
pSC200, giving rise to the plasmid pSC200-PA2873, which was
mobilized to P. aeruginosa PAO1 by triparental mating. Exconju-
gant PAO1 clones carrying pSC200-PA2873 cointegration were
selected on PIA plates supplemented with Gm and rhamnose. One
such clone, named PAO1 PrhaB::PA2873, was grown overnight in
20 ml of M9-citrate, Gm and rhamnose as the PrhaB inducer at
37uC with shaking. Cells were collected through centrifugation at
13,000 rpm, washed twice with PBS, and resuspended in a
suitable volume of PBS to reach an OD600 of 1. To test the effects
of PrhaB promoter modulation on growth, the cell suspension was
used to inoculate, with a 106 -fold dilution, M9-citrate supple-
mented with Gm, and either with rhamnose (M9-citrate-rham-
nose) or glucose (M9-citrate-glucose). 200 ml aliquots of PAO1
PrhaB::PA2873-inoculated M9-citrate-rhamnose and M9-citrate-
glucose were distributed in triplicates in ‘‘Well Optical Bottom’’
96-wells microplates (Nunc, Thermo Fisher Scientific) and
incubated for 21 hrs in a Sunrise microplate reader (TECAN
Group Ltd.) at 37uC with constant shaking and real time OD
measurement at 595 nm every 15 min. In parallel, to test PAO1
PrhaB::PA2873 growth on a solid medium, the cell suspension in
PBS at OD600 of 1 was serially diluted up to 10
27 and spotted on
solid M9-citrate with Gm, in the presence of rhamnose or glucose.
Results and Discussion
Identification of an antisense construct targeting PA2873
locus and impairing PAO1 growth
To identify novel essential genes in P. aeruginosa, we constructed
shotgun antisense libraries (SALs) in E. coli by cloning genomic
DNA fragments of P. aeruginosa PAO1 downstream the arabinose
inducible promoter PBAD of pVI533EH or pHERD20T. Genomic
inserts able to impair PAO1 growth, supposedly by antisense
transcription effects, were screened by mating transfer of SALs
from E. coli to PAO1 and replica-plating of exconjugants on
Pseudomonas Isolation Agar (PIA) supplemented with carbenicil-
lin, both in the absence and in the presence of arabinose. These
screenings resulted in the identification of several positive
pVI533EH and pHERD20T derivatives impairing PAO1 growth
when transferred from E. coli (manuscript in preparation). As
expected, some positives of this panel carried inserts corresponding
to already known ‘‘essential-for-growth’’ genes. For instance, in the
pHERD20T derivative pHERD-S2F1, in antisense orientation,
we detected a 331 bp DNA fragment that spanned from
coordinates 637810 to 638141 of PAO1 genome, within the
PA0577 locus coding for DnaG primase [24].
For a number of positives to SALs screenings, growth
impairment was also observed in the absence of arabinose,
suggesting that basal antisense expression of the insert in PAO1, a
regulatory context for PBAD not as restrictive as E. coli, was enough
to produce deleterious effects. One such pVI533EH derivative,
pVI-M4G6 (Figure 1), was further characterized in this study. The
insert of pVI-M4G6 was sequenced and found to correspond to a
PAO1 genomic fragment spanning coordinates 3226136 to
3226491 within PA2873 locus (from 898 to 1252 positions;
PA2873 total length: 2007 bp), which inserted downstream to
the PBAD promoter of pVI533EH in antisense orientation. To
assess the antisense effect, the insert of pVI-M4G6 was inverted to
give rise to pVI-M4G6i and then retested for PAO1 growth
impairment. As shown in Figure 1, unlike pVI-M4G6, pVI-
M4G6i was unable to impair PAO1 growth once it had been
transferred from E. coli. To rule out effects of sensitization to Cb,
pVI-M4G6 insert was recloned into the TetR vector pVLT31 [18],
downstream to the Ptrp-lac promoter, both in antisense and sense
orientations, giving rise to pVL-M4G6 and pVL-M4G6i, respec-
tively. As in the case of pVI533EH, only the antisense expression
of insert from pVLT31 again resulted in PAO1 growth
impairment (Figure 1). These results strongly suggested that pVI-
M4G6-induced growth impairment of PAO1 originated from the
expression of a transcript of about 350 nt antisense to PA2873
locus. We therefore speculated that the PA2873 locus could code for
a novel and uncharacterized essential function of PAO1.
Features of PA2873 gene product, locus and genomic
region
Bioinformatic analyses, listed in Pseudomonas Genome Data-
base (PGD) [16], on the structural features of the PA2873 product
(688 aa; Figure 2A), predict that it is an inner membrane protein
endowed with six transmembrane helices and a large periplasmic
domain between aa 180 and 544 (Figure S3); between aa 396 and
467, it has a highly recognizable structural sub-domain belonging
to the transglutaminase-like superfamily (PF01841 in PFAM
database [25]), a group of archaeal, bacterial and eukaryotic
proteins homologous to animal transglutaminases [17] (Figure S1).
It is interesting to note that the 5 transmembrane helices spanning
the first 180 aa were within the bacterial domain of unknown
function DUF3488 (PF11992 in the PFAM database [25]),
typically between 323 to 339 amino acids in length and found to
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be associated with PF01841. Figure S2 illustrates the distribution
among prokaryotic species of protein presenting the association of
PF01841 transglutaminase domain and DUF3488.
Unfortunately, the PA2873 product was annotated in PGD as a
‘‘hypothetical protein’’, i.e. no experimental evidence of in vivo
expression was available and thus its existence had only been
predicted during bioinformatic genome analysis. To provide
evidence of PA2873 product expression, we searched a peptide
database that resulted from our recent proteomic survey in PAO1
(unpublished) and found five peptides belonging to the PA2873
periplasmic domain (Table S3), originating from the trypsin
digestion of native membrane fractions. Consequently, we have
provided experimental evidence that removes the PA2873 product
from the status of ‘‘hypothetical protein’’. Since all five PA2873
peptides ‘‘shaved’’ by trypsin belonged to the predicted outside
membrane domain, this strongly supports the notion that it
actually emerges from membrane itself.
The presence of a transglutaminase-like domain (TG) in
PA2873 protein was intriguing. Transglutaminases (TGases) are
enzymes that establish covalent links between proteins through the
acyl-transfer reaction between the c-carboxamide group of
peptide-bound glutamine and the e-amino group of peptide-
bound lysine. Catalysis of this reaction involves a catalytic triad
consisting of cysteine, histidine and aspartate residues that are
well-conserved in eukaryotic and prokaryotic TGases [17]. First of
all, we verified the conservation of the catalytic triad in the
PA2873 TG domain by sequence alignment with characterized
members of the TGase superfamily: the human coagulation factor
XIII conserved domain [26], TGase from red sea bream liver
(fish-derived transglutaminase, FTG) [27] and WbmE, a periplas-
mic TGase of Bordetella bronchiseptica [28] involved in the post-
assembly modification of LPS O-antigen. As shown in Figure 2A,
the catalytic triad of PA2873 TG domain appeared to be well-
conserved. To assess whether the conservation of the catalytic
triad was correlated to the TGase activity, the N-(His)10-tagged
periplasmic domain (aa 180–544) of PA2873 protein (TG180–544)
was expressed in E. coli and subjected to affinity purification.
TGase activity of the purified protein was tested through a
colorimetric microassay, using 0.25 mU of purified guinea pig
TGase (gpTGase) as the reference enzyme activity (Figure 2B).
Negative control of TGase activity was gpTGase incubated with
EDTA. TG180–544 was positive to the TGase test. In actual fact,
2.5 mg of TG180–544, equal to reference gpTGase, showed TGase
activity that differed significantly from the negative control and
was about 45% of gpTGase activity in the absence of EDTA. To
test activity dependence from Ca2+, essential for eukaryotic
TGases [27], EDTA was added to TG180–544. Unlike gpTGase,
EDTA addition did not affect TG180–544 activity. This suggested
that PA2873 TGase activity is Ca2+-independent, similar to
members of the microbial transglutaminase family [29]. For the
features described above, we called the PA2873 gene product
‘‘transglutaminase protein A’’ (TgpA).
In PGD, PA2873 locus was predicted to cluster in an operon
with the adjacent loci PA2875, PA2874 and PA2872 (Figure 3A).
This cluster arrangement is conserved throughout the sequenced
P. aeruginosa strains with the exception of strain 39016, where there
is a 354 bp intergenic region between PA2873 and PA2872
orthologs. When sequenced-Pseudomonas species in PGD were
examined, it was found in P. fulva, P. mendocina, P. syringae and P.
stutzeri strains. In the latter case, the PA2872 ortholog was absent.
To profile the transcription of PA2875-2874-2873-2972 pre-
dicted operon, we performed RT-PCR experiments on total
RNAs purified from PAO1 cell samples, taken both at mid-
exponential (OD600 of 0.6) and at early-stationary phase (OD600 of
1.2) in LB at 37uC. To detect single ORF transcription, we used
oligo pairs which amplified ORF internal regions (i, iii, v, and vii;
Figure 3B). Furthermore, to detect ORF cotranscription, we used
oligo pairs which amplified regions spanning the 39 to 59 of
adjacent ORFs (ii, iv, and vi; Figure 3B). As shown in Figure 3B,
we could observe transcription of every ORF in both growth
stages. Furthermore, our data strongly suggested that PA2875,
PA2874 and PA2873 are co-transcribed and form a transcription
unit, while PA2872 is transcribed independently.
Mutagenesis of the PA2875-2874-2873 gene cluster
The essential role of PA2873 locus (tgpA), suggested by the results
of SALs screenings (see above), was validated by insertional
mutagenesis. Consequently, we also aimed to evaluate the essential
role of the co-transcribed PA2875 and PA2874 loci. For this
reason, each gene was targeted for knock-out by homologous
recombination-mediated cointegration of the suicide vector pDM4
carrying Cm resistance (CmR). Since pDM4 is incapable of
autonomous replication in PAO1, following conjugational transfer
of pDM4 from E. coli to PAO1, CmR clones can be selected only in
the event of pDM4 cointegration with the chromosome. The dnaG
gene for DNA primase [24] and algR gene for a LytTR-type two-
component response regulator [30] were used as positive and
negative controls of essentiality, respectively. For cointegration
targeting, we cloned internal 600–800 bp fragments of PA2875,
PA2874, tgpA, dnaG and algR respectively, into pDM4. The
resulting constructs were transferred from E. coli S17-lpir to
PAO1 by conjugation, selecting cointegration events by plating the
conjugation mixtures on PIA supplemented with Cm. Three
independent conjugation experiments were performed for each
gene involved. To take fluctuations of conjugation efficiency into
Figure 1. Analysis of the growth impairment elicited by the
M4G6 insert resulting from SALs screenings. E. coli donors
harbouring the pVI533-based vectors pVI-M4G6 and pVI-M4G6i, which
carry downstream PBAD promoter the M4G6 insert in antisense and
sense orientation, respectively, were mated with P. aeruginosa PAO1
and exconjugants were spotted onto PIA to counterselect E. coli cells.
The medium was also supplemented with carbenicillin to select for
pVI533 maintenance. As a control, empty pVI533 was transferred to
PAO1 with the same procedure. Induction of PBAD promoter was
achieved through the addition of 7.5 mM arabinose (ara). A similar
protocol, with the only variant of M9-citrate for donor counterselection,
was used for the transfer to PAO1 of pVLT31-based vectors pVLT31-
M4G6 and pVLT31-M4G6i, and empty pVLT31. Induction of pVLT31 Ptac
promoter was achieved through the addition of 1 mM IPTG.
doi:10.1371/journal.pone.0050323.g001
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account, the results of replicate experiments were expressed as a
percentage of CmR ex-conjugant clones relative to the negative
control algR. As shown in Figure 4A, targeting pDM4 cointegra-
tion to both PA2874 and tgpA gave rise to a dramatic decrease in
the yield of CmR ex-conjugant clones, comparable to dnaG
inactivation. On the contrary, targeting pDM4 cointegration to
PA2875 resulted in a yield of CmR ex-conjugants that was even
higher than the control algR.
Figure 2. Predicted domain organization and transglutaminase activity of TgpA protein. (A) Map of the predicted domains DUF3488
(PF11992) and TG (PF01841) along the primary sequence of the PA2873 gene product, called TgpA. The sequence of TgpA spanning aa 396 to 467 of
the TG domain is highlighted and aligned to homologous functional TG domains of human coagulation Factor XIII, fish-derived transglutaminase
(FTG) and WbmE protein from B. bronchiseptica. Conserved aminoacids of catalytic triad are indicated by an asterisk. (B) Colorimetric assay of
transglutaminase activity of purified TgpA TG180–544 domain by Transglutaminase Colorimetric Microassay Kit (TCM kit; Covalab). TCM kit uses
immobilized N-carbobenzoxy(CBZ)-Gln-Gly as the amine acceptor and biotin-conjugated cadaverine as the amine donor. The indicated amounts of
purified TgpA TG180–544 (stock: 2.7 mg/ml, 95% purity) were incubated in 96-well microtiter plate coated with CBZ-Gln-Gly at 37uC for 15 min with
calcium, DTT and biotinylated cadaverine, both in the presence and the absence of EDTA supplied in the kit. As a reference for TGase activity, the
indicated amounts of kit-included purified guinea pig TGase with specific activity of 0.1 U/mg were incubated under the same conditions. The wells
were washed extensively and filled with streptavidin-labelled horseradish peroxidase (HRP) to assay the formation of immobilized c-glutamyl-
cadaverine-biotin by OD450 measurement of HRP activity using H2O2 as substrate and tetramethyl benzidine as electron acceptor (chromogen).
doi:10.1371/journal.pone.0050323.g002
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These results strongly support the notion that tgpA is essential. In
the case of PA2874, the above results were not conclusive. In
actual fact, the low yield of CmR ex-conjugant clones may result
either from the essential role of PA2874 or from polar effects of the
cointegration in PA2874 on the expression of tgpA. We were
unable to discriminate these two possibilities by targeting pDM4
cointegration within PA2874 in a PAO1 strain expressing tgpA
from a plasmid vector. Several attempts to introduce the tgpA-
expressing vector pVLT31-PA2873 into PAO1 were unsuccessful.
Therefore, we suggested that unbalancing the tgpA expression may
be deleterious. Finally, PA2875 would appear to be non-essential.
Using RT-PCR, we profiled the PA2875-2874-tgpA gene cluster
transcription in a CmR ex-conjugant strain PAO1
PA2875::pDM4, both upstream and downstream of the site of
pDM4 insertion within PA2875. As shown in Figure 3B, we could
detect transcription both upstream (i; PA2875) and downstream of
pDM4 cointegration in PA2875 (i39), in PA2874 (iii) and in tgpA
(v), respectively. Therefore, we validated the lack of polar effects of
the pDM4 cointegration in PA2875. Furthermore, these results
strongly suggested the presence of promoter(s) downstream of the
site of pDM4 insertion within PA2875. By primer extension
analysis with an oligo annealing with 59 region of tgpA (not shown),
we could detect 59 transcript ends located at 231, around 2280
and 2335 from the translation start site of tgpA.
The essentiality of tgpA was further confirmed by conditional
mutagenesis. The first 300 bp of tgpA were cloned into the suicide
vector pSC200 [31] downstream of PrhaB, a rhamnose inducible/
glucose repressible promoter, to give rise to pSC200-PA2873.
Upon transfer to PAO1, pSC200-PA2873 cointegration event
placed tgpA under PrhaB control. In both liquid and solid media, the
PAO1 PrhaB::tgpA strain showed a specific conditional growth
phenotype (Figure 4B), i.e. repression of PrhaB by glucose strongly
impairs growth, while rhamnose addition allows normal growth.
Due to the low number of cells in the inoculum of liquid media,
growth rate was undetectable by microtiter reader during the
initial half-time of the experiments (Figure 4B). The growth of
PAO1 PrhaB::tgpA in liquid M9-citrate supplemented with either
rhamnose or glucose was monitored for 7 hrs from inoculum by
titration of colony forming units per ml (CFU/ml) on LB plates. As
shown in Figure 4C, PAO1 PrhaB::tgpA in rhamnose started
Figure 3. Genetic organization and transcription analysis of the genomic region including PA2873 locus (tgpA). (A) PA2875-2874-2873-
2872 gene cluster is represented according to visualization by GBrowse in Pseudomonas Genome Database. Locations of fragments amplified by the
oligo pairs (Roman numbers) used in RT-PCR-based transcription analysis (B) are shown along the region map. The position of plasmid pDM4
cointegration in PAO1 PA2875::pDM4 strain is indicated. (B) Total RNA was extracted from PAO1 and PAO1 PA2875::pDM4 cells in both exponential
(E) and stationary (S) phases, and analyzed by RT-PCR. RT untreated samples (RT2) as controls of genomic DNA contamination were included in the
analysis.
doi:10.1371/journal.pone.0050323.g003
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Figure 4. Mutagenesis analysis of the PA2875-2874- tgpA gene cluster. (A) Each indicated locus was targeted for knock-out by homologous
recombination-mediated cointegration of the suicide vector pDM4 carrying chloramphenicol resistance (CmR). The dnaG gene for DNA primase and
the algR gene for a LytTR-type two-component response regulator were used respectively as positive and negative controls of essentiality.
Cointegration targeting was achieved by cloning internal 600–800 bp fragments of PA2875, PA2874, tgpA, dnaG and algR, respectively, into pDM4.
The resulting constructs were transferred from E. coli S17-lpir to PAO1 by conjugation, selecting cointegration events by plating the conjugation
mixtures on PIA supplemented with chloramphenicol. Three independent conjugation experiments were performed. Efficiency of cointegration in a
given locus is expressed as a percentage of CmR ex-conjugant colonies relative to the negative control algR. (B) The rhamnose inducible/glucose
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growing and the number of cells was detectable 11 hrs from
inoculum (Figure 4B). On the contrary, for PAO1 PrhaB::tgpA in
glucose only residual growth was observed (Figure 4C). In this
case, the threshold of cell number detection by the microtiter
reader was barely achieved in the 21 hrs of analysis (Figure 4B).
Some escape from glucose repression and/or the activity of TgpA,
which might have a low turn-over rate, may account for the
residual growth of the inoculum cells in a glucose-supplemented
medium.
Conclusions
Overall, the results presented above strongly indicate that TgpA
plays a critical role in the viability of P. aeruginosa. The
unambiguous prediction of the presence of six transmembrane
helices (Figure S3), our detection in membrane fractions (see
above) and the export across inner membrane found by PhoA
fusion screen [32] would strongly suggest that TgpA acts at a
cytoplasmic membrane level. Figure S3 shows that the TgpA
region TG180–544 containing the functional TG domain has a high
probability of being exposed on the outward face of cytoplasmic
membrane, i.e. to protrude into the periplasmic space. Therefore,
we suggest that TgpA takes part in an essential function linked to
the cell wall. Specific but non-essential functions at cell wall level
have been shown for some prokaryotic proteins endowed with TG
domains. In the Methanothermobacter species, prophage proteins
PeiW and PeiP act as pseudomurein endoisopeptidases [33,34]. In
the periplasm of B. bronchiseptica, WbmE protein catalyzes the
deamidation of uronamide-rich O chains of lipopolysaccharide
(LPS) [28]. It is conceivable that TgpA activity can participate in
cell wall functions such as i) assembly of peptidoglycan structures
ii) maturation/secretion of key periplasmic proteins iii) assembly of
surface polypeptide structures iv) biogenesis/maturation of LPS.
Supporting Information
Figure S1 Graphical representation of the distribution
across species of the structural TGase domain belonging
to the transglutaminase-like superfamily [17] (PF01841
in PFAM database [25]). The radius of the arc, i.e. distance
from the root node at the center of the sunburst, shows the
taxonomic level (‘‘superkingdom’’, ‘‘kingdom’’, etc). The length of
the arc represents the number of domains at a given level. Among
the 1752 species represented in the figure, we found 4842
sequences containing the TGase domain. 265 sequences, belong-
ing to 238 prokaryotic species, present a specific association of
TGase domain in front of the domain of unknown function
DUF3488 (PF11992 in PFAM database [25]) containing typically
6 transmembrane helices.
(TIF)
Figure S2 Graphical representation of the distribution
of DUF3488 across prokaryotic species. The radius of the
arc, i.e. distance from the root node at the center of the sunburst,
shows the taxonomic level (‘‘superkingdom’’, ‘‘kingdom’’, etc). The
length of the arc represents the number of domains represented at
a given level. Among the 238 species represented in the figure, 234
present the specific architecture of the DUF3488 domain followed
by TGase domain.
(TIF)
Figure S3 Prediction of transmembrane helices in TgpA
(PA2873). Transmembrane helice prediction along the 668 aa
sequence of PA2873 was performed by TMHMM Server v.2.0
(http://www.cbs.dtu.dk/services/TMHMM/) [35]. TMHMM
supplies some statistics and a list of the locations of the predicted
transmembrane helices and the predicted location of the
intervening loop regions. The prediction gives the most probable
location and orientation of transmembrane helices in the
sequence. It is found by an algorithm called N-best that sums
over all paths through the model with the same location and
direction of the helices. Some statistics are given as follows.
Length: the length of the protein sequence; Number of predicted
TMHs: the number of predicted transmembrane helices; Exp
number of AAs in TMHs: the expected number of amino acids in
transmembrane helices. If this number is larger than 18 it is very
likely to be a transmembrane protein (OR have a signal peptide);
Exp number, first 60 AAs: the expected number of amino acids in
transmembrane helices in the first 60 amino acids of the protein;
Total prob of N-in: The total probability that the N-term is on the
cytoplasmic side of the membrane; POSSIBLE N-term signal
sequence: a warning that is produced when ‘‘Exp number, first 60
AAs’’ is larger than 10. The plot shows the posterior probabilities
of inside/outside/TM helix. At the top of the plot (between 1 and
1.2) the N-best prediction is shown. Note the high probability of
outside location of the region spanning aa 180 to 544 containing
the functional TG domain.
(TIF)
Table S1 List of bacterial strains and plasmids.
(PDF)
Table S2 Oligonucleotides.
(PDF)
Table S3 TgpA peptides detected through MudPIT
analysis of membrane fractions.
(PDF)
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repressible promoter PrhaB was inserted upstream to tgpA giving rise to PAO1 PrhaB::tgpA strain. To test the repression effects of glucose on growth
rate, overnight cultures of PAO1 PrhaB:: tgpA in M9-citrate supplemented with rhamnose were diluted to OD600 = 10
26 and inoculated in microtiter
wells filled with 200 ml of M9-citrate supplemented with either rhamnose or glucose. Culture growth at 37u with stirring was monitored in real-time
by OD600 measurement in a microtiter reader for 21 hrs. Specificity of glucose/rhamnose effects on the growth of PAO1 PrhaB::tgpA was assessed by
monitoring the PAO1 cultures in M9-citrate supplemented with either rhamnose or glucose. Note the opposite effects of glucose on growth of PAO1
PrhaB::PA2873 and PAO1, respectively. In the insert, overnight cultures of PAO1 PrhaB::tgpA in M9-citrate supplemented with rhamnose were also
tested for growth on solid M9-citrate supplemented with either rhamnose or glucose, by spotting 2 ml of 10-fold serial dilutions, from OD600 = 1 (left)
to OD600 = 10
26 (right). (C) During the first 7 hrs from inoculum, a time window in which growth rate was undetectable by microtiter reader, the
growth of PAO1 PrhaB::tgpA in liquid M9-citrate supplemented with either rhamnose or glucose was monitored by titration of colony-forming units
per ml (CFU/ml) on LB plates.
doi:10.1371/journal.pone.0050323.g004
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SUPPLEMENTARY FIGURES 
Figure S1 Graphical representation of the distribution across species of the structural TGase 
domain belonging to the transglutaminase-like superfamily [17] (PF01841 in PFAM database 
[25]). The radius of the arc, i.e. distance from the root node at the center of the sunburst, shows the 
taxonomic level ("superkingdom", "kingdom", etc). The length of the arc represents the number of 
domains at a given level. Among the 1752 species represented in the figure, we found 4842 sequences 
containing the TGase domain. 265 sequences, belonging to 238 prokaryotic species, present a specific 
association of TGase domain in front of the domain of unknown function DUF3488 (PF11992 in PFAM 
database [25]) containing typically 6 transmembrane helices. 
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Figure S2 Graphical representation of the distribution of DUF3488 across prokaryotic species. 
The radius of the arc, i.e. distance from the root node at the center of the sunburst, shows the 
taxonomic level ("superkingdom", "kingdom", etc). The length of the arc represents the number of 
domains represented at a given level. Among the 238 species represented in the figure, 234 present 
the specific architecture of the DUF3488 domain followed by TGase domain.
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Figure S3 Prediction of transmembrane helices in TgpA (PA2873). Transmembrane helice 
prediction along the 668 aa sequence of PA2873 was performed by TMHMM Server v.2.0 
(http://www.cbs.dtu.dk/services/TMHMM/) [35]. TMHMM supplies some statistics and a list of the 
locations of the predicted transmembrane helices and the predicted location of the intervening loop 
regions. The prediction gives the most probable location and orientation of transmembrane helices in 
the sequence. It is found by an algorithm called N-best that sums over all paths through the model with 
the same location and direction of the helices. Some statistics are given as follows. Length: the length 
of the protein sequence; Number of predicted TMHs: the number of predicted transmembrane helices; 
Exp number of AAs in TMHs: the expected number of amino acids in transmembrane helices. If this 
number is larger than 18 it is very likely to be a transmembrane protein (OR have a signal peptide); 
Exp number, first 60 AAs: the expected number of amino acids in transmembrane helices in the first 60 
amino acids of the protein; Total prob of N-in: The total probability that the N-term is on the cytoplasmic 
side of the membrane; POSSIBLE N-term signal sequence: a warning that is produced when "Exp 
number, first 60 AAs" is larger than 10. The plot shows the posterior probabilities of inside/outside/TM 
helix. At the top of the plot (between 1 and 1.2) the N-best prediction is shown. Note the high 
probability of outside location of the region spanning aa 180 to 544 containing the functional TG 
domain.
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Table S1: List of bacterial strains and plasmids. 
Strains or plasmids Genotype or description Reference 
Pseudomonas aeruginosa 
PAO1 [1]
PAO1 PA2875::pDM4 PA2875 disrupted by cointegration of pDM4 This work 
PAO1 PrhaB::tgpA PA2873 (tgpA) under the control of the 
rhamnose-dependent promoter PrhaB 
This work 
Escherichia coli 
JM109 recA1 endA1 gyrA96 thi hsdR17 supE44, 
relA1, ∆(lac-proAB) F’ (traD36, proAB+ lacIqZ 
∆M15) 
[2] 
HB101 [RK2013] recA, thi, hsdR, hsdM, proA, leu, strA [3] 
S17-λpir TpR SmR hsdR pro recA RP4-2-Tc::Mu-
Km::Tn7 (λpir) 
[4] 
C118-λpir araD139 ∆(ara leu)7697 ∆lacX74 phoA20 galE 
galK thi rpsE rpoB araEam recA1 (λpir) 
[5] 
Plasmids 
pHERD20T ApR, CbR broad-host-range araC-Pbad 
expression vector; blue/white screening for 
recombinants 
[6] 
pVI533EH ApR, CbR broad-host-range araC-Pbad 
expression vector 
[7] 
pVI533EH-M4G6 pVI533EH harbouring a fragment spanning 
position 898 to 1252 of PA2873 cloned in 
antisense direction. 
This work 
pVI533HE As pVI533EH with inverted MCS [7] 
pVI533HE-M4G6i pVI533HE harbouring a fragment spanning 
position 898 to 1252 of PA2873 cloned in 
sense direction. 
This work 
pVLT31 TcR, RSF1010-lacIq/Ptac,expression vector with 
MCS of pUC18 
[8] 
pVLT31-M4G6 pVLT31 harbouring a fragment spanning 
position 898 to 1252 of PA2873 cloned in 
antisense direction, subcloned from pVI533EH-
M4G6 
This work 
pVLT31-M4G6i pVLT31 harbouring a fragment spanning 
position 898 to 1252 of PA2873 cloned in 
sense direction. 
This work 
pDM4 CmR, suicide plasmid in Pseudomonas spp, 
pBR322 origin of replication, sacB 
[9] 
pDM4-algR pDM4 harbouring position 22 to 610 of algR 
within the MCS 
This work 
pDM4-dnaG pDM4 harbouring position 12 to  422 of dnaG 
within the MCS 
This work 
pDM4-PA2875 pDM4 harbouring position 242 to 825 of 
PA2875 within the MCS 
This work 
pDM4-PA2874 pDM4 harbouring position 156 to 883 of 
PA2874 within the MCS 
This work 
pDM4-PA2873 pDM4 harbouring position 590 to 1392 of 
PA2873 within the MCS 
This work 
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pSC200 GmR, oriR6K, PrhaB rhamnose-inducible 
promoter, mob+ 
[10] 
pSC200-PA2873 pSC200 harbouring the first 300 bp of PA2873 
downstream the PrhaB promoter 
This work 
p2N[M4G6 (180-544 
aa)] 
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544) of TgpA 
This work 
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Table S2. Oligonucleotides 
a Restriction enzyme sites are underlined 
b Oligo pairs used in the experiments shown in Figure 3. 
Oligo name Sequencea (5’→3’) 
RT-PCR oligo pairb 
2875fwRT CTGGAAGCCTGCCTGAAGGC i 2875revRT GGTACCGAGGATATCGCCCG
2875fw_3’ GGACGCGACTATGTGATTCC i3’ 2875rev_3’ CAACAGCCATTGCACCAG
2875-2874fw AGCAGCAGGAAGGTCAAC ii 2875-2874rev GACGCGACTATGTGATTCC 
2874fwRT ACGGATACCGCCGGCGAG iii 2874revRT GAACACCGGGTCCGCTCC
2874-2873fw TTCCACCAGTTTGAGGATGA iv 2874-2873rev CATGCAGTCCTGGAACTCT
2873fwRT GGTGGCGCAGGTACTGGTG v 2873revRT CGCGGCGGGTCTTCATTTCC 
2873-2872fw ATGATCCAGGGTTGCGTCT vi 2873-2872rev CCAGACGTCCAGGCAAAG 
2872fwRT GGTGGCGTTGATGTCGGCG vii 2872revRT GCATCCCGCAGCCCTTCG 
Primer extension 
2873_PE60 ATCCACAGCGGCATGTAGGC
Seq_Fw GAACGCTCGCTGTTGCTC
Seq_Rev CGCGGCGGGTCTTCATTTCC
Antisense libraries construction and screening 
M4G6Hind5’ CCCAAGCTTCGGCGCGCAGGACGAAAG 
M4G6Eco3’ CCGGAATTCCCGATTTCCACCTGCAGCG
pVI533F ATCACGGCAGAAAAGTCCAC
pVI533R CTTCTCTCATCCGCCAAAAC
pHERD-F ATCGCAACTCTCTACTGTTTCT
pHERD-R TGCAAGGCGATTAAGTTGGGT
RSP AGCGGATAACAATTTCACACAGGA
VLT31-rev AATTGGGGACCCTAGAGGTCC
pDM4-derivatives construction 
algRfwSalI GAAAGTCGACGAACCTCTGGCGCG
algRrevSalI GAAAGTCGACCAGCGCGTTGCGG 
dnaGfwSalI GAAAGTCGACGATACCGCAAAGCTTCATCG 
dnaGrevSalI GAAAGTCGACGGCCCTTCAGGTAGTTCACC 
2875fwSalI GAAAGTCGACAAGGACAGCGGGC 
2875revSalI GAAAGTCGACCGCCGGCAACACC
2874fwSalI GAAAGTCGACGATCAACTACCAGAACAGC
2874revSalI GAAAGTCGACAGTTCCAGGACTGCAT
2873fwSalI GAAAGTCGACTCTCGGAGAGCATGGC 
2873revSalI GAACGTCGACGCTCAGCCAGCC
2872fwSalI GAACGTCGACATCGATGAACTGCTG
2872revSalI GAACGTCGACAGCCACTGTTCGAG
pDM4-ori GTGACACAGGAACACTTAACG
pDM4-cat TGTCCCTCCTGTTCAGCTAC
pSC200-PA2873 construction 
TgFullFw CGGCGGCATATGAACGCGATTCCGC
Tg300RevXbaI AACTGCTCTAGACGCATCGCGGCGGGTC 
pSC200-824(fw) GCCCATTTTCCTGTCAGTAACGAGA 
pSC200-1400(rev) TAACGGTTGTGGACAACAGCCAGGG 
Table S3. TgpA peptides detected through MudPIT analysis of membrane fractions 
Peptide From residue To residue 
APGDIAELGR 203 212 
APQWSGEDALHWQK 250 263
LDVAQTDQTDTR 285 296 
HEPFAYTLKPPATGADGVDDFLFDTR 375 400
KPPATGADGVDDFLFDTR 383 400 
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Abstract 
The Gram-negative Pseudomonas aeruginosa is a metabolically versatile bacterium and one of the 
most deadly pathogens in compromised individuals, such as patients with cystic fibrosis, severe 
burns or impaired immunity. Compared with other pathogens, P. aeruginosa is very difficult to 
eradicate as it displays high intrinsic resistance to almost all antibiotics in clinical use and treatment 
of its infections is a growing challenge. The discovery of novel essential functions of P. aeruginosa 
could drive the development of alternative and effective anti-Pseudomonas molecules to overcome 
the extant mechanisms of resistance.  
In this work, we focused on the characterization of the PA0580 locus encoding the protein Gcp 
belonging to the Kae1/Qri7/YgjD family, which was one of the essential candidates resulting from 
antisense screenings that we performed previously in the P. aeruginosa strain PAO1. Combining 
several genetic approaches, we showed that Gcp is essential for P. aeruginosa. In addition, we 
focused on the product of PA3685 locus, the YeaZ protein, a putative partner of Gcp. We obtained 
evidence that YeaZ also plays a critical role in P. aeruginosa viability. 
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Introduction 
 
Pseudomonas aeruginosa is a versatile bacterium that can adapt to a broad range of ecological 
niches [1,2]. In addition, it can infect multiple hosts as diverse as plants, nematodes and mammals 
[3]. In humans is the third most common cause of nosocomial infections, such as chronic infection 
of the lungs in cystic fibrosis (CF) patients, urinary tract infections resulting from catheterization, 
burn wounds and keratitis [4–6]. P. aeruginosa is resistant to virtually all classes of antibiotics in 
clinical use and has consequently joined the ranks of “Superbugs” [7,8]. P. aeruginosa infections 
are difficult to eradicate due to its high intrinsic resistance, together with its ability to develop 
resistance, often multiples, through adaptation and mutation [9]. Therefore, P. aeruginosa is a major 
concern in hospital settings and its multi-drug resistance nature incredibly limited the number and 
effectiveness of therapeutic options [10].  
The discovery of novel essential genes or pathways that have not yet been targeted by clinical 
antibiotics can underlie the development of alternative effective antibacterials to overcome the 
extant mechanisms of resistance. We recently published an antisense-mediated strategy [11], 
established previously in S. aureus [12,13], for the identification of novel essential genes of P. 
aeruginosa. Among several growth-impairing genomic inserts that resulted from our antisense 
screenings, we focused on one that targeted the locus PA0580. 
PA0580, annotated in the Pseudomonas Genome Database (PGD) [14] as gcp or ygjD, encodes a 
protein, Gcp, which belongs to Kae1/Qri7/YgjD family (COG0533) including top-10 universal 
proteins of unknown function awaiting characterization [15,16]. Members of this family have been 
studied in terms of overall cellular effects mainly by modulation of protein expression studies. In 
yeast, Kae1 is not essential but forms part of the KEOPS complex involved in transcription, 
maintenance of telomeres, and segregation of chromosomes [17–19]. In prokaryotes, YgjD has been 
shown to be an essential gene product in many different species such as Staphylococcus aureus 
[20], Streptococcus pneumonia [21], Escherichia coli [22], Bacillus subtilis [23] Francisella 
novicida [24]. 
Several functions have been proposed for YgjD orthologs and their various partner proteins. A 
YgjD ortholog was annotated first 20 years ago as Gcp for O-sialoglycoprotein-endopeptidase in 
Mannheimia (formerly Pasteurella) haemolytica [25,26]. The endopeptidase activity of Gcp was 
never confirmed [19]. More recently, it has been shown that YgjD orthologs are involved in the 
generation of N6-threonyl-carbamoyl-adenosine (t6A), an universal modification found at position 
37 of tRNAs decoding ANN codons [27,28] (Figure S1). In E. coli, four proteins TsaB, TsaC, 
TsaD, and TsaE (formely YeaZ, YrdC, YgjD, and YjeE respectively) have been reported to be 
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‘necessary and sufficient’ for t6A synthesis in vitro [29]. Moreover, it has been published that the E. 
coli YgjD (TsaD) form a complex with YeaZ (TsaB) which is also essential for E. coli growth [22]. 
Although YeaZ and YgjD share 30% identity within their first 100 amino acids, YeaZ is only found 
in bacteria and was assigned to COG1214 which is annotated as “Inactive homolog of metal-
dependent proteases, putative molecular chaperone.”[19]. Recently, the structure of the Salmonella 
typhimurium YgjD ortholog was solved in complex with YeaZ to 2.3 Å resolution showing the 
typical ASKHA superfamily fold, with the protein organized into 2 lobes as an atypical DNA 
binding protein [30]. 
In this study, combining several genetic approaches, we showed that Gcp is essential for P. 
aeruginosa. In addition, we focused on the product of PA3685 locus, a YeaZ ortholog. Our results 
suggest that this protein also plays a critical role in P. aeruginosa viability.  
  
102
Methods and Materials 
 
Bacterial strains, plasmids and growth conditions 
The P. aeruginosa and E. coli strains, as well as the plasmids used in this study, are listed in Table 
S1. pHERD20T [31], used for the cloning procedures and for the construction of antisense libraries 
[11], is a E. coli/Pseudomonas shuttle vector carrying araC/PBAD pair and ampicillin/carbenicillin 
resistance. pHERD-E2-Agcp was obtained by cloning the EcoRI-HindIII fragment amplified by 
PCR from pHERD-S1E2 with primers AgcpFw and AgcpRev (Table S2) into pHERD20T digested 
with the same enzymes. pDM4 [32] is a suicide plasmid in Pseudomonas species carrying the 
chloramphenicol resistance. Plasmid pQE30 was purchased from QIAGEN and used for 
recombinant protein expression. Plasmid pSC200 carrying gentamicin resistance [33] enables the 
delivery of the rhamnose-inducible PrhaB promoter into the chromosome to drive the expression of a 
targeted gene. 
Bacteria were grown at 37 °C in Luria–Bertani (LB) broth, or in M9 minimal medium supplemented 
with 0.2% citrate (M9-citrate). Antibiotics were added at the following concentrations (µg/ml): 
carbenicillin (Cb) 300; ampicillin (Amp) 100; kanamycin (Km) 50; chloramphenicol (Cm) 30 and 
85 for E. coli and P. aeruginosa, respectively; 25; gentamicin (Gm) 25 and 50 for E. coli and P. 
aeruginosa, respectively. Arabinose, rhamnose, glucose and isopropyl-β-D-Thiogalactoside (IPTG) 
were used at concentrations of 7.5 mM, 0.2%, 1%, and 0.1 mM, respectively. In mating 
experiments, exconjugant P. aeruginosa PAO1 clones were selected on Pseudomonas Isolation 
Agar (PIA; Difco) with an appropriate antibiotic. 
Plasmids were mobilized from E. coli to P. aeruginosa PAO1 by conjugative triparental mating 
[34]. E. coli donor strains were grown overnight in LB broth supplemented with appropriate 
antibiotic. The recipient P. aeruginosa PAO1 and helper E. coli HB101/pRK2013 strains were 
grown overnight in LB broth at 42 °C and 37 °C respectively. Fifty microliters each of helper, 
recipient, and donor strains were mixed in 5 ml of sterile MgSO4 solution. After mixing, each 
mixture was filtered on 13 mm filters (containing pores of 0.45 µm in diameter; Millipore, Bedford, 
Mass., USA) and placed on nutrient agar plates. The plates were incubated at 37 °C overnight and 
then bacteria grown on filter were resuspended in 3 ml of a sterile MgSO4 solution. 100 µl aliquots 
of resuspended cells were plated onto nutrient agar plates containing appropriate antibiotic. 
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Cloning, expression and Gcp, YeaZ purification 
pQE30 clonings and construction pHR6HT-Gcp plasmid. The gcp open reading frame (ORF) was 
amplified from PAO1 genomic DNA by PCR with the forward primer GcpFULLfw and the reverse 
primer GcpFULLrev (Table S2). PCR product was digested with BamHI and HindIII and inserted 
into the commercial expression pQE30 (Qiagen) digested with the same enzymes to generate the 
Gcp expression plasmid pQE30-Gcp for expression of the 6xHis tagged protein. 
The PA3685 coding sequence was amplified from PAO1 genomic DNA by PCR with oligo pairs 
YeaZFULLfw/YeaZFULLrev, then PCR product followed the same protocol described above 
obtaining the plasmid pQE30-YeaZ for expression of the 6xHis tagged YeaZ protein. 
pHR6HT-Gcp was obtained by cloning EcoRI/SalI the fragment amplified by PCR with primers 
pQE30-RBS-Fw and pQE30-Sal-rev (Table S2) from pQE30-Gcp into pHERD20T digested with 
the same enzymes. This construct contains the synthetic ribosomal binding site of pQE30 for high 
translation rates, the 6xHis-tagged coding sequence of gcp and strong transcriptional terminator t0 
from phage lambda [35] and allows the expression of Gcp-6xHis-tagged protein directly in P. 
aeruginosa. PCR reactions were performed using DreamTaq Polymerase (Fermentas) with the 
addition of 1 M betaine (Sigma Aldrich), because of the high GC content of P. aeruginosa genome. 
 
Expression and purification of Gcp and YeaZ. M15[pREP4] transformed with pQE30-Gcp or 
pQE30-YeaZ were grown in LB medium supplemented with Amp and Km at 37°C until the 
logarithmic phase (at OD600 of 0.6) and induced by isopropyl-β-D-thiogalactoside (IPTG) at a final 
concentration of 0.1 mM for 5 hrs at 30 °C. PAO1 carrying pHR6HT-Gcp was cultured in LB 
medium supplemented with Cb for growth at 37°C until the logarithmic phase (at OD600 of 0.6) and 
induced by arabinose at a final concentration of 7.5 mM for 4 hrs at 37 °C. 
Cells were harvested and resuspended in resuspension buffer (50 mM Phosphate Buffer, 150 mM 
NaCl, 10 mM imidazole, pH 7.4). Cells were disrupted by French Press device (20 bar pressure for 
E. coli and 25 bar for P. aeruginosa) then cellular debris was removed by centrifugation at 7000 
rpm for 20 min at 4°C. Protein extracts were incubated with one tablet of protease inhibitor 
Complete Mini EDTA-free (Roche) 10 µg/ml DNase I (New England Biolabs) 5 µg/ml 
Ribonuclease A (Sigma) for 30 minutes at 4 °C. Extracts were centrifuged at 13000 rpm, for 45 
minutes at 4 °C then soluble fraction was collected and filtered (0.22 µm). 
FPLC was performed with 1 ml Ni-NTA Superflow (Qiagen), previously equilibrated with 20 ml of 
Phosphate Buffer. Column was washed with 50 ml of wash buffer (50 mM Phosphate Buffer, 150 
mM NaCl, 30 mM Imidazole, pH 7.4) before the bound His-tagged proteins were eluted by the 
addition of elution buffer (50 mM Phosphate Buffer, 150 mM NaCl, 200 mM Imidazole). Eluted 
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fractions were collected together using Pierce Protein Concentrators, 9K MWCO (Thermo 
Scientific) to remove imidazole and concentrate the sample that was subsequently loaded on a 
HiLoad 16/600 Superdex 75 pg (GE Healthcare) column to perform gel filtration chromatography 
analysis. 
 
Gel filtration chromatography. Analytical gel-filtration experiments were performed in an ÄKTA 
Purifier–10 system (GE Healthcare) with a HiLoad 16/600 Superdex 75 pg (GE Healthcare) 
column. A 2 ml aliquot of purified (His)6-Gcp/YeaZ proteins were eluted using 50 mM Tris/HCl, 
pH 7.4, 150 mM NaCl and 1 mM β-mercaptoethanol. Elution volumes were collected and protein 
was detected by absorbance at 280 nm. Molecular mass values for (His)6-Gcp/YeaZ were 
interpolated from a calibration curve using Aldolase (158 kDa), Conalbumin (75 kDa), Ovalbumin 
(44 kDa), Carbonic anhydrase (29 kDa), and Ribonuclease A (13.7 kDa) as standards (GE 
Healthcare). 
 
In vitro activity assays 
Protease activity assay. Detection of Gcp protease activity was carried out with EnzChek Protease 
Assay Kit (E6638, Molecular Probes, Life Technologies) that provides a FRET (fluorescence 
resonance energy transfer)-based method for the simple and accurate quantification of a wide range 
of protease activities The EnzChek Protease Assay Kit was used essentially according to 
manufacturer’s instructions. Gcp purified protein was mixed in a total volume of 200 µl with 1 
mg/ml bovine serum albumin (SIGMA) and 5 µg/ml BODIPY-FL labeled casein substrate in 
digestion buffer (10 mM Tris-HCl pH 7.8, 100 µM sodium azide) in a 96-well microtiter plate. The 
plate was incubated for 1h at 37 °C and fluorescence was measured at 485 nm excitation/525 nm 
emission in an Infinite M200 microplate reader (TECAN Group Ltd.). Trypsin (Sigma) 1 mg/ml 
was used as a control. 
 
ATPase activity assays. Gcp ATPase activity was determined using adenosine 5'-triphosphate 
(ATP) Bioluminescent Assay Kit (Sigma FL-AA). This kit allows quantitative bioluminescent 
determination of ATP through a reaction that emits light proportional to the ATP present. The 
adenosine 5'-triphosphate (ATP) Bioluminescent Assay Kit was used following the manufacturer׳s 
protocol. 10 µl solutions with all the compounds necessary (Mg2+ 1 mM, Na2CO3 10 mM, 
Threonine 10 mM, ATP 100 mM, purified Gcp 2 mg/ml) have been set up along with the control 
with the denatured protein (warmed at 95 °C for 15 minutes) and incubated at 25 °C for 1 hour. 
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Then 180 µl of the assay kit were added and measurements were made on a TD 20/20 luminometer 
(Turner Designs).  
 
RT-PCR analysis of PA3685 genomic region 
Total RNA was purified from P. aeruginosa PAO1 cells, grown in LB with aeration at 37 °C until 
OD600 of 0.6 (mid-exponential phase) was achieved using RNeasy Mini kits (Qiagen) that included 
DNase I treatment. Residual DNA was removed from purified RNA by further treatment with 
RNA-free DNase I (New England Biolabs) at 37 °C for 15 min, followed by DNase I inactivation 
with 2.5 mM EDTA at 65°C for 10 min. cDNA was generated by incubating 1 μg of RNA with 
Superscript II Reverse Transcriptase (RT) (Invitrogen), 100 pg of random primers (Invitrogen) and 
buffer supplied by the manufacturer for 50 min at 42 °C. RT was inactivated by incubation at 70 °C 
for 15 min. As a control of DNA contamination in the subsequent RT-PCR analysis, reactions were 
also run without RT. RT-PCR analysis was performed with the oligo pairs listed in Table S2.  
 
Mutagenesis analyses 
Insertional mutagenesis assay. DNA fragments about 300-500 bp of PA0580, PA2873, PA3685, 
dnaG and algR, respectively, were amplified by PCR with oligo pairs containing SalI restriction 
sites listed in Table S2, digested with SalI (New England Biolabs) and cloned into the 
corresponding site of pDM4. The cloning was checked by PCR with the oligo pair pDM4-
ori/pDM4-cat (Table S2). This procedure gave rise to pDM4 derivatives listed in Table S1 which 
were transferred from E. coli to P. aeruginosa PAO1 by triparental mating (see above for details) 
selecting exconjugant PAO1 clones carrying pDM4 cointegration on PIA plates supplemented with 
Cm. 
 
Generation of rhamnose-dependent conditional mutant. An approximately 300 bp fragment of 
PA0580 starting at the start codon was amplified by PCR with gcp-psc-fw and gcp-psc-rev oligos 
(Table S2) carrying NdeI and XbaI sites, respectively. PCR product was purified with QIAquick 
PCR Purification Kit (Qiagen), digested with NdeI and XbaI (New England Biolabs) and cloned 
into the corresponding sites of the vector pSC200. 
pSC200-PA0580 plasmid generated in E. coli JM109 was mobilized to P. aeruginosa PAO1 by 
triparental mating (see above). Exconjugant PAO1 clones carrying pSC200-PA0580 cointegration 
were selected on PIA plates supplemented with Gm and rhamnose. A clone, identified as PAO1 
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PrhaB::gcp , was checked by PCR with oligos annealing at both sides of pSC200 MCS and stored for 
subsequently analysis. 
 
Growth assay of conditional mutant. The PAO1 PrhaB::gcp clone, was grown overnight at 37 °C 
with shaking in 20 ml of M9-citrate, supplemented with Gm and rhamnose. 2 ml aliquots of the 
overnight culture were centrifuged at 13.000 rpm, the pellet was washed several times with PBS. 
Bacterial cells were adjusted to an optical density OD600 of 1.0 and serially diluted up to 10-6. To 
investigate the effects of PrhaB promoter modulation on growth, the cell suspension was used to 
inoculate M9-citrate supplemented with Gm, and either with rhamnose (M9-citrate-rhamnose) or 
glucose (M9-citrate-glucose). 200 μl aliquots of PAO1 PrhaB::gcp inoculated in  M9-citrate-
rhamnose and M9-citrate-glucose were distributed in triplicates in “Well Optical Bottom” 96-wells 
microplates (Nunc, Thermo Fisher Scientific) and incubated for 22 hrs in a Sunrise microplate 
reader (TECAN Group Ltd.) at 37 °C with constant shaking and real time OD measurement at 595 
nm every 15 min. In parallel, to investigate the growth defect of essential gene conditional mutants 
in solid media, the cell suspension in PBS at OD600 of 1 was serially diluted up to 10-7 and spotted 
on solid M9-citrate with Gm, in the presence of rhamnose or glucose and incubated for 12 hrs at 37 
°C. 
 
Complementation of conditional mutant PAO1 PrhaB::gcp. The recombinant plasmid pHR6HT-Gcp 
was introduced into PAO1 PrhaB::gcp by triparental mating (see above) and used for 
complementation in trans of conditional mutant. The mutant so obtained PAO1gcpC was selected 
on PIA medium supplemented with rhamnose, Cb and Gm. PAO1gcpC was grown overnight at 37 
°C with shaking in 20 ml of LD, supplemented with Cb, Gm and rhamnose. Overnight culture was 
centrifuged at 13.000 rpm and the pellet was washed three times with PBS. Bacterial cells were 
adjusted to an optical density OD600 of 1.0 and serially diluted up to 10-7: 2 µl drops from each 
dilution were transferred on M9-citrate media supplemented with arabinose and with glucose or 
rhamnose, and incubated for 12 hrs at 37 °C. 
 
Transmission electron microscopy analysis 
Transmission electron microscopy analysis of PAO1 PrhaB::gcp strain was carried out essentially as 
described by Stanley et al. [36]. For TEM observation of Epon resin-embedded samples, overnight 
cultures were centrifuged 30 minutes at 6000 g, resuspended in 2.5% gluteraldehyde in 0.1 M 
sodium cacodylate, incubated at ambient temperature for 15 minutes, centrifuged at 20000 g for 10 
minutes. After an overnight incubation at 4°C, samples were treated with 1% (wt/vol) OsO4 in 
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distilled water for 30 min on ice in darkness. The osmium fixation was followed by three 10 min 
washes in distilled water before initiation of the ethanol dehydration series. Finally, cells were 
dehydrated in a graded ethanol series (70, 80, 90, 96, and 100% ethanol), gradually infiltrated with 
Epon resin sections were made on an Ultracut E microtome (Reichert). Ultrathin sections of 80 nm, 
made with a diamond knife (Diatome), were collected on 200 mesh formvar/carbon copper grids, 
double stained with uranyl acetate and lead citrate and examined at an EFTEM Leo912ab 
transmission electron microscope (Zeiss) at 80 kV. Digital images were acquired by Esivision 
CCD-BM/1K system. Images were processed with Adobe Photoshop for contrast adjustment 
(Image-adjustments-autocontrast). 
 
Statistical analysis 
If not otherwise stated, all experiments were performed at least in triplicate and the data were 
analysed by one-way analysis of variance, with a p-value of 0.05 being significant, using the 
statistical software package R (R Core Team, 2013). 
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Results and Discussion 
 
Antisense targeting of PA0580 locus 
 
In a shotgun antisense approach to the identification of novel essential genes in P. aeruginosa [11], 
we identified 43 growth-impairing inserts carrying multiple loci. One such insert of 692 bps, named 
S1E2, corresponded to a PAO1 genomic region (coordinates 640687 to 639995) including the 3’ 
portions of two contiguous inverted ORFs (Figure S2): PA0581 (coordinates 640420 – 640989; - 
strand), from 302 to 569 positions, and PA0580 (639316 – 640341; + strand) from 680 to 1026 
positions. S1E2 insert orientation placed in the S1E2-carrying plasmid pHERD-S1E2 the 3’ 
portions of PA0581 and PA0580 downstream the PBAD promoter in sense and antisense direction, 
respectively. We speculated that the growth-impairment mediated by S1E2 was elicited by 
antisense effect on PA0580 because we found in the Database of Essential Genes (DEG) [37] 
several orthologs of PA0580. To test this hypothesis, a DNA fragment spanning 680 to 1026 of 
PA0580 was cloned downstream to the PBAD promoter of pHERD20T in antisense orientation to 
generate pHERD-E2-Agcp. Similarly to pHERD-S1E2, pHERD-E2-Agcp was able to impair PAO1 
growth once it had been transferred from E. coli. These results strongly suggested that the product 
of PA0580 locus, the Gcp protein, could play a novel and uncharacterized essential role in P. 
aeruginosa. 
 
Validation of PA0580 essentiality 
 
The essential role of PA0580 was validated by insertional mutagenesis. PA0580 was targeted for 
knock-out by homologous recombination-mediated cointegration of the suicide vector pDM4 
carrying Cm resistance (CmR). Since pDM4 is unable of autonomous replication in PAO1, 
following conjugal transfer from E. coli to PAO1, CmR clones can be selected only if pDM4 
cointegrates with the PAO1 chromosome. The dnaG gene for DNA primase, a single-strand DNA 
(ssDNA)-dependent RNA polymerase that plays a key role in DNA synthesis [38], and algR gene 
for a LytTR-type two-component response regulator [39] were used as positive and negative 
controls of essentiality, respectively. An additional positive control of essentiality was the tgpA 
gene that we recently characterized as essential [40]. 
Briefly, approximately 500 bp fragments of PA0580 (gcp), tgpA, dnaG and algR, were cloned into 
pDM4 and the resulting constructs were transferred from E. coli CC118-λpir to PAO1 by triparental 
mating. Cointegration events were selected by plating the conjugation mixtures on PIA 
supplemented with Cm. Three independent conjugation experiments were performed for each gene 
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and the results were expressed as a percentage of CmR ex-conjugant clones relative to the negative 
control algR. As shown in Figure 1, targeting pDM4 cointegration to PA0580 gave rise to a 
resounding decrease (more than 99%) in the yield of CmR ex-conjugant clones, comparable to tgpA 
inactivation and even lower than the results obtained for the positive control dnaG. 
To further assess the essentiality of PA0580, we performed conditional mutagenesis through the 
insertion of the rhamnose-induced and glucose-repressed PrhaB promoter upstream PA0580. In this 
approach, a fragment of approximately 300 bp spanning the 5' region of PA0580 was cloned into 
the suicide vector pSC200 and the resulting recombinant plasmid pSC200-PA0580 was transferred 
into P. aeruginosa PAO1. Following cointegration of pSC200-PA0580 with the PAO1 chromosome 
by homologous recombination, PA0580 was located downstream PrhaB and thus its expression could 
be stringently controlled by the amounts of rhamnose and glucose in the growth medium. The P. 
aeruginosa strain resulting from pSC200-PA0580 cointegration was named PAO1 PrhaB::gcp. To 
test the essentiality of PA0580, PAO1 PrhaB::gcp was inoculated in M9-citrate medium 
supplemented with either 0.2% rhamnose (permissive condition) or 1% glucose (non-permissive 
condition). As shown in Figure 2A and B, the PAO1 PrhaB::gcp strain showed a conditional 
rhamnose-dependent growth in both liquid and solid media. The strong impairing effects of glucose 
on growth were specific for PAO1 PrhaB::gcp since PAO1 wt grew efficiently on glucose (Figure 
2A). Due to the low number of cells in the inoculum, growth was expected to be initially 
undetectable by microtiter reader (Figure 2A). Therefore, the growth of PAO1 PrhaB::gcp was 
monitored for 6 hours from inoculum also by titration of colony forming units per ml (CFU/ml) on 
LB plates. As shown in Figure 2C, PAO1 PrhaB::gcp in rhamnose started growing and the number of 
cells was detectable about 12 hours from inoculum (Figure 2A). On the contrary, for PAO1 
PrhaB::gcp in glucose only residual growth was initially observed (Figure 2C) and the threshold of 
cell number detection was never reached (Figure 2A). Plasmid pHR6HT-Gcp, a pHERD20T 
derivative expressing PA0580 under the control of the PBAD promoter was introduced into PAO1 
PrhaB::gcp and growth in the presence of glucose was tested on solid medium. As shown in Figure 
2B, pHR6HT-Gcp, and not pHERD20T, could restore growth of PAO1 PrhaB::gcp in the presence of 
glucose. Overall, the results presented above strongly indicated that PA0580 product Gcp plays a 
critical role in the viability of P. aeruginosa. 
We investigated at cellular level the consequences of Gcp depletion. PAO1 PrhaB::gcp cells were 
inoculated as above in M9-citrate medium supplemented with either 0.2% rhamnose or 1% glucose 
and incubated overnight at 37° C. PAO1 PrhaB::gcp cells were then collected and processed for 
TEM observation. As shown in Figure 3, depletion of Gcp in the presence of glucose resulted in 
pleiotropic effects with unusual cellular morphologies, i.e, cell elongation and branching, 
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concatenated cells, anomalies in septation, “rough” outer membranes, lack of OM vescicles, etc. 
Similar effects were already described following YgjD depletion in E. coli [22]. 
 
Gcp protein forms homodimers and shows residual peptidase and ATPase activities 
 
Gcp is a 36.6 kDa protein annotated in PGD [14] as a O-sialoglycoprotein endopeptidase with a 
predicted extracellular localization. Different structural features can be predicted: the Pfam protein 
families database [42] recognizes, between aa 23 and 311, a conserved domain belonging to 
glycoprotease family (Peptidase_M22, PF00814) while TIGRFAMs database [43] identifies, 
between aa 3 and 318, a domain belonging to tRNA threonylcarbamoyl adenosine modification. 
These conflicting annotations regarding its function reflect 20 years of studies and attempts of 
characterization resulting in sometimes elusive data [17–19,22,25,44,45]. 
N-terminal (His)6-tagged full length Gcp was expressed in E. coli and purified as described in the 
Materials and Methods section. Unfortunately, as described previously for YgjD [22], we observed 
that Gcp was subjected to degradation during the purification steps. To overcome this problem, we 
performed the purification in P. aeruginosa. To this purpose, the pHERD20T shuttle vector has 
been engineered as described in the Materials and Methods section to give rise to pHR6HT-Gcp. 
Analytical gel filtration experiments were performed on purified Gcp. As shown in Figure 4, Gcp 
eluted as a single peak corresponding to a molecular weight of 75 kDa. This correlates with the 
estimated mass of the dimeric form of Gcp (74.5 kDa). Interestingly, our results are consistent with 
those proposed for the E. coli Gcp ortholog YgjD [22] while in S. typhimurium only the monomeric 
form was described [30].  
The Gcp protein was first described in Mannheimia haemolytica as a secreted protein endowed with 
glycopeptidase activity. To assess this proteolytic activity, the purified Gcp protein was tested 
through a fluorescence-based microassay at pH 7. As shown in Figure 5A, Gcp showed residual 
proteolytic activity. The assay was repeated at different pH values, ranging from 5.5 to 8.5. No 
increase of proteolytic activity was observed in this pH range. This results are consistent with those 
proposed previously by several research groups [28,46] that could not confirm the evidence for 
glycopeptidase activity which was initially claimed. 
More recently, it has been shown that YgjD orthologs are involved in N6-threonyl-carbamoyl-
adenosine (t6A), an universal modification found at position 37 of tRNAs decoding ANN codons 
[27,28] through a potential biochemical pathway and intermediates showed in Figure S1. In this 
context, it was proposed that YgjD could be an ATP-dependent protein [27,47] potentially endowed 
with ATPase. Therefore, we tested Gcp for ATPase activity through a bioluminescent assay. The 
experiments were performed in the presence of the putative cofactors [29], threonine and 
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bicarbonate, and using as control the same amount of inactivated protein. As shown in Figure 5B, 
Gcp showed residual ATPase activity. 
Putative partners of Gcp in P. aeruginosa 
It has been recently published [29] that in E. coli YgjD, renamed TsaD, interacts with other three 
proteins TsaB, TsaC and TsaE (formely YeaZ, YrdC, and YjeE, respectively) for t6A synthesis in 
vitro. We speculated the presence of these partners in P. aeruginosa. Sequence alignment analysis 
strongly suggested that the P. aeruginosa hypothetical proteins PA3685 (YeaZ), PA0022 (YrdC) 
and PA4948 (YjeE) are orthologs of E. coli TsaB, TsaC and TsaE, respectively (Table S3; Figure 
S3). We focused our attention on PA3685, since it was recently shown that physically interacts with 
Gcp in S. typhimurium and crystal structure of Gcp-YeaZ eterodimer was resolved [30]. PA3685 
encodes a small highly conserved protein unique to bacteria; it was found in all bacterial genomes 
sequenced to date, with the exceptions of the highly reduced genomes of the obligate 
endosymbionts Carsonella ruddii and Sulcia muelleri [48,49]. Like Gcp, with whom shares 30% 
identity within their first 100 amino acids, also YeaZ has been shown to be essential in many 
different species such as S. aureus [20], S. pneumonia [21], E. coli [22], B. subtilis [23] F. novicida 
[24]. First, we set out to validate the essential role in P. aeruginosa through the insertional 
mutagenesis approach described above. As shown in Figure 6A, targeting pDM4 cointegration to 
PA3685 gave rise to dramatic decrease in the yield of CmR ex-conjugant clones, comparable with 
the results obtained for the positive control dnaG. However, since in PGD PA3685 locus was 
predicted to be the first ORF of an operon which spans up to PA3679, it is possible that the results 
of insertional mutagenesis reflected a polar effect on downstream ORFs. The cluster arrangement 
annotated in PGD is not classified similarly in EcoCyc database [50] which instead indicates that 
there is no high-quality evidence to confirm the extent of this transcription unit. To clarify this 
annotation and to profile the co-transcription of the first three ORFs (PA3685-3684-3683), we 
performed RT-PCR experiments on total RNAs purified from PAO1 cell samples with oligo pairs 
which amplified regions spanning the 3’ to 5’ of adjacent ORFs. As shown in Figure 6B, we could 
observe co-transcription for PA3685-3684 and PA3684-3683 pairs but not for PA3685-3683. These 
results suggested that PA3685 and PA3683 do not belong to the same transcription unit. In this 
scenario, the insertional mutagenesis experiment described above suggests the essentiality of 
PA3685. However, polar effects on PA3684 of insertions within PA3685 cannot be ruled out. 
Finally, an N-(His)6-tagged YeaZ was purified and analytical gel filtration experiments were 
performed. As shown in Figure 6C, YeaZ eluted as single peak of 51 kDa that correlates with the 
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estimated molecular weight of the dimeric form (49.7 kDa). These results are consistent with the 
previous characterization of YeaZ orthologs in E.coli and S. typhimurium [22,30]. 
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Conclusions  
In this work, we showed the essentiality of Gcp, the gene product encoded by PA0580 and showed 
that its depletion resulted in pleiotropic effects with unusual cellular morphologies. We speculated 
that the role of Gcp in P. aeruginosa could be the same as YgjD in E.coli [29], i.e. an involvement 
in producing the t6A modification. This can be crucial for translation of several proteins and Gcp 
depletion could lead to an impairment of cell cycle progression. Moreover, the results presented 
above suggest that also YeaZ, a supposed partner of Gcp, plays a critical role in the viability of P. 
aeruginosa. To our knowledge, this represents the first report where both P. aeruginosa Gcp and 
YeaZ proteins were purified and their homodimeric nature was described. Further investigations 
will be required to unravel the role of Gcp and YeaZ in P. aeruginosa. YeaZ and Gcp are sequence-
related proteins, sharing 30% identity within their first 100 amino acids. While at least one copy of 
the gcp gene is found in the genome of every sequenced organism to date, yeaZ shows a different 
distribution, being present uniquely in bacteria. Therefore, YeaZ by itself, or its interaction with 
Gcp, could better represent a novel target for the development of innovative anti-Pseudomonas 
agents. 
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Figure 1. Insertional mutagenesis assay. Each indicated locus was targeted for knock-out by 
homologous recombination-mediated cointegration of the suicide vector pDM4 carrying 
chloramphenicol resistance (CmR). The dnaG gene and the algR gene were used respectively as 
positive and negative controls of essentiality. DNA fragments about 300-500 bp of gcp (PA0580), 
tgpA, dnaG and algR, respectively, were amplified by PCR and cloned into the corresponding site 
of pDM4. pDM4 derivatives obtained were transferred from E. coli CC118-λpir to P. aeruginosa 
PAO1 by triparental mating selecting exconjugant PAO1 clones carrying pDM4 cointegration on 
PIA plates supplemented with Cm. Three independent conjugation experiments were performed. 
Efficiency of cointegration in a given locus is expressed as a percentage of CmR ex-conjugant 
colonies relative to the negative control algR.  
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Figure 2. Conditional lethal phenotype of the rhamnose-dependent mutant PAO1 PrhaB::gcp. 
(A) The rhamnose inducible/glucose repressible promoter PrhaB was inserted upstream to gcp giving 
rise to PAO1 PrhaB::gcp strain. To test the repression effects of glucose on growth rate, overnight 
cultures of PAO1 PrhaB::gcp in M9-citrate supplemented with rhamnose were centrifuged, pellet 
washed, resuspended and bacterial cells were adjusted to an optical density OD600 of 1.0 and 
serially diluted up to 10-6. 200 μl aliquots of PAO1 PrhaB::gcp were inoculated in microtiter wells in 
M9-citrate-rhamnose and M9-citrate-glucose and incubated for 22 hours. Culture growth at 37° C 
with stirring was monitored in real-time by OD600 measurement in a microtiter reader every 15 
minutes. Note specificity of glucose/rhamnose effects on the growth of PAO1 PrhaB::gcp and 
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especially how glucose does not interfere in any way with the growth of wild type strain while, on 
the contrary, completely inhibits growth of PAO1 PrhaB::gcp. (B) Overnight cultures of PAO1 
PrhaB::gcp in M9-citrate supplemented with rhamnose were also tested for growth on solid M9-
citrate supplemented with either rhamnose or glucose, by spotting 2 μl of 10-fold serial dilutions, 
from OD600 = 1 (left) to OD600 = 10-6 (right). In the first lane is shown the control strain PAO1 wild 
type that, as in the previous experiment in liquid medium, is not influenced by the presence of 
glucose. Conversely, PAO1 PrhaB::gcp is able to grow only in plates supplemented with rhamnose 
but not with glucose as expected for a mutant with essential gene under the control of rhamnose 
promoter. Complementation in trans of mutant PAO1 PrhaB::gcp with recombinant plasmid 
pHR6HT-Gcp (PAO1gcpC) restored its ability to grow on glucose while the same mutant carrying 
the empty vector pHERD20T could not grow in the presence of repressor. (C) During the first 6 hrs 
from inoculum, a time window in which growth rate was undetectable by microtiter reader, the 
growth of PAO1 PrhaB::gcp in liquid M9-citrate supplemented with either rhamnose or glucose was 
monitored by titration of colony-forming units per ml (CFU/ml) on LB plates. 
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Figure 3. Cells depleted of Gcp display unusual morphologies. (A) Transmission electron 
micrographs of strain PAO1 PrhaB::gcp after growth in LB containing rhamnose. Note that, as 
expected, no unusual morphologies are displayed. (B) Transmission electron micrographs of strain 
PAO1 PrhaB::gcp after growth in LB containing glucose. Several growth defects are shown such as 
dead empty cells, elongated cells, anomalies in septum formation, "rough" outer membrane and lack 
of outer membrane vesicles. 
123
Figure 4. Analytical gel-filtration assay. A 2 ml aliquot of purified Gcp was analyzed with a 
HiLoad 16/600 Superdex 75 pg (GE Healthcare) column. The protein eluted predominantly as a 
single peak after gel filtration, corresponding to molecular masses of 75 kDa which was really close 
to the estimated masses for dimeric (74,5 kDa) form of N-(His)6-tagged Gcp. 
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Figure 5. Protease and ATPase activity of Gcp purified protein. (A) (His)6-Gcp purified protein, 
(20 µg/ml), has been tested for its protease activity at pH7.0. The assay provides a FRET-based 
method for the simple and accurate quantitation of a wide range of protease activities. The 
magnitude of the resultant signal (fluorescence at 485/525 nm) is proportional to the degree of 
substrate cleavage, and can therefore be used to quantitate the enzyme activity. (B) The ATPase 
activity was assessed using a commercial kit that, also in this case, allows quantification of the ATP 
present in the reaction correlating it with the fluorescence emitted (fluorescence at 485/525 nm). As 
a consequence, lower fluorescence correspond to higher ATPase activity. Gcp, compared to the 
control in which it was previously denatured and inactivated, shows greater activity estimated at 
approximately 15%. 
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Figure 6. Characterization of yeaZ (PA3685): a Gcp putative partner. (A) Insertional 
mutagenesis assay. Each indicated locus was targeted for knock-out by homologous 
recombination-mediated cointegration of the suicide vector pDM4 carrying chloramphenicol 
resistance (CmR). The dnaG gene and the algR gene were used respectively as positive and 
negative controls of essentiality. Three independent conjugation experiments were performed. 
Efficiency of cointegration in a given locus is expressed as a percentage of CmR ex-conjugant 
colonies relative to the negative control algR. (B) Genetic organization and transcription analysis 
of the genomic region including PA3685 locus. PA3685-3684-3683 gene cluster is represented 
according to visualization by GBrowse in PGD. Locations of oligo pairs (Roman numbers) 
used in RT-PCR-based transcription analysis are shown along the region map. Total RNA 
extracted from PAO1 exponential phase was 
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analyzed by RT-PCR. RT untreated samples (RT-) as controls of genomic DNA contamination 
were included in the analysis. (C) Analytical gel-filtration assay. A 2 ml aliquot of purified YeaZ 
was analyzed with a HiLoad 16/600 Superdex 75 pg (GE Healthcare) column. The protein eluted 
showed a single peak elution, corresponding to molecular masses of 51 kDa which was close to the 
estimated masses for dimeric (49.7 kDa) form of N-(His)6-tagged YeaZ. 
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Figure S1. (A) Schematic representation t6A modification. On the left is a pictured an anticodon 
loop of tRNA carrying NNU anticodon and an mRNA molecule carrying ANN codon. Adenosine at 
position 37 is indicated in white circle. On the right is the chemical structure of t6A-modified 
nucleoside. Chemical groups originating from threonine or carbonate are indicated in grey and bold, 
respectively. (B) Proposed reaction scheme leading to t6A biosynthesis. First step requires 
activation of bicarbonate to carboxy-AMP, then a condensation of carboxy-AMP with threonine 
occours to generate carbamoylthreonine. Carbamoylthreonine is subsequently activated to 
threonylcarbamoyladenylate and transfered to Gcp active site where second condensation reaction 
occurs to form t6A-modified tRNA. 
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Figure S2. Inserts orientation and organization. PAO1 genomic region targeted (coordinates 
640687 to 639995) by insert carried by pHERD-S1E2 is pictured as annotated in PGD GBrowse. In 
the first row below the genomic region is illustrated S1E2 insert. It targets in sense PA0581 (from 
569 to 302 positions) and in antisense PA0580 (from 1026 to 680 positions). In the second row is 
illustrated the sub-cloned E2-Agcp insert. It was cloned downstream to the PBAD promoter of 
pHERD20T in antisense orientation spanning between 680 and 1026 bps of PA0580. 
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Figure S3. Sequence alignment analysis of Gcp putative partners in P. aeruginosa. TsaB, TsaC 
and TsaE protein sequences were obtained from EcoCyc database and aligned in the NCBI BlastP 
suite (Organism = Pseudomonas aeruginosa PAO1 - taxid:208964) to trace back the corresponding 
PAO orthologs. Sequence alignments were performed with Clustal Omega and output files analyzed 
with Jalview generating alignment images for TsaB (A) TsaC (B) and TsaE (C). Conservation is 
measured as a numerical index reflecting the conservation of physico-chemical properties in the 
alignment: Conservation is visualised as a histogram giving the score (from 0 to 11) for each 
column below them. Conserved columns are indicated by '*' (score of 11) and columns with 
mutations where all properties are conserved are marked with a '+' (score of 10, indicating all 
properties are conserved). 
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Table S1: List of bacterial strains and plasmids. 
Strains or plasmids Genotype or description Reference 
Pseudomonas aeruginosa 
PAO1 [1] 
PAO1 PrhaB::gcp PA0580(gcp) under the control of the 
rhamnose-dependent promoter PrhaB 
This work 
PAO1gcpC PAO1 PrhaB::gcp complemented with 
pHR6HT-Gcp 
This work 
Escherichia coli 
JM109 recA1 endA1 gyrA96 thi hsdR17 supE44, 
relA1, Δ(lac-proAB) F’ (traD36, proAB+ lacIqZ 
ΔM15) 
[2] 
HB101 [RK2013] recA, thi, hsdR, hsdM, proA, leu, strA [3] 
S17-λpir TpR SmR hsdR pro recA RP4-2-Tc::Mu-
Km::Tn7 (λpir) 
[4] 
M15 [pREP4] NaIS,StrS,RifS, Thi-, Lac-, Ara+, Gal+, Mtl-, F-, 
RecA+, Uvr+, Lon+ 
[5] 
C118-λpir araD139 Δ(ara leu)7697 ΔlacX74 phoA20 galE 
galK thi rpsE rpoB araEam recA1 (λpir) 
[6] 
Plasmids 
pHERD20T AmpR, CbR broad-host-range araC-Pbad 
expression vector; blue/white screening for 
recombinants 
[7] 
pHERD-S1E2 pHERD20T harbouring a fragment spanning 
coordinates 640687 to 639995 of PAO1 
chromosome 
[8] 
pHERD-E2-Agcp pHERD20T harbouring a fragment spanning 
position 680 to 1026 of PA0580 cloned in 
antisense direction 
This work 
pHR6HT-Gcp pHERD20T harbouring 6xHis-tagged Gcp 
protein, RBS and terminator from pQE30 
This work 
pQE30 AmpR, CmR ,expression vector with phage T5 
promoter, N-terminus 6xHis-tag,  two strong 
transcriptional terminators   
Qiagen 
pQE30-Gcp pQE30 harbouring position 1 to 1026 of gcp 
within the MCS 
This work 
pQE30-YeaZ pQE30 harbouring position 1 to 888 of PA3685 
within the MCS 
This work 
pDM4 CmR, suicide plasmid in Pseudomonas spp, 
pBR322 origin of replication, sacB 
[9] 
pDM4-algR pDM4 harbouring position 22 to 610 of algR 
within the MCS 
[10] 
pDM4-dnaG pDM4 harbouring position 12 to  422 of dnaG 
within the MCS 
[10] 
pDM4-PA2873 pDM4 harbouring position 590 to 1392 of 
PA2873 within the MCS 
[10] 
pDM4-PA0580 pDM4 harbouring position 20 to 345 of PA0580 
within the MCS 
This work 
pDM4-PA3685 pDM4 harbouring position 22 to 282 of PA3685 
within the MCS 
This work 
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pSC200 GmR, oriR6K, PrhaB rhamnose-inducible 
promoter, mob+ 
[11] 
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Table S2. Oligonucleotides. 
a Restriction enzyme sites are underlined 
b Oligo pairs used in the experiments shown in Figure 6. 
Oligo name Sequencea (5’→3’) 
RT-PCR oligo pairb 
PA3685/84 fw GAAGGCGTGGAGGCGGAA i // ii PA3685/84 rev CGTCGCGATACGGCGTGA 
PA3684/83 fw GATGTCCTCGGCCTCGACCT iii // iv PA3684/83 rev GGCATAGAAGGTGGTATTGC 
PA3685 Fw AGTCACTACGAGGTGATCCCG ** PA3683 Rev ATGCAGGAATACGTATGGAGTC 
PA3684 Rev TGGCGGTGGAGTTGTAGCTGG 
InsertPA3684Fw ATGTTAGTCGACGGCTAGAGTGTGGAG 
InsertPA3684Rev CAATAGTCGACAGGGCCATCGCCGCA 
PA3685 Fw AGTCACTACGAGGTGATCCCG 
pHERD-E2-Agcp construction and screening 
AgcpFw CGCGAATTCTCAGACCGCCGGCAGCGAC 
AgcpRev CGCAAGCTTCTGGCAGCGTTGCGTCGA 
pHERD-Fw ATCGCAACTCTCTACTGTTTCT 
pHERD-Rev TGCAAGGCGATTAAGTTGGGT 
pQE30-ORFs construction and screening 
GcpFULLfw CGGACTGGATCCCGCGTGCTGGGACTG 
GcpFULLrev CGGACTAAGCTTTCAGACCGCCGGCAG 
YeaZFULLfw CTAAGGATCCTCCACTCTGTTGGCCC 
YeaZFULLrev CGACAAGCTTTCAGGGCGCTTTTTC 
pQE30-RBS-Fw GTGAGCGGATAACAATTTCAC 
pQE30-Sal-rev GTAACTGTCGACGCTCCTGAAAATCTC 
pQE30-fw CCCGAAAAGTGCCACCTG 
pQE30-rev GTTCTGAGGTCATTACTGG 
pDM4-ORFs construction 
pDM4-0580-fw CGAATCGTCGACAAACGTCCTGCGACGAA 
pDM4-0580-rev TCATAGGTCGACGTGCCCTTCCATGTGGT 
pDM4-3685-fw CGAAGTCGACGATACCTCCACCGAA 
pDM4-3685-rev CGAAGTCGACGGAGACCGCCAGTAC 
pDM4-2873-fw GAAAGTCGACTCTCGGAGAGCATGGC 
pDM4-2873-rev GAACGTCGACGCTCAGCCAGCC 
pDM4-algR-fw GAAAGTCGACGAACCTCTGGCGCG 
pDM4-algR-rev GAAAGTCGACCAGCGCGTTGCGG 
pDM4-dnaG-fw GAAAGTCGACGATACCGCAAAGCTTCATCG 
pDM4-dnaG-rev GAAAGTCGACGGCCCTTCAGGTAGTTCACC 
pDM4-ori GTGACACAGGAACACTTAACG 
pDM4-cat TGTCCCTCCTGTTCAGCTAC 
pSC200-PA0580 construction 
gcp-psc-fw CCGGCACATATGCGCGTGCTGGGA 
gcp-psc-rev CCGGCATCTAGAGAAGGCCATCGC 
pSC200-824(fw) GCCCATTTTCCTGTCAGTAACGAGA 
pSC200-1400(rev) TAACGGTTGTGGACAACAGCCAGGG 
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Table S3. Sequence alignment analysis and relative scores of putative P.aeruginosa Gcp 
partners. 
Strain Score 
E.coli P.aeruginosa Coverage E-Value Identities 
TsaB hypothetical protein PA3685 96% 6,00E-63 49% 
TsaC hypothetical protein PA0022 92% 3,00E-50 52% 
TsaE hypothetical protein PA4948 98% 6,00E-58 58% 
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